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Summary 
 
The process of alternative polyadenylation (APA) is a widespread gene 
regulatory mechanism that generates mRNAs with different 3’ ends, allowing 
mRNAs to interact with different sets of RNA regulators such as microRNAs and 
RNA-binding proteins. Recent studies have shown that during development in 
both insects and mammals, mRNAs with extended 3’ UTRs are restricted to the 
nervous system suggesting that extended 3’ UTRs might play important roles 
during the formation and function of the nervous system. With its powerful 
genetics Drosophila emerges as an excellent system to study the molecular 
mechanisms and biological roles of APA within the physiological context of neural 
development. Much of the work is centred in the roles of the Cleavage Factor I 
(CFI) complex, because (i) is the complex with the highest evolutionary 
conservation between humans and Drosophila, (ii) it is expressed at very high 
level in neural tissues, and (iii) has a well-established structure and function in 
mammalian cells. Through the combination of genetic, molecular and genomic 
databases, I first show that the cleavage and polyadenylation (CPA) machinery 
in Drosophila is as complex as its human counterpart and shows an enrichment 
of expression in the nervous system. Secondly, using a suite of genetic and 
behavioural methods, I show that a mutation in the Drosophila orthologue of 
CFI25 affects feeding in the Drosophila larvae and is required for major 
developmental transitions. Third, I explore the mechanisms by which APA is 
controlled in the developing nervous system by CFI factor depletion. As a result 
of this, genes with reported neural 3’ UTR extensions change their patterns of 
APA. Altogether, this work adds to the current understanding of the phenomenon 
of APA within the nervous system and gives new insights on the biological roles 
of CPA factors for behaviour and neural function.  
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Many people would accept that we do not really have knowledge of the world; we 
have knowledge only of our representations of the world. Yet we seem 
condemned by our constitution to treat these representations as if they were the 
world, for our everyday experience feels as if it were of a given and immediate 
world 
 
Francisco Varela 
In The Embodied Mind 
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Chapter 1  
General Introduction 
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1.1 Preface 
A central question in modern biology is how the nervous system is formed. 
Recent experiments have shown that the complexity of neural tissues is 
correlated to pervasive post-transcriptional modifications. For example, it has 
been shown that alternative splicing (AS), in which exons are included or 
excluded in a tissue-specific way and therefore different proteins are produced 
(Chen and Manley 2009), is particularly widespread in the mammalian nervous 
system, where neural-specific protein isoforms are expressed in this tissue to 
contribute to its functional complexity (Raj and Blencowe 2015). Furthermore, 
these specific patterns of AS within the nervous system can be achieved by RNA-
Binding proteins (RBPs) that are also specifically expressed in this tissue 
(Licatalosi et al. 2012). Similarly, other regulators of gene expression, such as 
microRNAs (miRNAs) can also play neural-specific roles by restricted expression 
in this tissue and thus targeting neural genes (Kapsimali et al. 2007; Wheeler et 
al. 2006). Finally, transcription factors also play important roles for the patterning 
and functioning of the nervous system in both vertebrates and invertebrates. A 
good example of this are the Hox genes, which have an important role for cell-
specification along the anteroposterior axis in bilateral animals (Krumlauf et al. 
1993) and show neural-specific mRNA processing events, such as 3’ UTR 
extensions achieved by alternative polyadenylation (APA), a phenomenon 
discovered in Drosophila (Thomsen et al. 2010; Rogulja-Ortmann et al. 2014). 
APA therefore can control mRNA localization, stability and translation efficiency 
by differential 3’ UTR expression (Di Giammartino et al. 2011). Interestingly, as I 
will discuss in detail in this study, shortly after the first reports of Hox-neural 3’ 
UTR extensions, this phenomenon was far from being an oddity of these category 
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of key developmental genes. Instead, hundreds of genes were shown to display 
drastically long 3’ UTRs during neural development in Drosophila (Thomsen et 
al. 2010; Hilgers et al. 2011; Smibert et al. 2012) and thousands of genes in 
mammals (Miura et al. 2013). Implying that the nervous system, perhaps contrary 
to other tissues, relies enormously in RNA processing events to be able to 
develop and function in a reproducible way.  
Although the general-consensus explanation for the biological meaning of these 
3’ UTR extensions is based on differential targeting by trans-acting factors - such 
as miRNAS and RBPs - it is evident that this is hardly the full reason when 
considering the extent at which RNA PolII can bypass termination sites that in 
theory should fulfil these conditions (with modest extensions of less than 1 kb 
(Patraquim et al. 2011)) but instead produce extensions of up to 12 kb (Hilgers 
et al. 2011). These observations point to the question: How is alternative 
polyadenylation controlled during neural development and what are its biological 
roles? 
The following work addresses the molecular mechanisms that control APA and 
its biological roles during Drosophila neural development. For this, I identify the 
factors that control mRNA 3’ processing in Drosophila, and then analyse their 
expression in different tissues and developmental stages in order to test a 
prevalent model that proposes the abundance of cleavage and polyadenylation 
(CPA) factors within cells trigger the selection of alternative polyadenylation sites 
(PAS) in pre-mRNAs (Takagaki et al. 1996).  
Given that most studies that have tested the aforementioned model were 
performed in vitro in cells in culture, I explore the expression of CPA factors 
during the formation of the nervous system to look for the mechanisms that 
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control neural APA. Further, I focus in the most conserved cleavage and 
polyadenylation complex subunit between Drosophila and humans: Cleavage 
factor I (CFI), analysing its role not only for APA within the nervous system, but 
also for behaviour.  
In this chapter, I will first introduce the concept of RNA 3’ termination and its 
discovery; second, I will present the discovery of factors that control both 
cleavage and polyadenylation and describe them in terms of structure and 
function; third, I will describe the concept of alternative cleavage and 
polyadenylation and reported cases that showcase its biological roles; fourth, I 
will discuss the models that have been proposed to explain the mechanisms 
controlling APA; and finally, I will discuss in detail the phenomenon of extensive 
3’ UTR extensions in the nervous system. 
1.2 Discovery of mRNA polyadenylation in eukaryotic cells 
The first pieces of evidence about enzymes that were able to synthetize 
polynucleotides came from the 1950s by Severo Ochoa and colleagues. They 
reported an enzyme from the microorganism Azotobacter vinelandii, a gram-
negative bacterium used to study nitrogen fixation that was able to synthetize 
highly polymerized polynucleotides from 5’-nucleoside diphosphates in a reaction 
that required Mg++. Furthermore, these polynucleotides were shown to be made 
of 5’-nucleoside units linked to one another through 3’-phosphoribose ester 
bonds. Interestingly, the synthetized polynucleotides had a biochemistry 
indistinguishable from that of natural RNA (Grunberg-Manago et al. 1956; 
Grunberg-Manago et al. 1955). Following this discovery, Arthur Kornberg and 
colleagues revealed that this process was also reversible and showed this in the 
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model microorganism Escherichia coli (Littauer and Kornberg 1957). Although 
the work of Severo Ochoa and Arthur Kornberg during the late 1950s about the 
mechanisms of the biological synthesis of ribonucleic and deoxyribonucleic acids 
led them to win the Nobel Prize in Physiology or Medicine in 1959, the biological 
meaning of RNA polynucleotides within the cell remained unclear. 
During the next decade it was reported for the first time that an enzyme extracted 
from calf thymus nuclei was able to synthetize a sequence of adenylate units from 
ATP, which was acid-insoluble and required Mg++ for its polymerization activity. 
Apart from being the first report of this process in mammalian cells, this was the 
first study that proposed the existence of these poly(A) polymers at the end of 
endogenous RNA molecules and that they were tightly bound to proteins 
(Edmonds and Abrams 1960). Nonetheless, the potential relevance and roles of 
mRNA polyadenylation as post-transcriptional modifications in 3’-ends of most 
transcripts of eukaryotic cells were not uncovered until another decade later. In 
the 1970s it was confirmed by several groups that poly(A) sequences were found 
in RNA extracted from HeLa cells and mouse sarcoma 180 cells. These long 
poly(A) sequences made this fraction of the RNA resistant to RNAse treatment 
and were not present in the translated proteins. Reasonably, it was proposed that 
these regions were relevant for translation and could act as binding sites for other 
proteins (Darnell et al. 1971; Lee et al. 1971; Edmonds et al. 1971). It was also 
proposed that a Poly(A) Polymerase (PAP), such as the one described 10 years 
earlier, could be the enzyme catalysing these reactions in vivo (Edmonds and 
Abrams 1960). Finally, the first mechanisms by which poly(A) tails were added to 
mRNA 3’-ends during transcription were elucidated. To the surprise of the 
scientific field, in which it was generally assumed that 3’end termination occurred 
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simply by transcriptional termination per se, it was shown by experiments with 
viral RNA that RNA PolII proceeds past the signals for 3’-end termination to be 
subsequently cleaved and polyadenylated. Thus, CIS elements within the RNA 
molecule were postulated to exist that are interpreted by the cell for cleavage and 
addition of poly(A) by a PAP and this was shown to occur before mRNA splicing 
(Ford and Hsu 1978; Manley et al. 1982; Nevins and Darnell 1978). Remarkably, 
the presence of more than one signal within RNA molecules to be selected for 3’-
end termination was already proposed in these studies from the 1970s and early 
1980s. However, the factors that control 3’-end processing, the specific CIS 
elements within RNAs that control cleavage and polyadenylation and the concept 
of alternative cleavage and polyadenylation with its associated implications still 
remained unknown. 
Nowadays it is known that RNA polyadenylation is shared among Eukarya and 
the only genes which are cleaved, but not polyadenylated, are replication-
dependent histone mRNAs (Dávila and Samuelsson 2008; Marzluff et al. 2008). 
Instead of having a poly(A) tail, these pre-mRNAs contain an RNA stem-loop 
structure close to their 3’ end, which is recognized by the U7 snRNP and proteins 
such as Stem-loop binding protein (SLBP), together with a subset of factors from 
the canonical 3’ end machinery  (Dávila and Samuelsson 2008), which will be 
discussed in the next section. On the other hand, the primary structure and 
biochemical characterization of the bovine PAP was done in 1991 by both James 
Manley and colleagues and by Elmar Wahle independently ( Manley et al. 1991; 
Wahle 1991b). It was not until the year 2000 that the crystal structure of the 
mammalian PAP was resolved (Martin et al. 2000). As a result, the key domains 
for its function were described: It has an N-terminal catalytic domain which 
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polymerises adenosines using ATP as a substrate and an RNA-Binding region 
that overlaps with a nuclear localization signal (NLS) near the C-terminus. 
Additionally, vertebrates have an extra region towards the C-terminal domain 
which is rich in serines and threonines, making it a target for post-translational 
modifications, such as phosphorylation at multiple sites (Martin et al. 2000).  
During recent years, studies addressing the question on the biological meaning 
of mRNA polyadenylation within cells have made enormous progress since the 
first reports on this process in the 1960s. For example, it has been shown that 
the median length of the poly(A) tail is a property conserved among different 
species, with mammalian cells having 69-96 nucleotides, plants (Arabidopsis 
thaliana) and Drosophila S2 cells having 50-51 nucleotides, and budding 
(Saccharomyces cerevisiae) and fission (Schizosaccharomyces pombe) yeast 
having 27 and 28 nucleotides. What is more, the length of the poly(A) tails are 
conserved between orthologous mRNAs (Subtelny et al. 2014). In terms of 
function, it has been shown that the length of the poly(A) tail is tightly regulated 
during the somatic cell cycle and controls translation efficiency. For example, the 
cell-cycle regulatory genes CDK1, TOP2A and FBXO5 present a dramatic 
decrease in the length of their poly(A) tail which represses their translation during 
M-phase (Park et al. 2016). In this same study, the authors show that for genes 
to be able to escape this translational repression observed in M-phase, a terminal 
oligopyrimidine (TOP) tract is required at the end of their poly(A) tail. Lastly, the 
length of the poly(A) tail has been shown to be coupled to translational efficiency 
during the early development in zebra fish (Danio rerio) and in frogs (Xenopus 
laevis) embryos. However, after gastrulation, this coupling diminishes and goes 
to the point of being absent in non-embryonic tissues, highlighting the role of 
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poly(A) tails to work as a developmental switch for translational control during 
early embryogenesis (Subtelny et al. 2014). 
1.3 Protein factors and RNA CIS elements that control mRNA 3’-end 
cleavage and polyadenylation 
In the previous section we discussed the discovery of mRNA polyadenylation as 
a general post-transcriptional modification observed across all eukaryotes. Also, 
I showed that the first pieces of evidence about one of the members of what is 
now known as the “Cleavage and Polyadenylation” (CPA) machinery was 
discovered almost 60 years ago: the Poly(A) polymerase (PAP)  (Edmonds and 
Abrams 1960). In this section I will discuss all the other factors that control 3’-end 
formation and briefly their structure and how they work, according to the latest 
studies in this emerging field in modern biology.  
The first members of the mammalian cleavage and polyadenylation (CPA) 
machinery were initially discovered by biochemical fractionation approaches in 
the late 1980s (Gilmartin and Nevins 1989; Takagaki et al. 1989). In a study 
conducted by James Manley and colleagues in 1988 (Takagaki et al. 1988), the 
authors provided evidence for the existence of a “cleavage/specificity” factor 
(CSF) that could efficiently cleave SV40 late pre-mRNAs at a poly(A) addition site 
and that this factor could be separated chromatographically from PAP. 
Interestingly, while isolated PAP could perform its functions in vitro only in a non-
specific manner, addition of CSF caused it to function in a sequence-specific way 
by requiring the signal “AAUAAA”. This sequence was shown several years 
earlier by Nick Proudfoot and George Brownlee to be present in a variety of RNA 
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molecules about 20 nucleotides from the poly(A) tail (Proudfoot and Brownlee 
1976) and now is known as the Polyadenylation signal (PAS). 
After the description of CSF in this study from 1988, James Manley and 
colleagues showed that CSF could be further fractionated into four different 
subunits. The first one, known as “Specificity factor” (SF), was required for both 
specific cleavage and for specific polyadenylation. Two other factors, coined as 
“cleavage factors I and II” (CFI and CFII) were sufficient for accurate cleavage of 
pre-mRNAs when mixed with SF. The last factor, coined as “Cleavage stimulation 
factor” (CSTF), enhanced the efficiency of the cleavage reaction significantly 
when added to a mixture with the other three factors. Furthermore, none of these 
factors contained or required RNA components for their function, apart from the 
substrate pre-mRNA itself. Finally, PAP was shown to be a necessary component 
to cleave several other pre-mRNAs, apart from the one tested (Takagaki et al. 
1989). Since the early 1990s, it was shown that each one of these factors 
discovered in 1989 was made of more subunits: CSF was re-named to “Cleavage 
and polyadenylation specificity factor” (CPSF) and shown to be made of four 
subunits of 160, 100, 73 and 30 kDa after purification and fractionation from calf 
thymus. This multisubunit CPA complex was also shown to bind to the poly(A) 
signal “AAUAAA” and be required for both cleavage and polyadenylation 
(Bienroth et al. 1991; Murthy and Manley 1992). More than a decade later, 
another member of CPSF was described in human cells (HeLa), Fip1 (Kaufmann 
et al. 2004). Intriguingly, although the presence of an endonuclease was required 
to be part of the CPA machinery to cleave the pre-mRNA substrates, its identity 
was not uncovered until 2006, when it was revealed to be also member of CPSF 
(CPSF73) (Mandel et al. 2006), a result consistent with the evidence for CPSF 
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as required for cleavage. Additionally, another factor from CPSF was discovered 
in even more recent years, such as WDR33 in 2009 (Shi et al. 2009).  
To summarise, the current information about CPSF shows that is composed of 
six subunits: CPSF160, CPSF100, CPSF73, CPSF30, Fip1 and WDR33. 
CPSF160 is the largest subunit. In mammals, it is composed of tandem WD40 
repeats clustered into three major β-propellers (Neuwald and Poleksic 2000) and 
can be UV-crosslinked to pre-mRNAs in a poly(A) signal (PAS)-dependent 
manner (Keller et al. 1991). The mammalian CPSF100 is similar to CPSF73 in 
structure, both belonging to the β-CASP family (Callebaut et al. 2002), but while 
CPSF73 acts as a hydrolase in coordination with metal ions (Mandel et al. 2006), 
CPSF100 does not have functional motifs to bind zinc ions, making this factor 
incapable of catalysis (Dominski et al. 2005). CPSF30 is the smallest CPSF 
subunit and in mammals consists of five CCCH zinc finger motifs and a CCHC 
zinc knuckle motif at its C terminus, which is absent in its yeast homolog Yth1 
(Puck et al. 1997). Fip1, as mentioned earlier, was discovered in 2004 and stably 
associates with all other members of CPSF, being required for both cleavage and 
polyadenylation (Kaufmann et al. 2004). The human version is almost twice as 
large as its yeast counterpart and is similar in domain organization only towards 
its acidic N-terminus (Preker et al. 1995). This version  also has an arginine-rich 
RNA-Binding Motif towards its C-terminus that binds preferentially to U-rich 
sequence elements within pre-mRNAs, which yeast do not have (Kaufmann et 
al. 2004). Lastly, WDR33, as mentioned earlier, was the last component of CPSF 
discovered (Shi et al. 2009). Although its exact molecular function is not well 
understood, its structure has been described in mammals as having an N-
terminal WD40 domain, a middle collagen-like domain, and a C-terminal glycine-
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proline-arginine (GPR) domain (Ito et al. 2001). A representation of the domain 
architecture of the members of CPSF in humans is shown in Figure 1.1. 
Of the four previously described original components required for cleavage and 
polyadenylation presented in 1989 by James Manley and colleagues (CSF, 
CSTF, CFII and CFII) (Takagaki et al. 1989), CSTF was shown to be composed 
of three subunits of 77, 64 and 50 kDa and was required for efficient cleavage of 
pre-mRNA substrates (Takagaki et al. 1990). CSTF77 is the largest subunit of 
CSTF and bridges CSTF64 (which binds RNA) with CSTF50 (which interacts with 
other proteins). The molecular structure of CSTF77 shows a HAT (Half a TPR) 
domain towards its N-terminal, which has been involved in RNA processing 
(Preker and Keller 1998). The molecular structure of this domain in mice shows 
that CSTF77 can dimerize through the HAT domain (Bai et al. 2007), which 
makes the whole CSTF complex work as a dimer, with two of each one of its 
components. In the aforementioned study that described the CSTF complex in 
1990 (Takagaki et al. 1990) the authors show that CSTF64 could be UV-
crosslinked with “AAUAAA” containing RNAs, similarly as the case for CPSF160 
(Keller et al. 1991). CSTF64 was later shown to bind pre-mRNAs in U-rich 
sequences downstream of the PAS and be able to influence the site of cleavage 
by CPSF (MacDonald et al. 1994). 
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Figure 1.1 Domain organization of the human CPSF subunits 
Diagram of the organization of domains of the six different members of CPSF in 
humans. N-terminal is to the left and C-terminal is to the right. “MβL” stands for 
“metallo-β-lactamase domain”. “ZF” stands for “Zinc Finger domain”. “ZincK” 
stands for “Zinc Knuckle Motif”. “RD” means “Arginine and aspartate rich 
domain”. “R” means arginine-rich domain. And “GPR” means “glycine-proline-
arginine domain”. Diagram taken from (Xiang et al. 2014). 
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Three years later, it was shown that this U-rich sequence, which could also be 
GU-rich, was the binding site for CSTF64 downstream of the PAS and was known 
as the “Downstream sequence element” (DSE) (Takagaki and Manley 1997). The 
molecular structure of CSTF64 showed an RNA Recognition Motif towards its N-
terminus and a repeated structure in its C-terminal region in which a pentapeptide 
sequence (MEARA/G) is repeated 12 times. Also, a segment of approximately 
270 amino acids surrounds this repeat and is highly enriched in proline and 
glycine (Takagaki et al. 1992). CSTF50 is the smallest subunit of CSTF and is 
only existent in metazoans. Similarly to CSTF77, it contains an N-terminal 
dimerization domain and seven WD40 repeats in its C-terminal, further 
supporting the role of the CSTF complex as a dimer (Takagaki and Manley 2000). 
A representation of the domain architecture of the members of CSTF in humans 
is shown in Figure 1.2. 
The CFI complex was purified and biochemically characterized in 1996 
(Ruegsegger et al. 1996). In mammals, it is composed of four subunits: CFI25, 
CFI68, CFI59 and CFI72. While CFI59 is a mammalian paralog of CFI68, CFI72 
is an isoform of CFI68 (Ruepp et al. 2011). The CFI complex, which is also only 
present in metazoans, also acts as a dimer, with two CFI25 units and two CFI68 
units (or CFI59 or CFI72). Nonetheless, both CFI59 and CFI72 are functionally 
redundant with CFI68 (Ruegsegger et al. 1998). Although we will discuss the 
structure and roles of CFI in detail in subsequent chapters in line with 
experimental results, we can mention that CFI binds to RNA even in the absence 
of the already mentioned “AAUAAA” hexamer, which works as the canonical 
PAS. Furthermore, CFI was described as a determinant of poly(A) site 
recognition in an PAS-independent manner by recruiting Fip1 and PAP to the  
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Figure 1.2 Domain organization of the human CSTF subunits 
Diagram of the organization of domains of the three different members of CSTF 
in humans. N-terminal is to the left and C-terminal is to the right. “HAT” stands 
for “Half a TPR”. “RRM” stands for “Rna Recognition Motif”. Diagram taken from 
(Xiang et al. 2014). 
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RNA substrate and acting during the initial stages of transcription (Venkataraman 
et al. 2005). This binding site for CFI was discovered by SELEX experiments and 
revealed to be UGUAN (N = A > U >= C/G) (Brown and Gilmartin 2003), which is 
located upstream of the PAS (contrary to the CSTF binding site “DSE” located 
downstream from the PAS). After the crystal structure of CFI25 in association 
with RNA was resolved, the authors showed that two “UGUA” elements are 
bound by each one of the CFI25 subunits at the same time, highlighting the 
potential regulatory roles of CFI25 for PAS selection, as we will soon discuss 
(Yang et al. 2010). The molecular architecture of the human CFI25 shows a 
central Nudix domain, which is a widespread family of proteins that act as 
pyrophosphohydrolases. CFI25 nonetheless presents changes in this catalytic 
domain causing the protein to be unable to function as a hydrolase. Instead, its 
Nudix domain is used to bind RNA, as well as CFI68 (Trésaugues et al. 2008; 
McLennan 2006). CFI25 also has an RNA-binding domain towards its N-terminal 
from the Nudix domain. Given that – as mentioned earlier - CFI25 acts as a dimer 
within the CFI complex with two UGUA sequences bound in an anti-parallel 
fashion (Yang et al. 2010), a model was proposed in which CFI25 binds UGUAs 
neighbouring different PAS selectively and loops out the pre-mRNA molecule, 
proposing a mechanism by which the process of alternative polyadenylation, 
which we will discuss in the next section, occurs at the molecular level (Yang et 
al. 2011). CFI68 on the other hand has a different architecture than CFI25: it has 
a proline-rich region in the middle and an RS domain towards its C-terminal. 
Interestingly, this features resemble the structure of splicing factors (Ruegsegger 
et al. 1998). What is more, CFI68 has been shown to interact with factors from 
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the splicing machinery including U1 snRNP and U2AF 65 (Awasthi and Alwine 
2003; Millevoi et al. 2006), bridging 3’ end processing with mRNA splicing.  
In addition to the domains present in CFI68 and absent in CFI25, CFI68 has an 
RNA Recognition Motif (RRM) in its N-terminal. Nonetheless, the affinity of this 
domain for RNA is rather weak, but it is enhanced after interaction with CFI25, in 
which each one of the CFI25 units binds one CFI68 through its RRM, forming a 
tetramer with both CFI25 and CFI68 proteins facing each other (Li et al. 2011). A 
representation of the domain architecture of the members of CFI in humans, 
together with the proposed mechanism for PAS selection, is shown in Figure 1.3. 
CFII is composed of two factors, Pcf11 and Clp1, and although this complex has 
not been fully characterized in mammals (because it has been mostly studied in 
yeast), there are studies covering their roles in human cells. For example, 
depletion of Pcf11 in HeLa cells was shown to reduce 3’-end termination 
efficiency. Also, evidence was provided for Pcf11 being required for degradation 
of the 3’ product after cleavage has occurred (West and Proudfoot 2008). The 
molecular structure of this complex in humans is not well understood, although it 
is known to be twice as large as its yeast counterpart and to have sequence 
homology at its N-terminal, where it has a “CTD Interacting Domain” (CID) (de 
Vries et al. 2000). Clp1 in humans is better studied than its partner Pcf11 and 
surprisingly, it shows diverse biological roles beyond 3’ end formation in humans. 
For example, Clp1 acts as a 5’-OH polynucleotide kinase and has been involved 
in the activation of siRNAs; these last molecules that are incorporated into the 
“RNA-induced silencing complex” (RISC) for gene silencing (Weitzer and 
Martinez 2007). 
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Figure 1.3 Domain organization of the human CFI subunits and model for 
PAS selection  
(Legend on the following page) 
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Figure 1.3 Domain organization of the human CFI subunits and model for 
PAS selection  
(A) Diagram of the domain organization in the two different members of CFI in 
humans. N-terminal is to the left and C-terminal is to the right. “RRM” stands for 
“Rna Recognition Motif”. “RS” means “arginine and serine domain”. Diagram 
taken from (Xiang et al. 2014). (B-C) Proposed model for alternative PAS 
selection by CFI (B). When the “Poly(A) site 1” is selected, the two closest UGUA 
elements are bound simultaneously by CFI in an antiparallel fashion, allowing 
CPSF to bind to the “AAUAAA” PAS sequence and CSTF to the DSE within this 
poly(A) site. (C) When “Poly(A) site 2” is selected, only the first UGUA element is 
bound by CFI, while the UGUA element neighbouring the Poly(A) site 2 is used 
(looping out all the mRNA elements between these two sequences, including the 
“Poly(A) site 1”). Thus, both the PAS and the DSE (to be bound by CPSF and 
CSTF) are used within “poly(A) site 2”. Diagram taken from (Yang et al. 2011). 
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Furthermore, Clp1 has also been shown to be involved in tRNA splicing (Ramirez 
et al. 2008). Regarding 3’ end processing, Clp1 interacts with components of 
CPSF and CFI, although its role as a kinase is not required for cleavage and 
polyadenylation (de Vries et al. 2000). Human Clp1 shows high sequence 
homology with its yeast counterpart, which has a central ATPase domain and two 
other smaller domain in its termini (de Vries et al. 2000). A representation of the 
domain architecture of the members of CFII is shown in Figure 1.4. The yeast 
members are shown because their structure has been fully described (which is 
not being the case for the human counterparts). 
So far, I have described the components that form part of each one of the 
complexes involved in cleavage and polyadenylation: CPSF, CSTF, CFI and 
CFII. I have also described briefly their function and structure in human cells, with 
the exception of CFII, which is much better studied in yeast. During the 1990s, 
more members of the CPA machinery were discovered, which do not form part 
of any of the above-mentioned complexes. In this work, we will categorize them 
as the “Non-Complex” group. One of the member of this group is PAP, which was 
already described in this Chapter.  
In 1996, a protein named “Symplekin” was described as being localized in the 
cytoplasmic face of the plaque associated with the tight junction-containing zone 
of polar epithelial cells and Sertoli cells from testis (Keon et al. 1996). Its 
association with the CPA machinery only came four years after, when it was 
shown to interact with the CSTF complex, more specifically with CSTF64 
(Takagaki and Manley 2000). Symplekin acts as a scaffolding protein, which 
bridges different components of the CPA machinery together (its name comes  
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Figure 1.4 Domain organization of the yeast CFII subunits 
Diagram of the organization of domains of the two different members of CFII in 
yeast. N-terminal is to the left and C-terminal is to the right. “CID” stands for “CTD 
Interacting Domain”. “Q20” means a consecutive glutamines domain. “C2H2” and 
C2HC” are Zinc Finger domains. Diagram taken from (Xiang et al. 2014). 
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from a Greek word that means “to tie together, to weave, to be intertwined”, 
coined in the cited study from 1996). Its structure presents binding domains for 
CPSF73 and CSTF64. Moreover, Symplekin binds to CSTF64 by competing with 
CSTF77 in a mutually exclusive manner, and while its interaction with CSTF64 is 
limiting for histone pre-mRNA processing, it is relatively unimportant for general 
cleavage and polyadenylation (Ruepp et al. 2011).  
The last core CPA factor that forms part of the “Non-Complex” group is PABPN1, 
which binds to the poly(A) tail and has a cytoplasmic counterpart named PABP. 
This last was discovered in 1973 (Blobel 1973). PABPN1 was instead discovered 
nearly 20 years later by Elmar Wahle (Wahle 1991a) (whom as mentioned earlier 
also characterized PAP independently from James Manley (Wahle 1991b)).  
In the first of these studies by Wahle, PABPN1 was shown to interact with CPSF 
and bind to the poly(A) tail in the nucleus. More specifically, a transition from a 
slow initiation phase of polyadenylation to rapid elongation occurred when the 
poly(A) tail was long enough to act as a binding platform for PABPN1. Thus, 
PABPN1 controls PAP efficiency. Also, Elmar Wahle correctly speculated that 
PABPN1 could control the length of the poly(A) tail (Wahle 1991a). Four years 
later, this same author demonstrated that the addition of either CPSF or PABPN1 
separately to a mix only gave moderate processivity to in vitro RNA 
polyadenylation reactions. However, when they acted together, a rapid addition 
of poly(A) was observed, reaching a limit of 200 to 300 nt (Wahle 1995).  
The molecular structure of PABPN1 shows that in contains a single RNA-
recognition motif (RRM), contrary to its cytoplasmic counterpart, which contains 
four. Furthermore, this RRM separates an arginine-rich C-terminal domain from 
an acidic N-terminal domain, which are essential for poly(A) binding and 
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stimulation of PAP, respectively (Ge et al. 2008). A representation of the domain 
architecture of the “Non-Complex” CPA factors in humans is shown in figure 1.5. 
Although it plays a much more general role in RNA transcription, the largest 
subunit of RNA PolII participates (among other processes) in 3’-end formation 
through its C-terminal domain (CTD) by interacting with CPA complexes such as 
CPSF and CSTF both in vivo and in vitro (Hirose and Manley 1998; McCracken 
et al. 1997). Pcf11, as I mentioned earlier, has a CID domain which also interacts 
with the CTD of RNA PolII, bridging 3’end processing with transcription (de Vries 
et al. 2000). A diagram representing the CPA machinery bound to RNA at its key 
CIS regulatory elements is shown in Figure 1.6. 
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Figure 1.5 Domain organization of the “Non-Complex” CPA factors in 
humans 
Diagram of the organization of domains of the three “Non-Complex” CPA factors 
in humans. N-terminal is to the left and C-terminal is to the right. “S/T-rich” means 
“Serine and threonine rich domain”. “E-rich” means “Glutamate rich domain”. 
“CC” stands for “Coiled-coil” domain. “RRM” stands for “RNA Recognition Motif” 
and “R-Rich” means “Arginine reach domain”. Diagram taken from (Xiang et al. 
2014). 
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Figure 1.6 Diagram of 3’-end cleavage and polyadenylation machinery and 
CIS regulatory elements in pre-mRNA 
Diagram of the CPA machinery with its complexes distinguished by colour code 
as described in section 1.3. The brackets indicate the name of each complex and 
the specific name of their subunits. At the bottom a pre-mRNA is represented as 
a grey rectangle: UGUA is the CFI binding site, PAS is the Poly(A) site bound by 
CPSF and DSE is the downstream sequence element bound. The cleavage site 
is depicted as scissors and located between the PAS and the Downstream 
Sequence Element (DSE). Note that both CSTF and CFI are shown with their 
subunits as dimers.  
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1.4 mRNA alternative polyadenylation and biological roles 
In the previous section I described the components that form part of the CPA 
machinery and their functions, as well as the main CIS regulatory elements within 
pre-mRNAs that dictate the site of cleavage and polyadenylation. As I showed in 
Figure 1.3 for CFI, pre-mRNAs can have more than one PAS with all its 
associated regulatory elements. Therefore, the CPA machinery will need to 
choose one of them to perform its function. As a result of this, mRNAs with 
different 3’ ends will be generated. This process is known as “Alternative 
Polyadenylation” (APA), and it will be discussed in this section, together with its 
biological roles.  
APA is a widespread phenomenon in eukaryotes, with nearly 70% of all human 
and mammalian genes displaying alternative 3’-ends isoforms (APA) (Derti et al. 
2012; Hoque et al. 2013).  In addition to this, approximately half of all genes in 
vertebrates such as the zebrafish and invertebrates such as C. elegans and 
Drosophila, also display alternative 3’-ends isoforms (Ulitsky et al. 2012; Smibert 
et al. 2012; Jan et al. 2011). Crucially, misregulation of 3’-formation and APA can 
lead to catastrophic consequences in the cell, and to diseases in humans such 
as cancer, thrombophilia and some thalassemias (Danckwardt et al. 2008; Erson-
Bensan and Can 2016). Thus, the correct orchestration of this process in 
eukaryotes is vital.  
As mentioned in the previous section, one of the main CIS regulatory elements 
required for cleavage and polyadenylation is the Poly(A) signal or PAS, whose 
canonical sequence is the hexamer “AAUAAA”, discovered in 1976 (Proudfoot 
and Brownlee 1976). This signal can be located within the 3’UTR region of a pre-
mRNA, generating isoforms with different 3’UTR length but coding for the same 
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protein. The signal can also be located in the coding sequence or introns of a 
pre-mRNA molecule, generating different protein isoforms (similarly to alternative 
splicing (Pan et al. 2008; Black 2003)). A representation of the two general types 
of APA is shown in figure 1.7.  
In the former case, it has been shown that 3’ UTRs act as binding platforms for 
trans-acting factors such as miRNAs and RBPs. In this way, a longer 3’UTR is 
able to undergo more regulation by such factors. For example, this was shown to 
be the case for the Hox genes in 12 Drosophila species, where the long and the 
short 3’UTRs of these key developmental genes contained very different miRNA 
target sites. Furthermore, although the level of sequence conservation in 3’ UTRs 
among the 12 species studied was low, the authors show similar RNA topology 
by in silico RNA folding simulations, indicating that the structure of 3’ UTRs was 
under high selective pressure (Patraquim et al. 2011).  
In the latter case, that of coding-sequence APA or APA within introns and exons, 
Poly(A) sites located upstream of the 3’UTR can change the protein coded in the 
affected genes, diversifying the transcriptome and proteome. For example, the 
gene Cyclin D1 is key for the cell cycle by regulating the progression from G1 to 
S phase. As a result of polymorphisms in human populations, one of the introns 
of Cyclin D1 can contain a PAS, and when this element is used for 3’-UTR 
termination it generates a shorter protein, which is constitutively nuclear and 
expressed at high levels. This short protein isoform has been related to several 
human cancers, including breast and prostate cancer (Knudsen et al. 2006; Burd 
et al. 2006; Wang et al. 2008). The selection of either short or long 3’ UTRs by 
APA can have a repertoire of functions in biology. For example, two cold-induced  
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Figure 1.7 Diagram of the two main categories of APA 
(A-B) Diagrams representing Coding Region APA (A) and 3’ UTR APA (B). 
Proximal and distal poly(A) sites are indicated by blue and red pins, respectively. 
Light green boxes represent UTRs. Light blue boxes represent shared coding 
regions. Dark blue and yellow boxes represent unshared coding regions and lines 
represent introns. Diagram taken and modified from (Di Giammartino et al. 2011). 
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RBPs, Cirbp and Rbm3, were shown to be important regulators for temperature-
entrained circadian gene expression cycles through APA. More specifically, the 
depletion of these proteins triggered the use of proximal PAS and shorter 3’ 
UTRs, whereas low temperature, which triggers and upregulation of both Cirbp 
and Rbm3, triggered the use of distal PAS and longer 3’ UTRs. Furthermore, the 
authors found that the use of either proximal or distal PAS in several genes 
regulated by these factors showed strong circadian oscillations. Thus, this study 
reveals an interesting connection between cyclic environmental cues and the 
control of gene expression through APA in mice (Liu et al. 2013).  
At the molecular level, the selection of either short or long 3’ UTRs can have an 
impact on properties such as protein amounts and RNA localization. Regarding 
the former case, it has been shown that short 3’ UTRs tend to produce higher 
amount of proteins, partly because of having fewer miRNA target sites (Ransom 
et al. 2008; Mayr and Bartel 2009). Regarding the latter case, it has been shown 
that 3’ UTRs can regulate RNA localization. For example, the brain-derived 
neurotrophic factor (BDNF) expresses the short 3’ UTR in the somata of neurons, 
whereas the long 3’ UTR is also localized in dendrites (An et al. 2008). 
Interestingly, 3’ UTRs can also regulate protein localization independently of RNA 
localization. For instance, the long 3’UTR of the human CD47 gene enables 
expression of this protein in the cell surface, whereas the short 3’UTR RNA 
isoform enables protein localization to the endoplasmic reticulum. Interestingly, 
the mechanism underlying this decision was shown to be post-translational, given 
that the long 3’UTRs binds to proteins such as HuR and SET, that interact with 
the site of translation for this isoform only (Berkovits and Mayr 2015). 
46 
 
In summary, I have shown that the selection of alternative 3’-end sites by APA 
within pre-mRNAs can have a variety of biological roles, and that this process, 
when misregulated, leads to catastrophic effects related with relevant aspects of 
human health. From an evolutionarily point of view, it is interesting to note that 
there is a clear correlation between 3’ UTR length and morphological complexity, 
defined in this context as the number of cell types present in each organism. A 
study in 2012 addressed this fascinating question by using mature mRNA 
sequences and 3’ UTRs from 15 different organisms, going from yeast, as to have 
a reference from a unicellular eukaryote, through tunicates, nematodes, insects, 
frogs, fish, birds, dogs, cattle, rodents, chimpanzees and humans. The authors 
found that the median 3’ UTR length increased as the number of cell types did in 
an exponential fashion (Chen et al. 2012). As expected, yeast had the shortest 
median 3’ UTR length with nearly 100 nucleotides, while humans and 
chimpanzees were in the top with median 3’ UTR lengths of approximately 800 
nucleotides. Moreover, this increase in cellular diversity was also correlated with 
an accumulation of miRNA genes and targets. The authors suggest that an 
expansion of post-transcriptional regulatory circuits can contribute to the 
emergence of new cell types during animal evolution, thus placing APA as a 
relevant actor for the evolution of life on earth. 
Intriguingly, the expression of long 3’ UTR isoforms in metazoans can show 
biases in different tissues. As will be discussed in this chapter, the nervous 
system has emerged as an important actor because it can express these long 3’ 
UTRs in an exclusive way when compared with other tissues during development 
(Thomsen et al. 2010; Hilgers et al. 2011; Smibert et al. 2012), relating the 
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molecular complexity of post-transcriptional regulation with the inherent 
complexity of the brain and nervous tissue. 
1.5 Models and evidence on alternative polyadenylation control 
As discussed in the previous sections, APA is a widespread phenomenon with a 
repertoire of biological roles. Still, how APA is controlled remains only partly 
understood. One model that can explain why some tissues show radically 
different profiles of APA in comparison with others (to be further discussed ahead) 
proposes that the presence of specific factors other than core the CPA factors 
(such as the ones described in section 1.3) can force transcripts to bypass 
proximal PASs in the cells where they are expressed. Evidence for this model 
was provided in 2014 by our laboratory. In this study, the authors showed that 
the RNA-binding protein ELAV, which is a neural-specific RBP, controlled Ubx 
RNA-processing. More specifically, removal of ELAV leads to a shortening in the 
3’UTR of the Hox gene Ubx, while the ectopic expression of ELAV during germ 
band extension stage (during which the short isoform of Ubx is expressed) leads 
to an increase in the long isoform (Rogulja-Ortmann et al. 2014). These 
interesting experiments showed that ELAV is sufficient to control Hox RNA-
processing in vivo.  
Yet, examples of more neural-specific factors that can explain the drastically 
different profiles of APA observed in the nervous system are scarce. Also, other 
mechanisms can be involved in a non-exclusive way. One such mechanism that 
can explain how different PAS are selected involves the same core CPA factors 
described previously. This time, it is not their presence or absence which acts a 
switch on 3’ UTR length, but their abundance. Evidence for this model was 
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presented back in 1996 by the group of James Manley and colleagues 
concerning CSTF64 (See figure 1.2 and 1.6 for its structure and function). In this 
study, the authors showed that during differentiation of mouse B-lymphocytes 
there is a switch in immunoglobulin M (IgM) from a membrane-bound (µm) form 
to a secreted (µs) form. Interestingly, this switch is caused by effects in IgM 
mRNA processing instead of post-translational modifications, through coding-
region APA (See figure 1.7). For the secreted form to be expressed, an upstream 
µs PAS is selected, which excludes the last two exons of the IgM pre-mRNA.  
On the other hand, for the membrane-bound form to be expressed, a more distal 
µm PAS is selected, which includes these exons. The authors show that this 
switch is triggered by CSTF64 amounts, where high levels of CSTF64 lead to the 
use of the µs site (secreted form), while low levels of CSTF lead to the use of the 
µm form (membrane-bound) (Takagaki et al. 1996). Moreover, the authors show 
in vitro that CSTF64 shows higher affinity for the µm PAS and that this PAS is 
stronger than the µs one. Thus, CSTF64 expression is repressed in mouse 
primary B-cells, triggering the use of the µm PAS and keeping IgM from being 
secreted.  
This study is interesting for two main reasons, the first one is that it was the first 
study providing experimental evidence for the “CPA abundance” model of APA 
control, the second one is that the idea of “strong” and “weak” poly(A) sites was 
used in the context of this model. Although the concepts of “strong” and “weak” 
PAS is somehow ambiguous given the complexity of RNA sequences and 
structure in mammals. Progress in clarifying its meaning was being made while 
the CPA factors were being discovered in the late 1980s. For example, in 1989, 
a study showed that when compared with the canonical PAS hexamer 
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“AAUAAA”, described by Nick Proudfoot in 1976 (Proudfoot and Brownlee 1976), 
the variant “AUUAAA” had approximately 80% the processing efficiency in vitro 
from its canonical counterpart, by experiments with viral SV40 RNA (Wilusz et al. 
1989). During the next year, a systematic dissection of the “AAUAAA” hexamer 
by mutating the nucleotides in each one of the positions showed that all 18 
changes significantly reduced the efficiency of cleavage and polyadenylation, 
with the exception of “AGUAAA”, which showed an efficiency close to 30% when 
compared with its canonical counterpart, also by experiments with viral SV40 
RNA (Sheets et al. 1990).  
During the years it was also shown that apart from the PAS signal itself, the 
previously discussed motifs upstream and downstream of the PAS that are bound 
by CFI and CSTF, respectively, also contribute to the strength of a PAS by either 
using canonical or less efficient, related sequences (Zhao et al. 1999; Bagga et 
al. 1995). Interestingly, it has been shown that distal PASs tend to be “stronger” 
than their proximal counterparts within the same mRNA in humans (Legendre 
and Gautheret 2003), as also in the case of CSTF64 binding to IgM pre-mRNAs 
in mouse lymphocytes (Takagaki et al. 1996). Most likely, the reason for this is 
that a distal PAS will have to outcompete the proximal one to be used, given that 
RNA PolII will first confront the proximal PAS during transcription.  
Another factor that will affect the apparent usage of either proximal or distal PAS 
is the stability of each one of these transcripts. This can be an important 
consideration, given that most techniques are based on measuring steady-state 
mRNA levels (Moore 2012). 
More recent experiments using siRNA knockdown of CPA factors in human cells 
have also shown that depletion of core CPA factors can affect APA, supporting 
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the notion that CPA factor levels are an important cue to dictate PAS usage. As 
we will discuss in subsequent chapters in more detail, CFI has emerged as a key 
factor controlling 3’UTR length by experiments of this kind (Kubo et al. 2006; 
Masamha et al. 2014). Other factors have also been tested in vitro by knockdown 
experiments and shown to control APA in different general modes. For example 
a study using siRNA knockdowns in C2C12 cells proposed a subset of principles 
for PAS site selection. For instance, Pcf11 and Fip1 enhanced the use of proximal 
PAS, while CFI25, CFI68 and PABPN1 enhanced the use of distal PAS (Li et al. 
2015).  
Thus although pieces of evidence supporting different proposed models as to 
explain how APA is controlled have been developed since the 1990s, a unifying 
model that can accurately explain these decisions is missing. To achieve this, 
future research will need to be focused in both the CIS regulatory elements and 
the dynamics of CPA factor expression in different cell types, and to consider 
more deeply the molecular mechanisms of APA in metazoans, given that most of 
our current knowledge on how APA is controlled comes from experiments in vitro. 
Thus, one of the main aim of this study is to advance the understanding on how 
APA is controlled during the formation of the central nervous system by using 
Drosophila melanogaster, as we will discuss in the next section. 
1.6 Tissue-specific patterns of alternative polyadenylation in the nervous 
system 
In 2010, a study conducted at the Alonso Lab in the University of Sussex showed 
for the first time that during Drosophila embryogenesis, the Hox gene 
Ultrabithorax (Ubx) showed a peculiar characteristic at the level of mRNA 
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expression: during early embryogenesis, short 3’UTR isoforms were expressed 
in the epidermis, while during late embryogenesis, long 3’ UTR isoforms were 
observed to be restricted to the nervous system. Moreover, these extensions 
displayed more binding sites for miRNAs iab4/8 (Thomsen et al. 2010), which is 
a miRNA locus located in the bithorax complex (BX-C) that generates miRNAs 
from both DNA strands and regulate expression of these posterior Hox genes 
(Tyler et al. 2008; Bender 2008). 
As mentioned before, the Hox genes are key developmental genes that pattern 
the anteroposterior axis of all bilateral animals and also play a role in the 
formation of the nervous system (Miller et al. 2001; Mallo and Alonso 2013; 
Rogulja-Ortmann and Technau 2008). This key observation is shown in Figure 
1.8. Instead of being an unusual characteristic of Ubx mRNA processing, the 
authors showed that all other Hox genes with alternative 3’ UTR isoforms: 
Antennapedia  (Antp), abdominal-A (abd-A) and Abdominal-B (Abd-B) also 
displayed the same trend (Thomsen et al. 2010), as shown in Figure 1.9. 
Interestingly, as we mentioned previously from a study one year later also from 
the Alonso Lab (Patraquim et al. 2011), the distal 3’ UTRs of these genes showed 
an expansion in binding sites for miRNA iab4/8, which were evolutionarily 
conserved among different Drosophila species. The authors, therefore, proposed 
that APA works as a “Context-dependent” mechanism that is able to modulate 
visibility to miRNAs.  
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Figure 1.8 The Hox gene Ubx produces different 3’ UTR isoforms with the 
distal 3’ UTR expressed in the nervous system 
(Legend on the following page) 
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Figure 1.8 The Hox gene Ubx produces different 3’ UTR isoforms during 
embryogenesis, with the distal 3’ UTR expressed in the nervous system 
(A) Diagram of the 3’ UTR of Ubx indicating the two different PAS by inverted 
triangles and miRNA iab4/8 target sites by boxes, considering each strand in 
detail (5p and 3p). Note that miR-iab4-5p only targets the distal 3’ UTR and that 
target sites in the distal 3’ UTR show more evolutionary conservation than the 
ones in the universal 3’ UTR. The level of conservation of these miRNA target 
sites is indicated by stars (B and C) mRNA localization of the Universal 3’ UTR 
of Ubx in stage 11 (B) and stage 16 (C) embryos. Note that the chromogenic 
signal is strong in both the epidermis in stage 11 embryos (B) as well as in the 
nervous system in stage 16 embryos (ventral view) (C). (D and E) mRNA 
localization of the distal 3’ UTR of Ubx in stage 11 (D) and stage 16 I embryos. 
Note that the chromogenic signal is very weak in the epidermis of stage 11 
embryos (D), while is strong in the nervous system (ventral view) of stage 16 
embryos I. Figure taken from (Thomsen et al. 2010). 
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Figure 1.9 abd-A, Abd-B and Antp also express the distal 3’ UTR in the 
nervous system  
(Legend on the following page) 
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Figure 1.9 abd-A, Abd-B and Antp also express the distal 3’ UTR in the 
nervous system  
(A-C) Diagrams of the 3’ UTR of abd-A (A), Abd-B (B) and Antp (C) as shown in 
figure 1.8 panel A. The location of the RNA in situ hybridization probes used in 
this study to detect these isoforms, as well as primers for qPCR are shown (See 
Thomsen et al. 2010). (D and E) mRNA localization of the Universal 3’ UTR of 
abd-A in stage 11 (D) and stage 16 I embryos. Note that the chromogenic signal 
is strong in both the epidermis in stage 11 embryos (D) as well as in the nervous 
system in stage 16 embryos (ventral view) I. (F and G) mRNA localization of the 
distal 3’ UTR of abd-A in stage 11 (F) and stage 16 (G) embryos. Note that the 
chromogenic signal is absent in the epidermis of stage 11 embryos (F), while is 
strong in the nervous system (ventral view) of stage 16 embryos (G). (H-K) 
Analysis for Abd-B as done for abd-A (D-G), note that the same trend is observed. 
(L-O) Analysis for Antp as done for abd-A (D-G), note that the same trend is also 
observed, although this time there is more expression of the distal 3’UTR in the 
epidermis of stage 11 embryos (N). Figure taken from (Thomsen et al. 2010). 
 
  
56 
 
During the next year (2011), another group led by Valérie Hilgers and colleagues 
showed that this property of “Neural-extended” 3-UTRs was not exclusive to the 
Hox genes and they identified other 30 genes that displayed the same trend 
(Hilgers et al. 2011). Remarkably, this time the extensions in some genes were 
shown to be more than 10 times longer than the ones observed In the Hox genes. 
As we will discuss in chapter 5, a comparison of the 3’ UTR length reported in 
this study versus the current databases shows that some extensions can be even 
longer than annotated in the study (Hilgers et al. 2011). 
During 2012, another group led by Eric Lai showed that this property of “Neural-
extended” 3’ UTRs was even broader, concerning almost 400 genes and life 
stages other than embryogenesis, such as larvae, pupae and adults. 
Interestingly, while the nervous systems showed a bias towards 3’ UTR 
lengthening, the testis showed a bias towards 3’ UTR shortening (Smibert et al. 
2012).  
During the next year in 2013, it was shown that this well-established observation 
in Drosophila was far from being an exception of insects and that the complex 
mammalian brain also showed extensive 3’ UTR lengthening, with 2035 genes in 
the mouse and 1847 genes in humans using substantially distal novel 3’ UTRs 
according to RNA-seq data (Miura et al. 2013). In line with what was observed in 
the Hilgers study, Northern Blot analysis of selected genes showed transcripts 
displaying exceptionally long 3’ UTRs, with lengths of more than 10 kb and some 
of more than 18 kb. The authors report thousands of conserved miRNA sites 
present in these extensions which are strongly enriched for well-studied neural 
miRNAs (Miura et al. 2013). Yet, it is difficult to ascribe miRNA binding sites and 
potentially RBP binding sites as the only or main biological reasons for such 
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extensions. Bioinformatics analyses have already shown that only modest 
extensions of 1 kb or less are enough for differential miRNA targeting (Patraquim 
et al. 2011). Thus, the meaning of these extremely long 3’ UTRs in neural tissues 
remains unclear and will be discussed in subsequent chapters. 
1.7 Aims and outcomes of this thesis 
As discussed in the previous sections, the phenomenon of APA and its bias for 
producing long 3’ UTRs in the nervous system of both vertebrates and 
invertebrates is a recent field of study that has grown rapidly since 2010. Despite 
this, the complete molecular identity and characteristics of CPA factors, let alone 
their biological functions beyond 3’-end processing in metazoans, together with 
the mechanisms by which APA is controlled, remain not fully understood. Thus, 
as it was the case for the biological meaning of RNA poly(A) polymers within living 
cells in the early 1960s, the biological meaning of extremely long 3’ UTRs in the 
nervous system is similarly enigmatic nowadays.  
This dissertation aims at addressing the following questions. In chapter 3, I ask 
about evidence to test the model of “CPA factor abundance” for PAS selection in 
the context of neural development. To achieve this, I first interrogate the identity 
of core CPA factors in Drosophila and compare them with their known human 
and yeast counterparts for protein similarity and redundancy. I then address their 
expression levels during Drosophila embryogenesis by using databases to look 
for patterns that can suggest changes in CPA factor abundance as development 
progresses. Then, I analyse the expression patterns of Drosophila CPA factors 
in life stages other than embryos in different tissues by using databases and I 
explore differences within the nervous system in terms of tissue-specific CPA 
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factor expression levels. I then analyse the expression pattern of the members of 
CFI, the most conserved CPA complex between humans and Drosophila and the 
one with the highest expression levels in the nervous system, and I show that in 
late stages both CFI25 and CFI68 are highly expressed and restricted to the 
developing nervous system, correlated with the observed trend of extended 3’ 
UTRs reported 6 years earlier. 
In Chapter 4, I ask about the roles that the Drosophila orthologue of CFI25 has 
for nervous system function. I show that a mutation in this gene affects feeding 
behaviour in the Drosophila larvae and is required for developmental transitions 
between larval stages. I address the reasons of the observed phenotype by 
identifying candidate target genes that can connect larval feeding with the 
molecular function of CFI25. I also show that a subset of the identified genes are 
affected in APA patterns, as well as mRNA expression levels. And I discuss the 
potential molecular mechanisms that can explain the observed phenotype. 
In Chapter 5, I address the question of the molecular mechanisms to achieve 3’ 
UTR extensions within the developing nervous system. I show that the reported 
3’ UTR lengths of genes that were described in 2011 by Valerie Hilgers are not 
accurate when compared with the current databases and that the extensions of 
3’ UTRs can go below or above than published measurements, resulting in 3’ 
UTR lengths comparable as those observed in human tissues. I then address the 
question on the roles of CFI factor abundance within the developing nervous 
system in relation with these extensions. Finally, I show that neural-specific 
knockdown of CFI factors can affect APA in a subset of the genes reported in 
2011 for 3’ UTR extensions, as well as in a subset of the Hox genes.  
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The reasons for differential sensitivity to CFI depletion is explored by considering 
both 3’ UTR length and composition. Consequently, a bioinformatic approach is 
used to scan for enriched motifs in the 3’ UTRs of these neural-extended genes 
to look for a molecular mechanism that can explain the different sensitivity shown 
by these genes to depletion in CFI factors. 
Altogether, this work shows that the Drosophila CPA machinery is as complex as 
its human counterpart and that neural 3’ UTR extensions are achieved by CFI 
factor abundance, making Drosophila an excellent system to address the 
molecular mechanisms that control APA during the formation of the nervous 
system. Also, this work shows that the members of CFI are key for nervous 
system function, because a mutation in one of these factors (CFI25) can affect 
feeding and impair larval developmental transitions, unravelling unprecedented 
roles for core CPA factors when considered at the organismal level, and 
suggesting other potential biological roles of the CPA machinery that remain to 
be discovered. 
 
 
  
60 
 
Chapter 2  
Materials and Methods  
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2.1 Stocks and fly husbandry  
Fruit flies (Drosophila melanogaster) were cultured using molasses food following 
standard procedures at 25°C on a 12 hour light and dark cycle. Oregon R was 
used as a wild type strain. All Drosophila stocks used in this study are depicted 
in table 2.1 
Table 2.1 Drosophila stocks 
ID Genotype Origin 
Oregon R Wild Type Host laboratory 
w1118 w1118 Host laboratory 
TM3, Dfd-GMR-
nvYFP 
w*; ry506 Dr1/TM3,  P{Dfd-GMR-
nvYFP}3, Sb1 
Bloomington Stock 
Center #23231 
CG7185 GFP Tag y1 w* ; CG7185[38575]::2XTY1-
SGFP-V5-preTEV-BLRP-
3XFLAG 
Vienna Drosophila 
Resource Center 
#318105 
CFI25G19200 y1 w* ; P{EP}CG3689G19200 / TM3, 
Sb1 Ser1 
Bloomington Stock 
Center #28422 
CFI68CC00645  w* ; P{w[+mC]=PTT-
GC}CG7185[CC00645] 
Bloomington Stock 
Center #51539 
UAS – CFI25 RNAi y* w1118 ; UAS–CG3689 RNAi Vienna Drosophila 
Resource Center 
#105499/KK 
UAS – CFI68 RNAi y1 sc* v1 ; P{TriP.HMS00113}attP2 Bloomington Stock 
Center # 34804 
Elav>Gal4 P{GAL4-elav.L}2 / CyO Bloomington Stock 
Center #8765 
CFI25Revertant Excision of P{EP} from stock 
#28422 
This study 
CG4022GS12916 y1 w67c23 ; P{GSV6}GS12916 / 
TM3, Sb1 Ser1 
Kyoto Stock Center 
#204369 
CG4022c05627 w1118 ; Pbac{PB}CG4022c05627 Bloomington Stock 
Center #17716 
Δ2-3 transposase w* ; P{Δ2-3} e1/ Tm6 Donated by Juan 
Pablo Couso Lab 
 
 
62 
 
2.2 Embryo collection and fixation 
Flies were kept in small collection cages at 25°C with apple juice agar plates 
supplemented with yeast paste for embryo laying. Collected embryos were 
dechorionated in 50% bleach for about 3 minutes and then fixed for 20 minutes 
in 3.5 mL heptane / (1.813 mL 10% ultrapure formaldehyde and 1.687 mL 
1XPBS) at room temperature. The fixative was removed and the embryos were 
devitellinized in methanol with vigorous shaking for at least 2 minutes. Embryos 
were rinsed three times with 100% methanol, then rinsed with 100% ethanol and 
stored in 100% ethanol at -20°C for later use. 
2.3 Generation of CFI25 mutant revertants 
The Drosophila CFI25 mutant stock y1 w* ; P{EP}CG3689G19200 / TM3, Sb1 Ser1 
was isogenized by backcrossing it into a standard w1118 genetic background with 
a balancer third chromosome (TM3,  P{Dfd-GMR-nvYFP}3, Sb1). Then, isogenic 
P{EP}CG3689G19200 mutants, in which feeding was tested beforehand, were 
crossed with the stock w* ; P{Δ2-3} e1/ Tm6. Subsequently, P{EP}CG3689G19200/ 
P{Δ2-3} males were crossed to the w*; ry506 Dr1/TM3,  P{Dfd-GMR-nvYFP}3, Sb1 
balancer stock to establish new revertant lines from white-eyed males. 32 
independent revertant stocks were generated in which confirmation of the 
excision of the P{EP} element was done by PCR and sequencing, using Oregon 
R wild types as a negative control and the original CFI25 mutants as a positive 
control. CG3689Revertant 4, in which the excision does not damage CFI25 and the 
whole P{EP} element was excised, was used as the control for feeding for CFI25 
mutants. 
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2.4 Antibody staining 
Antibody stainings were performed using a standard protocol as follows. Fixed 
embryos were rehydrated in 50% PBTx / Ethanol (1XPBS 0.3% Triton X-100) and 
then washed several times in PBTx. Primary antibodies (diluted in PBTx) were 
incubated overnight at 4°C. Secondary antibodies were incubated for two hours 
at room temperature and washed with PBTx. After secondary antibody 
incubation, embryos were incubated with DAPI for 15 minutes to label the nuclei, 
washed with PBTx and mounted in Vectashield (Vector Laboratories). All 
antibodies and respective concentrations (v/v) used in this study are listed below 
(Table 2.2 and 2.3). Fluorescent imaging was carried out using a Leica DM600 
fluorescent microscope and a Leica SP8 confocal microscope. All images were 
processed and analysed by ImageJ. 
Table 2.2 Primary antibodies used in this study 
Name Host Concentration Origin 
Anti-elav Mouse 1:100 Developmental studies hybridoma 
bank  
Anti- futsch Mouse 1:100 Developmental studies hybridoma 
bank  
Anti – NUDT21 
(CFI25) 
Rabbit 1:1000 Abcam  
Anti-GFP  Rabbit 1:500 Life Technologies 
Anti-tubulin Mouse 1:500 Developmental studies hybridoma 
bank 
 
Table 2.3 Secondary antibodies used in this study 
Name Concentration  Origin 
Anti-mouse Alexa 488 1:750 Life Technologies 
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Anti-rabbit Alexa 488 1:750 Life Technologies 
Anti-mouse HRP 1:3000 Cell Signalling Technology 
Anti-rabbit HRP 1:3000 Dako 
 
2.5 RNA probes 
Templates of RNA probes for RNA in situ hybridisation were obtained from PCR 
amplified genomic fragments or cDNA (see table 2.4) and cloned into pGEM-T 
easy (Promega) according to the manufacturer’s instructions. Plasmids were 
linearized with a unique restriction site, purified by QIAquick PCR purification kit 
(Qiagen) according to the manufacturer’s instructions and their concentration was 
measured using the Nanodrop 2000 spectrophotometer (Thermo scientific). 
Sense and Antisense probes were synthesised using digoxigenin (DIG) RNA 
labelling mix (Roche) according to the manufacturer’s instructions with either T7 
or SP6 RNA polymerase (Roche), depending on the orientation of the insert. After 
in vitro transcription, the DNA template was removed with DNAse I (New England 
Biolabs) and RNA probes were precipitated with 2.5 µl 4M lithium chloride and 
75 µl pre-chilled 70% ethanol solution at -80°C overnight. RNA probes were 
centrifuged at 4°C for 30 minutes and air-dried at room temperature. RNA pellets 
were re-suspended in 50 µl hybridisation buffer (50% formamide (ACROS), 5X 
SSC (Sigma), 100 µg/ml salmon sperm DNA (Invitrogen), 0.1% PBTween 
(1XPBS RNAse-free, 0.1% tween 20 (Sigma)), aliquoted and stored at -80°C. 
Table 2.4 Primer sequences and RNA probes length 
Gene Forward primer (5’ to 3’) 
Reverse primer (5’ 
to 3’) 
Probe length 
(bp) Source 
CFI25 CGTCCAGCCGGTTAATTT 
GTTAGGTAGCGC
TATCGTTG 955 This study 
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abd-A-
universal 
CCCACCATCAAC
CAACTTTC 
TACTTGCGCAATT
GTTTTGC 428 
(Thomsen et 
al. 2010) 
abd-A 
distal 
GTTTTACTCCGCC
TGGGAAG 
AATCCCCTTGGC
TGAAATCT 403 
(Thomsen et 
al. 2010) 
 
2.6 Fluorescent RNA in situ hybridisation (FISH) 
In situ hybridisations were performed similarly to that described by 
(Beckervordersandforth et al. 2008) but with slight modifications. Fixed embryos 
were rehydrated in PBTween (1XPBS RNAse-free 0.1% Tween 20), pre-treated 
with 3% H2O2 in Ethanol for 20 minutes to quench endogenous HRPs and with 
sodium borohydride (0.001% in PBTween) for 10 minutes to reduce auto-
fluorescence. Embryos were then pre-hybridised in hybridisation buffer for two 
hours at 55°C. 200-300 ng of DIG-labelled RNA probes in hybridisation buffer 
were denatured at 80°C for 5 minutes. RNA probes were then incubated with the 
pre-treated embryos at 55°C overnight. All steps were carried out in RNAse-free 
conditions. 
For detection of the DIG-labeled RNA probes, embryos were blocked in TNB 
buffer (0.1 M Tris PH 7.5 (Fisher), 0.15 M NaCl (Fisher), 0.5% blocking reagent 
(Roche)) for 30 minutes and incubated with 1:500 anti-DIG-POD in TNB buffer 
for 2 hours at room temperature. The fluorescence signal was detected using the 
Cy3 TSA amplification kit (Perkin Elmer) according to manufacturer’s instructions.  
2.7 RNA extraction 
RNA was extracted from staged embryos using TRI reagent (Sigma) following 
the manufacturer’s instructions. 50-100 staged embryos were homogenized in 50 
µl of TRI reagent using a sterile RNAse-free pestle in 1.5 ml Eppendorf tubes. 
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After homogenization, 450 µl of TRI reagent were added and the tubes were 
incubated for 5 minutes at room temperature to dissociate nucleoprotein 
complexes. The samples were centrifuged for 10 minutes at 4°C to precipitate 
the insoluble material and the high molecular weight DNA. After centrifugation, 
the supernatant was transferred to a new 1.5 ml Eppendorf tube. RNA was 
separated from DNA and proteins by adding 100 µl of RNAse-free chloroform 
(Sigma Aldrich), mixing and incubating for 15 minutes at room temperature. The 
different phases – aqueous phase (RNA), interphase and organic phase (DNA 
and proteins) – were separated by 15 minutes of centrifugation at 4°C and the 
aqueous phase was transferred to a new tube. The RNA was precipitated with 
250 µl RNAse-free isopropanol (Sigma Aldrich) at -20°C for one hour, followed 
by centrifugation at maximum speed for 30 minutes at 4°C. The precipitated RNA 
was washed twice with RNAse-free 75% ethanol, resuspended in nuclease-free 
water and stored at -80°C until use. The concentration of RNA was measured by 
Nanodrop 2000 spectrophotometer (Thermo Scientific). All steps were carried out 
in RNAse-free conditions.  
2.8 Reverse transcription (RT) 
1 µg of total RNA was treated with DNAse I (New England Biolabs) at 37°C for 
10 minutes to eliminate genomic DNA. Treated RNA samples were used for 
cDNA synthesis using oligo(dT) primers (Invitrogen) and MuLV Reverse 
Transcriptase (Invitrogen). The same amount of RNA was used when comparing 
different genotypes. 
Total RNA was mixed with 3 µl of oligo(dT) and water to a final volume of 12 µl, 
denatured at 75°C for 3 minutes and placed on ice. Then, the remaining RT 
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components were added – 2 µl of 10X RT buffer (Invitrogen), 4 µl of 2.5 M dNTP 
mix (Invitrogen), 1 µl of RNAse inhibitor (Invitrogen) and 1 µl of MuLV Reverse 
Transcriptase (For the No-RT controls, 1 µl of nuclease-free water was used 
instead of MuLV Reverse Transcriptase) – and incubated at 44°C for one hour 
for cDNA synthesis. An additional incubation at 92°C for 10 minutes inactivated 
the Reverse Transcriptase. The cDNA samples were stored at -20°C until use. 
2.9 Semi-quantitative RT-PCR 
PCR reactions were prepared on ice to a final volume of 25 µl as follows: 2.5 µl 
of 10X PCR buffer (New England Biolabs), 0.5 µl of 10 mM dNTP mix (New 
England Biolabs), 1 µl of 10 µM forward/reverse primer (See table 2.5), 0.25 µl 
of standard Taq DNA polymerase (New England Biolabs), 1 µl of cDNA and 18.75 
µl of nuclease-free water. PCRs were performed using an Eppendorf PCR 
machine with the following conditions: 
1 cycle:  
Extended DNA denaturation at 95°C for 5 minutes 
25 to 35 cycles (depending on each pair of primers):  
Denaturation at 95°C for 30 seconds 
Primer annealing at 55°C for 30 seconds 
 Extension at 72°C for 30 seconds 
Hold: 4°C 
Each primer pair was optimised to ensure that the reaction was on the 
exponential phase of amplification. 
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Expression values were normalised using reference gene RpA1. At least three 
independent biological replicates were done for each experiment. 
All experiments included two negative controls: (i) PCR with 1 µl of No-RT 
reaction to control for genomic DNA contamination from each RT reaction and (ii) 
PCR with nuclease-free water to control for PCR mix contamination. All 
experiments also included one positive control: Genomic DNA template to control 
for PCR reaction and primer binding. 
Table 2.5 Semi-quantitative RT-PCR primers 
Gene Forward primer 
(5’ to 3’) 
Reverse primer 
(5’ to 3’) 
Amplicon 
length (bp) Source 
Ubx Universal GAAATGACGCGGAGACAGAT 
AATCTGCGCTC
CTTCCACTA 236 
(Thomsen et 
al. 2010) 
Ubx Distal GAACGAAGGCAGATGCAAAT 
GGTAAGTGGTC
GGATGCAGT 225 
(Thomsen et 
al. 2010) 
abd-A 
Universal 
CGGGTTTTATTG
CTGTGGAT 
CGTTGGCCCAG
AGACTCTAC 193 
(Thomsen et 
al. 2010) 
abd-A Distal CCTTTTCGATGAGGTCCAAA 
CGGTTTCGGTC
GGTCTAATA 219 
(Thomsen et 
al. 2010) 
Antp Universal ACGGAGTCTACCCACTTAAA 
GATCTGAGGTC
ACATGAGTTG 336 This study 
Antp Distal GAGGACGGAATGGCAAACTA 
GTCTTTTCACCT
GGGATTGG 165 
(Thomsen et 
al. 2010) 
Abd-B 
Universal 
CGTATTTCTCTC
AACGCTCTC 
CGGAGTGTGTC
TTCTTGTTT 300 This study 
Abd-B Distal TCCGTACAACACCATTTTCG 
AGTGGCGATTA
CGAGCTGAT 229 
(Thomsen et 
al. 2010) 
Elav Universal AGTAGCAGGCAGGAGAAA 
GACTGTGCCAA
CCTTTGA 303 This study 
Elav Distal GACGAACTGCTCCGATTT 
CGCTCTTCTCC
GATTACTTAC 284 This study 
ADAR 
Universal 
TGTATATGCTAA
GTTCAGTTTACG 
GCTTAAAGTGCT
TGTTTATAATGT
G 
223 This study 
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ADAR Distal CCCGCTAAACCAGTGATAAG 
GCGTTTAGCCC
AGAATGT 319 This study 
Nrg Universal GAACAACAAGCAACACAACA 
GAGCGGGACAA
AGATATACAG 320 This study 
Nrg Distal CGAATCGGTTCGGCTTTAT 
GAGGCTGGGTA
TTGGTTATTC 300 This study 
Pum Universal GCATACACCCACACAATGA 
TTGGCTTACTTG
GCTAACAG 318 This study 
Pum Distal GCAGGGCTCGGTATTATTT 
TTCGCTGGCTTA
CACTAAC 330 This study 
Imp Universal AGCACCCACCACAATTTAC 
GCGCGCTGCTT
TCTATTA 320 This study 
Imp Distal GGAACGAAACGAAACGAAAC 
GCTCAGTCTCC
AGTTGATTAC 282 This study 
Ago1 Universal CCACTTCCTTCCCTCAAATC 
CAAACTTGTGCC
TGACATTC 281 This study 
Ago1 Distal ATGCGAGTTTGTGAAATATGC 
GGGTACATTTC
GTGGGTTTA 244 This study 
Brat Universal CGGTCTCTCCAGCTCTAAT 
CGAGGGTTTGA
AGTGAGAAG 341 This study 
Brat Distal CTTGAGGATGTGTGTGCATAG 
CCGTGTGGCTT
TCGTATTT 294 This study 
Wdb Universal CCAAGATCAGTAAGAGCGTAAG 
ATTAACGCGGA
CACACAC 305 This study 
Wdb Distal CTAAGCGACGTGTGTGTAAG 
CAAACAGGTCG
AGTCGATAAG 307 This study 
Nmo Universal AGAACATGGAGGAGAGGAG 
TACCGCTGCTG
CTTTAAC 298 This study 
Nmo Distal AAACACTCGATACGCTAACC 
CTTTGTTGCGTG
CCTTTAC 290 This study 
Fne Universal AGATGAGCCAGACGACAA 
GAGTTATGCTG
GTAGTTCCTAAA 296 This study 
Fne Distal GCCCAGCAGCTAATGAAA 
GGGTGTGTAAG
TGTGAACTG 302 This study 
Nej Universal CAGCTACAATGGTTGGTAGG 
GTTGGTCTTCGT
CGTCATC 103 This study 
Nej Distal CATAGGGATCGGGATTAGGA 
GCGTCGTTGTT
GTGTTTG 311 This study 
Gβ13F 
Universal 
GAAACAGAAAC
AGCAGCATAAG 
GTTGTTGTGGTC
TACGTTCTA 304 This study 
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Gβ13F Distal GGCCAGTCAGTCAGTTAATC 
GGTTTCCTCCAT
CTTCATCTT 303 This study 
Shep Universal ACCCAGCATCCAGAATCTA 
CTCACTTGCCG
CTGTTT 299 This study 
Shep Distal ACCCACACCAAATAGTTTCC 
GCGTTCATTCCT
CCTCTATG 306 This study 
Step Universal CAGCTCGGCGAATCTTT 
TGATGGCTTGTT
TCGAGTC 227 This study 
Step Distal CGGCTTACTGACGTCTAATC 
TTACCGCCGTC
CTTTATATTC 311 This study 
Hrb27C 
Universal 
CAGCACTCTCA
CCCATTTAG 
TGGTATTTCGCG
CTCTATTC 286 This study 
Hrb27C Distal GATGCGCCAAATGCAAAC 
ACTCTCGTTCTG
AGGGATTAG 317 This study 
MeiP26 
Universal 
CAAAGCGCGCA
ACAATC 
GCTGTCGATGA
GGCAAAT 298 This study 
MeiP26 Distal CGCAAACGGCAGACTATT 
CGAGGGATTGA
TGGACTATTG 303 This study 
Kurtz Universal TACCAATAGCCATGGTAAACAG 
CAGGTGTGGCC
GAAATAC 196 This study 
Kurtz Distal CCATTTCCGTCTGTCTGTATAA 
ACCACATTTCGC
CATTACA 202 This study 
RanBPM 
Universal 
GTTCAGACCAG
CAAACGA 
CCGATGAAGAT
GAGCTGAC 217 This study 
RanBPM Distal CACATTCGGCAAACATGAATAG 
ACACATTGTCAG
AATGGCATA 138 This study 
S6k Universal CGCCAATCGAAACAGACA 
CGTTGCAGTTGT
CCCTAAA 208 This study 
S6k Distal CCGTTCAGGGCTCATATTG 
CCTGTGTGGCT
TTCTGTT 223 This study 
For Universal GAGAATCAGAACCCGTTTCCT 
TTCGATGCGAG
CTGCTG 150 This study 
For Distal GGTCTGTGACTCTGTTTCAG 
CAGTAGAGAGG
CCACATAGA 215 This study 
Lov Universal GACCAGGAAATGAACCCTAC 
TGCTTACGGGA
CAAGGA 196 This study 
Lov Distal GGAAGCAAGTTGAGGGAAA 
GGAACGTGCAC
AACTATGA 198 This study 
Itp-r83A 
Universal 
TCAATGCGGGA
TGAACAAT 
TTTAACAGCCCT
AAGTTCTCTG 201 This study 
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Itp-r83A 
Distal 
GAAGCGAGTTG
TGTTGGTTA 
CAAAGATATATT
CTCCACTTTGCA
C 
124 This study 
Klu Universal CCAGCTTAGTGCTACAGAAA 
TGGAATTGCTAG
CTGTATCG 313 This study 
Klu Distal AGAAACGAACGCTACACAAA 
CACGAAAGGTG
AGGTGATTC 320 This study 
Shi Universal GGGCAGATGCTTAGTGACGA 
CGATAAGCGAA
AGCAACGCC 338 This study 
Shi Distal TTCGAATCGCAGTGCAGGAG 
GCGGACATTGC
GTTGCTAAA 249 This study 
NPFR 
Universal 
AGAGCTCGAAG
CCTGTAA 
TCCTAGGAACT
GTTGAGAGAA 195 This study 
NPFR Distal TGAGGTCTGGTCTCGTGTCT 
CAGCCAGAGTG
TTTCCCGAT 196 This study 
RanBPM GGCCATCGAACATACACTAC 
TGTGCTTGAAC
GTCTTGG 261 This study 
CFI25 CCCTTACGAACTACACATTCG 
GTGTCCTCAACA
ATCCACTC 383 This study 
CFI68 CACTGGTCACAGCCATTT 
GCGTTCACGTT
CTCTACTG 351 This study 
RpA1 AAGAGCATCGACGACCTGAT 
GCCACATTCAAC
CGCTTATT 213 
Host 
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2.10 Agarose gel electrophoresis 
RNA and PCR products were visualized by agarose gel electrophoresis. All 
agarose gels were made at 1% (w/v) by dissolving nuclease-free agarose 
(Fisher) in 1X SB buffer (2.25 g Boric Acid (Fisher) and 0.4 g Sodium hydroxide 
(Sigma Aldrich) in 1 L of double distilled water). The mixture was heated in a 
microwave until it was completely homogenised. After cooling, 250 µl of 0.1 
mg/ml ethidium bromide was added to the liquid agarose solution before pouring 
into the gel cast system. Samples were prepared in 1X loading buffer (Thermo 
Scientific), loaded into the wells of the gels alongside a 100 bp DNA ladder (New 
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England Biolabs) and subjected to electrophoresis in 1X SB buffer for 30 minutes 
at 150 V. 
Gel pictures were taken using a Uvidoc gel documentation system (Uvitec 
Cambridge) and UviPhotoMW image analysis software. Quantification of the gels 
was done with ImageJ. 
2.11 Western Blotting 
20 – 50 embryos were homogenised in 20 µl of 2X Laemmli buffer (4% SDS, 20% 
glycerol, 0.004% bromophenol blue, 0.125 M Tris HCl, PH 6.8) in a 1.5 ml 
Eppendorf tube, 2 µl of β-mercaptoethanol were added to the samples and boiled 
at 95°C for five minutes. Proteins were separated on a 12% SDS-PAGE gel at 
100V for 2 hours, then electrophoretically transferred onto a 0.45 µm 
nitrocellulose membrane (GE Healthcare Life Sciences). After protein transfer, 
membranes were blocked in 5% milk PBST (1XPBS 0.1% Tween 20) for one 
hour and then incubated with primary antibodies overnight at 4°C (See table 2.2 
and 2.3 for antibodies). Membranes were washed and incubated with 1:3000 anti-
mouse-HRP or anti-rabbit HRP secondary antibodies in 5% milk PBST for 1 hour. 
Detection was performed using Clarity Western ECL Substrate (Bio-Rad) 
according to manufacturer’s instructions.  
2.12 Larval feeding behaviour  
Freshly hatched first instar larva (< 30 minutes post hatching) were placed in blue 
yeast paste, a modified recipe from (Zinke et al. 1999) (5 g yeast (Saf-Levure), 5 
ml water and 0.1 gr Bromophenol Blue (Sigma Aldrich)) in agar plates and left to 
feed on this medium for one hour at 25°C. Then, they were washed from the 
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yeast paste with 1XPBS and scored for the presence of food in their guts by using 
a Leica MZ75 dissecting Scope. For visualization of the digestive system, yeast 
paste was mixed with DAPI (20 µg/ml DAPI in yeast paste) and the larvae were 
fed as previously described, with the only difference that after one hour of feeding 
the larvae were mounted in 70% glycerol 1XPBS and visualized on a Leica 
DM600 fluorescent microscope to observe the stained nuclei. 
2.13 Statistical analysis 
Statistical analyses were carried out in Prism GraphPad 6.0 software package 
(http://www.graphpad.com/scientific-software/prism/). Unpaired, two-sided t-
tests or non-parametric, unpaired Mann-Whitney tests to compare ranks were 
used, depending on the features of the data. Significance level was binned 
according to p-values’ probability: Non significant (n.s) p > 0.05, * p < 0.05, ** p 
< 0.01 *** p < 0.001, **** p < 0.0001. 
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Chapter 3  
The cleavage and polyadenylation 
machinery in Drosophila  
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3.1 Chapter overview 
More than 60% of all human and mammalian genes display alternative 
polyadenylation (APA) (Derti et al. 2012; Hoque et al. 2013). APA allows the 
generation of mRNAs with different 3’UTRs, which can control mRNA 
localization, stability and translation efficiency, therefore modulating protein 
function (Di Giammartino et al. 2011). In addition to this, approximately half of all 
genes in other vertebrates, such as zebrafish, and invertebrates, such as C. 
elegans and Drosophila, also display reported APA isoforms (Ulitsky et al. 2012; 
Smibert et al. 2012; Jan et al. 2011), supporting the notion that APA is a pervasive 
phenomenon for controlling gene expression. Although the mechanisms by which 
APA is controlled are not well understood, one prevalent model proposes that the 
relative abundance of core cleavage and polyadenylation (CPA) factors within 
the cell and differential strength of polyadenylation sites (PAS) can modulate PAS 
selection (Takagaki et al. 1996). In this chapter, I address the strength of this 
model in the context of neural development in Drosophila melanogaster, a system 
where the expression of long 3’UTR isoforms have been shown to be restricted 
to the nervous system (Thomsen et al. 2010; Hilgers et al. 2011; Smibert et al. 
2012). I identify the Drosophila orthologues of core human CPA factors and I 
observe that their expression levels decrease over the course of embryogenesis. 
I also observe an enrichment of CPA expression in the nervous system, 
suggesting that the proposed model for APA selection may operate in this 
developmental context. I also focus on Cleavage Factor I (CFI), which is the most 
evolutionarily conserved CPA complex and most highly expressed in neural 
tissues. The expression patterns CFI components CFI25 and CFI68 show strong 
enrichment in the nervous system and are also essential for viability to adulthood. 
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3.2 Results  
3.2.1 The Drosophila cleavage and polyadenylation machinery is as 
complex as its human counterpart and has lower gene redundancy 
As discussed in Chapter 1, since the discovery of CPA factors in the late 1980s, 
there has been evident progress in the exploration of mechanisms that control 
APA. For example, one key experiment which provided experimental evidence 
for the current model of APA controlled by CPA factor abundance is the IgM 
heavy chain switch controlled by the abundance of CSTF64 in B-Lymphocytes 
(Takagaki et al. 1996). However, this and other similar studies conducted on cells 
in culture present limitations, as they cannot completely reproduce what is 
observed in multicellular organisms. Complex processes cannot be recapitulated 
in cell culture, for example the formation of the nervous system, a tissue of great 
interest in this context, given its property of producing extensively long 3’ UTRs 
(Thomsen et al. 2010; Hilgers et al. 2011; Smibert et al. 2012). A similar issue 
arises in yeast, which was widely used for biochemical identification of CPA 
factors in the first place. This is compounded by this unicellular organism also 
having low conservation at the protein level in CPA factors, when compared to 
mammals.  
Thus, in order to consider the nervous system in its complexity and to address 
the question on how APA is controlled within this tissue, a system is required that 
allows genetic manipulations using the whole organism. Because of this, the fruit 
fly Drosophila melanogaster emerges as an excellent system to study this 
question given that it is a well-established model organism that is widely used for 
genetic manipulations including availability of mutants, a variety of genetic tools, 
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a rapid life cycle, low costs of maintenance and large numbers of individuals that 
can be generated (Venken and Bellen 2005; Jeibmann and Paulus 2009; Brand 
and Perrimon 1993). In addition, fruit flies possess a nervous system that, 
although not as complex as its mammalian counterpart, still undergoes pervasive 
3’ UTR lengthening (Thomsen et al. 2010). However, in order to use Drosophila 
to address the question on conserved CPA factor expression control during 
neural development, it is required to identify and evaluate the presence of the 
known mammalian CPA factors in this system.  
Shortly after the sequencing of the Drosophila genome in 2000 (Adams et al. 
2000), a study used these earliest sequences to look for the presence of 
orthologues of mammalian splicing factors (Proteins and small nuclear RNAs) in 
Drosophila, as well as proteins related with mRNA processing in general (Mount 
and Salz 2000). In this study, the authors found evidence for the presence of a 
subset of members of the 3’-end machinery, although in many cases functional 
data for the identified Drosophila gene was not available. For example, CG5222 
was labelled as “Related to CPSF-100 and -73”, although the latest genome 
assembly of Drosophila (BDGP6) shows no relation of this gene with either 
CPSF100 or CPSF73 in terms of paralogs and orthologues. Therefore, in order 
to be able to use Drosophila to address the question on how APA is controlled 
during neural development, I used the latest release of both the human (Yates et 
al. 2016) and Drosophila (Attrill et al. 2016) genomes to identify the Drosophila 
orthologues of all the known core CPA factors by BLAST (BLASTN version 2.5.0) 
(Johnson et al. 2008). I found that indeed all core members of the human CPA 
machinery have orthologues in Drosophila. Moreover, when also comparing the 
known yeast proteins against their human counterparts, I found that most 
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Drosophila CPA factors have much higher similarity at the protein level, as shown 
in Figure 3.1. When we consider other studies that also analysed the presence 
of Drosophila orthologues of human genes including general transcription factors 
(Aoyagi and Wassarman 2000) and genes involved in human diseases (Bier 
2005), these results are expected. This high level of similarity observed between 
the human and the Drosophila CPA machinery also suggests that the process of 
cleavage and polyadenylation is not only ancient, but also has been under 
considerable evolutionary selective pressure, which in itself is another advantage 
for this study, meaning that our results can be extrapolated to humans. It has 
been recently shown that other molecular complexes involved in chromatin 
modifications and association with RNA PolII, like the PAF complex (Shi et al. 
1996) can also play roles in APA in mammalian cells (Yang et al. 2016). The 
orthologues of the PAF complex have been investigated in Drosophila (Adelman 
et al. 2006) and striking differences were shown in terms of subunit composition 
and function between these species. Because of this, we will only consider the 
core CPA factors (Figure 1.6) in this study. Shortly after our own analysis of 
Drosophila orthologues of CPA factors, a study in 2012 revealed orthologues of 
members of the CPA machinery in 14 different species, including Drosophila 
using BLAST (Darmon and Lutz 2012). In this study, the authors compared the 
protein domains of CPA factors in these 14 species to assess their structural 
similarity. Because of this, we did not go on to study the specific protein domain 
similarity between humans and Drosophila since we expected, from our protein 
sequence similarity analysis, that they are highly analogous between the two 
species.  
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Figure 3.1 The Drosophila CPA machinery is as complex as its human 
counterpart 
(Legend on the following page) 
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Figure 3.1 The Drosophila CPA machinery is as complex as its human 
counterpart 
Diagram of the human CPA machinery indicating the similarity with its yeast (A) 
and Drosophila (B) orthologues by colour code. Please note that the architecture 
of the yeast CPA machinery is different, but the human architecture was used in 
all diagrams for simplicity. The blue colour indicates the absence of orthologues. 
Note that all factors have orthologues in the Drosophila genome and they show 
higher similarity than their yeast counterparts. The sequences of the human 
proteins were extracted from “Uniprot” (Bateman et al. 2015), the sequences of 
the yeast proteins were extracted from “Saccharomyces Genome Database” 
(Cherry et al. 2012) and the sequences of the Drosophila proteins were extracted 
from “Flybase” (Attrill et al. 2016), when more than one protein isoform was 
present in each species, I used the most similar ones for this diagram, taking in 
account the covered region. Protein sequence comparison was done using the 
NCBI protein-protein BLAST (BLASTP version 2.5.0) (Altschul et al. 1997). 
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Another consideration for the use of Drosophila to study the process of APA, is 
that this model organism has been shown to possess low gene redundancy when 
compared with mammals. Thus, genetic alterations in Drosophila can be 
informative because of lack of redundant genes to cover their function. A good 
example of this phenomenon are the Hox genes. These key developmental 
genes have only one copy each in the Drosophila genome, the model organism 
in which they were discovered (Lewis 1978; Mallo and Alonso 2013) but they can 
have up to four copies each, known as paralogs, in the human and mouse 
genome, with redundant functions (Favier and Dollé 1997; Soshnikova et al. 
2013). To address these considerations, I asked the question of how redundant 
are the CPA factors in the Drosophila genome in comparison with the mammalian 
CPA machinery. This analysis will give valuable information for subsequent 
interpretation of experimental data and will also indicate if, similar to the Hox 
genes, Drosophila is a good system to study these factors to uncover gene 
function and biological roles.  
To achieve this, I analysed both human and Drosophila CPA factor genes in 
“Ensembl” (Yates et al. 2016) to scan for paralogues. I observe that only 3 
Drosophila factors: CPSF73, CPSF30 and CSTF50 have one paralogue in the 
genome. In contrast, 7 human factors: CFI68, CPSF73, CPSF30, CSTF64, 
CSTF50, PAP and PABPN1 had paralogues in the human genome, with PAP, 
PABPN1 and CPSF30 having two paralogues each, as shown in Figure 3.2. 
These results confirm our hypothesis that while the Drosophila CPA machinery 
is as complex as its human counterpart, it also displays lower gene redundancy. 
Studies with the mammalian CPA machinery have shown that paralogs of these 
factors can have specialized functions that are tissue-specific. For example, the  
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Figure 3.2 The Drosophila CPA machinery has lower gene redundancy 
than its human counterpart 
Gene redundancy analysis for the human (A) and Drosophila (B) CPA machinery. 
Note that the human complex has more paralogues in its genome, with two copies 
for PABPN1, PAP and CPSF30. The identification of paralogues in the human 
and Drosophila genome was done using “Ensembl” (Yates et al. 2016). 
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paralog of CSTF64 is known as τCSTF64 (tau-CSTF64). This paralogue has 
been shown to mediate testis-specific PAS selection in the mouse, given that the 
normal CSTF64 gene is inactive during male meiosis (Dass et al. 2001).  
Interestingly, in vitro experiments show that CSTF64 and τCSTF64 display 
different binding affinities for RNA (Monarez et al. 2007), pointing towards the 
complexity of APA regulation in mammalian tissues. Another example of this is 
PAP, which displays 2 paralogs: “PAP β” and “PAP γ”: PAP γ, also known as 
“Neo-PAP”, was discovered in 2001 from human tumour cDNA samples. While 
normal PAP is phosphorylated throughout the cell cycle, Neo-PAP did not show 
signs of phosphorylation, even though this paralogue is also found in the nucleus, 
similar to the canonical PAP (Topalian et al. 2001). These studies show that even 
tissues with abnormally high rates of proliferation, such as human tumours, also 
make use of tissue-specific CPA factor paralogues to achieve their functions. 
Similar to the Hox genes, functional redundancy and back-up genes are an 
established feature of the mammalian CPA machinery. Thus, the low redundancy 
observed in Drosophila also makes it an excellent system to study the molecular 
mechanisms controlling APA during neural development.  
3.2.2 Analysis of evolutionary conservation v/s molecular function of CPA 
factors between humans and Drosophila 
To understand the key steps during 3’ end termination and APA, I decided to 
observe the evolutionary conservation of the most conserved CPA factors 
between Drosophila and humans and in this way relate their conservation with 
their biological functions. From the analysis shown in Figure 3.1, I observe that 
the members of CFI complex: CFI25 (Drosophila CG3689) and CFI68 
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(Drosophila CG7185) are the most conserved proteins between Drosophila and 
humans, with 77% and 79% similarity, respectively. Furthermore, their protein 
domains are also conserved, which will be discussed later in more detail, as it 
indicates functional similarities. These factors were shown to bind to UGUA 
sequences upstream of the polyadenylation sequence (PAS). As I mentioned 
earlier, the crystal structure of CFI suggests that an RNA-looping mechanism 
works to control APA (Figure 1.3) (Yang et al. 2011). These observations 
regarding CFI, as well as its reported effects in APA in cells in culture (Masamha 
et al. 2014; Kubo et al. 2006), make this molecular complex an interesting 
candidate to study further in Drosophila by using known information regarding its 
function in mammalian cells to test if they operate within the nervous system to 
control APA in flies as well.  
The next factors in the similarity ranking are two components of CPSF: CPSF73 
and WDR33, and one component of CSTF: CSTF64, all of them showing 67% 
similarity at the protein level between humans and Drosophila. As described 
earlier, CPSF73 is the endonuclease that cleaves pre-mRNA substrates 
(Banerjee et al. 2006) and WDR33 (Drosophila CG1109) was the final component 
of CPSF discovered (Shi et al. 2009), which has been shown to bind pre-mRNAs, 
specifically the PAS, both in vitro and in vivo (Schonemann et al. 2014).  This 
suggests that WDR33 is the CPSF member responsible for PAS binding, and not 
CPSF160, as has been postulated in previous studies (Murthy and Manley 1995). 
CSTF64 binds to pre-mRNAs and participates in the recognition of the GU-rich 
downstream element (Perez-Canadillas and Varani 2003).  
PAP and PABPN1, showing 61% and 63% protein similarity in Drosophila and 
humans, respectively, are also considered in our ranking study. PAP (Drosophila 
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hrg) is the polymerase that synthesises the poly(A) tail of pre-mRNAs. Since its 
discovery (Wahle 1991b), its structure and function has been well established in 
the literature (Martin et al. 2000; Balbo and Bohm 2007). PABPN1 (Drosophila 
Pabp2) binds to the poly(A) tail and controls its length and PAP processivity  
(Kerwitz et al. 2003; Wahle 1991a). The next factors in this ranking are the 
members of CFII: Pcf11 and Clp1 (Drosophila cbc), showing 56% and 57% 
protein similarity, respectively. CFII is the least characterized complex in 
mammals, and has been studied more thoroughly in yeast (Noble et al. 2007). 
Pcf11 has been shown to interact with the C terminal Domain (CTD) of RNA 
Polymerase II (RNA Pol II), controlling transcription termination (Hollingworth et 
al. 2006). Clp1 binds adenosine triphosphate (ATP) and interacts with Pcf11, 
acting as a bridge between RNA Pol II and the CPA machinery (Haddad et al. 
2012).  
A summary of the aforementioned ranking of protein similarity between the 
Drosophila and human CPA machinery, together with diagrams of their biological 
functions, is shown in Figure 3.3. These observations suggest that both CFI25 
and CFI68 perform key roles for Drosophila 3’ end processing, given their 
extremely high similarity at the protein level with their human counterparts. What 
is more, the observation that all core CPA factors are present in the Drosophila 
genome (Figure 3.1) and that the redundancy observed is much lower than that 
of the mammalian counterparts (Figure 3.2) show us that Drosophila is an 
excellent system to pursue study of the control of APA during neural 
development. In order to explore this, I address the expression levels of CPA  
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Figure 3.3 Protein similarity ranking between the Drosophila and human 
CPA machinery and biological functions  
(Legend on the following page) 
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Figure 3.2 Protein similarity ranking between the Drosophila and human 
CPA machinery and biological function  
Diagrams of the CPA complexes colour coded as in figure 3.1, ordered from top 
to bottom according to their level of protein similarity between Drosophila and 
humans. In each case, a diagram of their biological function is shown, where the 
grey rectangle represents a pre-mRNA from 5’ to 3’ with the main cis-regulatory 
elements indicated. UGUA is the binding site for CFI, PAS is the binding site for 
CPSF and DSE is the binding site for CSTF. The dotted red lines with the scissors 
represents the cleavage site. An already cleaved and polyadenylated mRNA is 
represented for the Non-complex group, to show that PAP and PABPN1 interact 
with the poly(A) tail. CFII are represented as interacting with RNA Pol II. 
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factors during embryogenesis, to see if there is a noticeable change that can be 
related to the onset of 3’ UTR extensions observed during late embryogenesis. 
This experiment will also allow us to test whether 3’ UTR neural extensions are 
achieved by a mechanism in line with the “CPA factor abundance” model by using 
genetic tools available in Drosophila. Further, I examine the expression patterns 
of Drosophila CPA factors in different tissues, to also address whether the 
nervous system displays differential CPA factor expression that can be related to 
the observed 3’ UTR extensions. These experiments and their results will be 
described in the following section.  
3.2.3 The Drosophila cleavage and polyadenylation factors show similar 
expression levels during embryogenesis and an enrichment in neural 
tissues 
As described in the previous section, all human core CPA factors have 
orthologues in Drosophila, with high levels of protein similarity. Furthermore, I 
show that the genetic redundancy of the Drosophila CPA machinery is 
considerably lower than in mammals.  
Experiments in vitro have shown that during differentiation of C2C12 cells into 
myotubes, there is a pervasive lengthening of 3’ UTRs. During this process, a 
downregulation is observed in the expression levels of all CSTF factors: CSTF50, 
CSTF64 and CSTF77 (Ji et al. 2009). These observations suggest that changes 
in the expression levels of core CPA factors can be used as a cue for differential 
PAS selection during cellular differentiation, as shown for the IgM heavy chain 
switch system mentioned previously (Takagaki et al. 1996). Therefore, we asked 
the question: Do expression levels of CPA factors change throughout Drosophila 
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embryogenesis? This is an important question because as we mentioned 
previously, during embryogenesis there is a pervasive lengthening of 3’ UTRs 
within the nervous system (Thomsen et al. 2010; Hilgers et al. 2011). Thus, 
observation of changes in expression levels of CPA factors during this process 
will confirm a trend seen in experimental conditions in vitro and will also allow us 
to precisely manipulate this in vivo in further experiments.  
Data were retrieved from the modENCODE project (Graveley et al. 2011) to 
evaluate the expression levels of all CPA factors during embryogenesis. In this 
database, the authors use RNA-seq to analyse gene expression in thousands of 
Drosophila transcripts during different life stages, including embryogenesis. 
Accordingly, gene expression levels are measured as “Reads Per Kilobase of 
transcript per Million Mapped Reads” (RPKM), which are the measurement units 
given by the RNA-seq method employed in modENCODE (Illumina poly(A) + 
RNA-Seq), these measurements are proportional to the number of cDNA 
fragments that originate from each gene mRNA and are normalized by both 
sequencing depth and gene length. The RPKM measurements were plotted 
against 2 hours-time windows from 0 to 24 hours, covering the full period of 
embryogenesis. To represent these data I grouped CPA factor expression by 
complex, as shown in Figure 3.4. From this analysis, it can be observed that the 
members that form part of the same complex show comparable expression levels 
across embryogenesis, with high expression levels during early embryogenesis 
and low expression levels during late embryogenesis. To show this trend, I 
transformed the RPKM values to relative levels, using the highest expression 
point as 100% and modifying the rest accordingly, with the average of the relative 
expression levels of all CPA complexes shown as a red curve. Rpl32, a ribosomal  
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Figure 3.4 The Drosophila CPA factors show similar expression levels 
throughout embryogenesis 
(Legend on the following page) 
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Figure 3.4 The Drosophila CPA factors show similar expression levels 
throughout embryogenesis 
(A-G) Graphs representing the RNA expression levels, as measured by RPKM 
values (Reads Per Kilobase of transcript per Million mapped reads), of CFI (A), 
CFII (B), CPSF (C), CSTF (D), the Non-Complex group (E), the average of A-D 
(F) and Rpl32 (G) throughout embryogenesis, separated in 2-hours windows. 
Each curve in the diagram represents a member of that complex. At the top, 
embryo diagrams for four representative stages in the indicated time windows 
(Modified from Hartenstein, 1993). Note that for the four complexes CFI, CFII, 
CPSF and CSTF (A-D) the expression levels of their members show a 
comparable trend, having high expression levels during early embryogenesis and 
low expression levels towards late embryogenesis. In contrast, the members that 
do not form part of any complex (Non-Complex group) (E) do not show this trend. 
(F) Relative expression levels of all CPA complexes, using the highest expression 
point as 100% and modifying the rest accordingly. (G) Rpl32 is used as a negative 
control to show that this trend is not a biased generated by the technique 
employed. 
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gene used as a negative control, does not follow this same trend in expression. 
Thus, this observed downregulation in expression of CPA factor as development 
progresses, follows the trend observed during 3’ UTR lengthening in C2C12 cells, 
suggesting that the biological meaning of this decrease in expression, in line with 
the “CPA factor abundance” model, could be related with the shift from proximal 
PAS usage to distal PAS usage in the nervous system. However, the observed 
decrease in expression can be interpreted in another way, given that as 
development progresses, more cells are produced and the tissues become more 
complex. Thus, this could be because there is a general reduction in CPA factor 
expression levels in all cells, or by progressive restricted expression in the 
nervous system. To address whether this is an actual downregulation of CPA 
expression or a consequence of development, we need to analyse the expression 
patterns of CPA factors in detail, which I will explore later in this study.  
I show that similar to studies performed in vitro, a downregulation in the 
expression of CPA factors is observed over the course of Drosophila 
embryogenesis. A question that needs to be addressed for the purpose of this 
investigation is whether this phenomenon is related to the specific control of 
expression within the developing nervous system. By using the model on CPA 
factor abundance for the control of APA as our reference, we expect that neural-
specific CPA factor expression levels are used in order to achieve its extensive 
3’ UTR extensions, resulting in levels being higher or lower when compared to 
tissues in which this pervasive 3’ UTR lengthening is not observed. To address 
this question using available data, I analysed the expression levels of CPA factors 
in Drosophila in different tissues and life stages to see if the nervous system, 
when compared with other tissues, is different in terms of CPA factor expression, 
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therefore offering an indication of the mechanisms used for tissue-specific 3’ UTR 
lengthening.  
Tissue expression data was retrieved from Drosophila third instar larvae and 
adults, which are the available life stages from the Fly Atlas project (Chintapalli 
et al. 2007). This project employs Drosophila microarray chips (GeneChip 
Drosophila Genome 2.0 Array, Affymetrix) mapping the expression of 18770 
transcripts, including all the CPA factor genes. The same amount of RNA per 
tissue (1500 ng) is used for amplification and hybridisation and 4 biological 
replicates are performed. For each gene and tissue, the mRNA SIGNAL value 
was extracted, which represents how abundant the mRNA is in that particular 
tissue and stage. This dataset allowed the analysis of the expression levels of 
the CPA factors in larval and adult tissues, modifying the error bars as to 
represent the calculated confidence intervals of the mean (95%) (SEM given in 
original dataset). Subsequently, a horizontal line is drawn from the lower limit of 
the CNS category for larva, and from the Brain category for Adults. In this way, 
statistical significance is revealed when there is no overlap of the horizontal line 
with the values coming from the other tissues. 
The life stages studied within the Drosophila life cycle, as well as the tissues 
sampled for CPA factor expression levels and their embryonic origin in 
comparison with their human counterparts are shown in Figure 3.5. Although 
humans and Drosophila diverged more than 700 million years ago (Nei et al. 
2001), the tissues used in this study all have a direct homolog in humans. Thus, 
these observations could also be extrapolated in the context of human biology. 
The results of this analysis are shown in figures 3.6, 3.7 and 3.8 and show that 
all members of CFI and CSTF, together with PAP and symplekin show  
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Figure 3.5 Drosophila life cycle and stages used for tissue expression 
analysis with their developmental origin compared between humans and 
Drosophila 
(Legend on the following page)  
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Figure 3.5 Drosophila life cycle and stages used for tissue expression 
analysis with their developmental origin compared between humans and 
Drosophila 
 (A) Life cycle diagram of Drosophila. For CPA factor tissue expression analysis 
the category “Larva” means third instar larva (L3) and “Adult” means 7 days-old 
males and females, both from the “Canton S” wild type strain. A female is 
depicted in the diagram. The time that each developmental stage takes since egg 
laying at 25°C is shown. (B) Diagram of the larval and adult tissues used in this 
study and their human analogues. Organised by the embryonic layer from which 
they form. The arrows connect analogous tissues between the two species. Note 
that all larval and adult tissues used have a corresponding homolog in humans 
and mammals in general. The origin of Drosophila larval and adult tissues was 
retrieved from (Hartenstein, 1993). The origin of human tissues was retrieved 
from (Sadler, 2011). 
 
 
 
 
 
 
 
 
 
96 
 
 
Figure 3.6 mRNA expression analysis of CFI and CFII factors in 
Drosophila larval and adult tissues  
(Legend on the following page) 
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Figure 3.6 mRNA expression analysis of CFI and CFII factors in 
Drosophila larval and adult tissues  
mRNA expression levels for CFI and CFII factors in larval and adult tissues. Error 
bars represent the calculated confidence intervals of the mean (95%) (SEM given 
in original dataset). A horizontal line is drawn from the lower limit of the CNS 
category for larva, and from the Brain category for Adults to display statistical 
significance when compared with other tissues. In larvae, CFI25, CFI68 and Clp1 
show significantly higher expression levels in the CNS when compared with the 
rest of larval tissues. This trend is not seen in adult tissues, in which usually the 
ovaries, testis and male accessory glands show the higher expression levels. “T-
Ab ganglion” stands for Thoracicoabdominal ganglion. 
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Figure 3.7  mRNA expression analysis of CPSF factors in Drosophila 
larval and adult tissues  
mRNA expression levels for CPSF factors in larval and adult tissues. In larval 
tissues, CPSF160, CPSF73 and CPSF30 show significantly higher expression 
levels in the CNS when compared with the rest of larval tissues. This trend is not 
seen in adult tissues, in which ovaries show much higher expression levels 
compared with the rest. Error bars calculated as in Fig 3.6 
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Figure 3.8  mRNA expression analysis of CSTF and “Non-Complex” 
factors in Drosophila larval and adult tissues 
mRNA expression levels for CSTF and “Non-Complex” factors in larval and adult 
tissues. In larval tissues, CSTF50, CSTF77, CSTF64, PAP and Sym show 
significantly higher expression levels in the CNS when compared with the rest of 
larval tissues. This trend is not seen in adult tissues, in which ovaries show much 
higher expression levels compared with the rest. Error bars calculated as in Fig 
3.6 
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significantly higher expression levels in the larval nervous system when 
compared with the rest of the tissues in larvae and adult flies. Conversely, CFII, 
CPSF and PABN1 do not show an enrichment in the larval nervous system, 
although some specific members of these complexes still show neural 
enrichment in larvae, including Clp1, CPSF160, CPSF73, CPSF30 and WDR33. 
On the other hand, none of the CPA factors showed any enrichment in the adult 
brain when compared with other adult tissues.  
The tissues with the highest expression levels of CPA factors in adults are 
actually the testis and ovaries, together with their accessory glands and 
structures. These observations suggest that CPA factors may play crucial roles 
during the formation and rewiring of the nervous system in larvae, possibly 
requiring the orchestration of APA patterns in genes involved in this process. 
Once the developed adult organism is formed, CPA factors may play only a 
physiological role while their developmental one required during earlier stages is 
not strongly required anymore. Thus, the high expression levels observed in the 
adult germline might reflect the importance of the maternal transmission of CPA 
factors to the next generation. These results suggest that the biological meaning 
of this neural enrichment in CPA factor expression can be related to the 
extensively long 3’ UTRs that are observed in this tissue, a hypothesis that is in 
line with the discussed model of CPA factor abundance for PAS selection 
(Takagaki et al. 1996). Thus, in order to have an indication of which CPA factors 
may be key for neural APA to then be experimentally tested, I compare only the 
neural expression levels among them, to then study their expression patterns 
during embryogenesis and address whether the changes in expression levels 
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observed during this process (Figure 3.4) are caused by restriction of expression 
within the nervous system. 
3.2.4 The members of the CFI complex show the highest expression levels 
in neural tissues in larvae and adults and show neural expression 
patterns during late embryogenesis 
From the analysis on the expression levels of CPA factors in different tissues in 
Drosophila in section 3.2.2, it can be observed that nearly 70% of all CPA factors 
show higher expression levels in neural tissues than in other larval tissues. If we 
compare only the neural expression levels across the 16 different CPA factors, 
we see that the members of CFI show the highest expression levels, together 
with PAP and PABPN1, as shown in figure 3.9. Both PAP and PABPN1 are 
factors that act after the APA decision has been made. As will be further 
discussed in section 3.2.4, their biological function in Drosophila, as analysed by 
means of mutations, has been covered in the literature (Murata et al. 2001; 
Murata et al. 1996; Benoit et al. 2005). However, the members of CFI remain 
uncharacterised in Drosophila. As mentioned previously, CFI members have 
been implicated in the control of alternative polyadenylation (Kim et al. 2010). In 
the case of CFI25, it has been shown to be directly implicated in the development 
of glioblastoma and in the shortening of 3’UTRs in glioblastoma patients 
(Masamha et al. 2014). Because of these reasons, our work focused primarily on 
the members of CFI in more detail. First, we analysed the expression patterns of 
CFI25 and CFI68 during Drosophila embryogenesis to see whether they showed 
an enrichment in the nervous system, the logic underlying this experiment is to 
investigate whether the tissue-specific enrichment observed in larval and adult  
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Figure 3.9  Expression levels of Drosophila CPA factors in larval and adult 
neural tissues  
(Legend on the following page) 
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Figure 3.9 Expression levels of Drosophila CPA factors in larval and adult 
neural tissues  
(A-B) Graphs representing the expression levels of CPA factors in larval CNS (A) 
and adult brains (B), according to Fly Atlas (Chintapalli et al. 2007), ranked from 
higher to lower values. Error bars calculated as in Fig 3.6. A horizontal line is 
drawn from the lower limit of CFI25 and CFI68 to show statistical significance 
when compared with other CPA factors. Note that the CFI members are among 
the most abundantly expressed genes in these tissues, together with PAP and 
PABPN1. 
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neural tissues by the FlyAtlas project also occurs in the neural tissues during 
embryogenesis. To analyse the expression pattern of CFI25, I designed and 
synthesised fluorescently labelled anti-sense RNA probes to detect CFI25 mRNA 
transcripts by in situ hybridization (See chapter 2 materials and methods), as a 
control, I used sense probes from the same sequence in order to consider 
unspecific signal. From these experiments it can be seen that during early stages 
of embryogenesis there is ubiquitous signal of CFI25 transcripts. Interestingly, an 
enrichment of expression can be observed within the central nervous system 
during late embryogenesis from stage 14 onwards (Figure 3.10). Furthermore, 
during stage 16, the signal can be seen mostly from the embryonic ventral nerve 
cord and the brain. These results, when compared with the RNA-seq data from 
modENCODE during embryogenesis (Figure 3.4) suggest that the hypothesis of 
a general reduction in CPA factor expression levels in all cells does not account 
for the observed reduction in CPA factor levels during embryogenesis, but rather 
it is a result of the progressive restriction of expression within the nervous system, 
as shown for CFI25.  
To analyse the expression pattern of CFI68, we used a GFP reporter line 
generated recently by Pavel Tomancak’s group (Sarov et al. 2016) (See table 
2.1). The expression pattern of CFI68 as reported by this GFP line, shows the 
same dynamics as CFI25 (Figure 3.11), by which we observe strong neural 
expression during late stages of embryogenesis. These results suggest that CFI 
factors may have a key role for the formation and functioning of the nervous 
system in Drosophila. Surprisingly, CFI factors have not been studied in this 
context even though the nervous system in the late Drosophila embryo has been 
shown to be a tissue that selectively expresses long 3’UTR isoforms of several  
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Figure 3.10  CFI25 shows neural expression pattern during late 
embryogenesis  
(Legend on the following page) 
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Figure 3.10 CFI25 shows neural expression pattern during late 
embryogenesis  
(A-F) CFI25 mRNA staining by in situ hybridization in embryonic stages 12 (A), 
stage 14 (C) and stage 16 (E). Control sense probes were used for the 
corresponding stages (B, D and F). At stage 12 we see a ubiquitous expression 
pattern, which is also seen for earlier embryonic stages (Data not shown). 
However, at stage 14 (C) the embryos show an enrichment of signal in their 
ventral nerve cord and brain. During stage 16 (E), the embryos show strong signal 
in the ventral nerve cord. DAPI was used to label the nuclei and therefore the 
contour of the embryos. (F) Diagram of a lateral view of a stage 13 embryo 
depicting the location and anatomy of the CNS (Modified from Hartenstein, 1993). 
In all pictures and diagram, anterior is to the left and dorsal to the top. 
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Figure 3.11 CFI68 shows neural expression pattern during late 
embryogenesis 
(A-C) GFP stainings in Drosophila embryos for a CFI68-GFP reporter line. (A) 
Lateral view of a stage 12 embryo (Anterior is to the left), during this stage, the 
expression pattern of this GFP reporter is ubiquitous; this is also the case for 
earlier stages (Data not shown). However, during embryonic stage 14 (B) the 
GFP signal shows an enrichment in the central nervous system (Brain and ventral 
nerve cord). During stage 16 (C) the ventral nerve cord shows strong GFP signal 
(Ventral view). DAPI was used to label the nuclei and therefore the contour of the 
embryos. Anterior is to the left and dorsal to the top. 
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genes (Thomsen et al. 2010; Hilgers et al. 2011; Smibert et al. 2012). Thus, I 
address the question on what are the biological roles played by CFI factors in 
Drosophila, as well as other CPA factors. 
3.2.5 Biological roles of Drosophila cleavage and polyadenylation factors 
Drosophila offers a great advantage to assess the biological roles of CPA factors, 
not only because of its homology with mammalian CPA factors and its lower 
redundancy (Figure 3.1 and 3.2), but also because of the accessibility to 
collections of mutant stocks which are publicly available and can be used to study 
gene function. Although more than 85% of Drosophila CPA factors have available 
mutations as transgenic stocks, only four of them have been studied in this 
context to uncover their biological roles: Pcf11 (Milchanowski et al. 2004), 
PABPN1 (Benoit et al. 2005; Kwon et al. 2013), PAP (Murata et al. 2001; Cruz et 
al. 2009; Milchanowski et al. 2004) and CSTF77 (Audibert and Simonelig 1999; 
Fitch et al. 1992; Simonelig et al. 1996; Perrimon et al. 1989; Schalet and Lefevre 
1973; Peter et al. 2002). Unexpectedly, the study of the majority of CPA factors 
have been largely ignored in Drosophila. A representation of this discrepancy is 
shown in Figure 3.12 and a detailed analysis is shown in Table 3.1. From the four 
studied CPA factors, the variety of phenotypes observed is diverse, from defects 
in wing morphology in the case of PAP, where this gene plays a role in the Notch 
cascade (Murata and Ogura 1996) to developmental defects as in the case of 
PABPN1, where this gene controls poly(A) tail length during embryogenesis 
(Benoit et al. 2005). These observations suggest that the CPA machinery is key 
for animal formation and function at the organismal level beyond its molecular 
function. As a result of the analysis of CFI25 and CFI68 (Fig 3.9, 3.10 and 3.11),  
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Figure 3.12  Availability of Drosophila CPA factor mutant stocks v/s 
biological roles uncovered by mutational analysis 
(Legend on the following page) 
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Figure 3.12 Availability of Drosophila CPA factor mutant stocks v/s 
biological roles uncovered by mutational analysis 
(A) Diagram of the CPA machinery, as used in figure 3.1, representing the CPA 
factors that have publicly available mutant stocks versus the factors with no 
available stocks. An account of the number of stocks available is shown in the 
brackets, with a detailed analysis in table 3.1 (B) Diagram showing the CPA 
factors with available mutant stocks and the factors that have been studied by 
mutational analysis to uncover their biological functions. 
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Table 3.1 Availability of Drosophila CPA factor mutant stocks v/s biological roles uncovered by mutational analysis 
Complex Gene Drosophila name 
Mutant 
stocks 
available 
Genotype (Simplified) Nature of mutation Phenotype Reference 
CFI 
CFI25 CG3689 1 P{EP}CG3689G19200 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CFI68 CG7185 4 
P{wHy}CG7185DG14101 Transposable element insertion No information available 
(Bellen et al. 
2004) 
P{PTTGC}CG7185CC00645 Transposable element insertion No information available 
(Buszczak et 
al. 2007) 
P{RS3}CG7185CB-6365-3 Transposable element insertion No information available 
(Ryder et al. 
2004) 
PBac{RB}CG7185e04468 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CFII 
Pcf11 Pcf11 2 
P{lacW}Pcf11k08015 Transposable element insertion 
Reduced number of crystal cells in 
late embryos 
(Milchanowski 
et al. 2004) 
P{lacW}Pcf11k08023 Transposable element insertion No information available 
(Bellen et al. 
2004) 
Clp1 cbc 3 PBac{RB}cbce00083 Transposable element insertion No information available 
(Bellen et al. 
2004) 
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cbcT7-1 
Point mutation by 
ethyl 
methanesulfonate 
No information available 
Personal 
communication 
to FlyBase 
cbcT13-5 
Point mutation by 
ethyl 
methanesulfonate 
No information available 
Personal 
communication 
to FlyBase 
CPSF 
CPSF160 CPSF160 1 P{EP}Cpsf160G8231 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CPSF100 CPSF100 3 
PBac{WH}Cpsf100f00376 Transposable element insertion No information available 
(Bellen et al. 
2004) 
PBac{RB}Cpsf100e01814 Transposable element insertion No information available 
(Bellen et al. 
2004) 
PBac{WH}Cpsf100f00691 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CPSF73 CPSF73 0 - - - - 
CPSF30 Clp 0 - - - - 
Fip1 Fip1 1 P{EPgy2}Fip1EY20218 Transposable element insertion No information available 
(Bellen et al. 
2004) 
WDR33 CG1109 2 P{wHy}CG1109DG23504 Transposable element insertion No information available 
(Bellen et al. 
2004) 
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PBac{RB}CG1109e00264 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CSTF CSTF77 Su(f) 10 
su(f)8 ethyl methanesulfonate 
Adult females with reduced number 
of follicle cells in the ovaries. 
(Audibert and 
Simonelig 
1999) 
su(f)1 X ray 
enhancement of wa phenotype at 
29°C and almost complete 
suppression of f1 phenotype 
(Fitch et al. 
1992) 
su(f)5 Internal deletion by X ray No information available 
(Simonelig et 
al. 1996) 
su(f)16-185 Breakpoint within su(f) No information available 
(Simonelig et 
al. 1996) 
su(f)6 Internal deletion by X ray 
Lethality during larval or pupal 
stages 
(Perrimon et 
al.1989) 
su(f)3 diethyl sulfate, ethyl methanesulfonate 
su(f)4/su(f)3 females show the "pale 
bristles" phenotype in some of the 
bristles and hairs 
(Schalet and 
Lefevre 1973) 
P{lacW}su(f)G0393 Transposable element insertion lethality before end of larval stage 
(Peter et al. 
2002) 
Mi{ET1}su(f)MB05229 Transposable element insertion No information available 
(Bellen et al. 
2004) 
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Mi{MIC}su(f)MI07412 Transposable element insertion No information available 
(Venken et al. 
2011) 
Mi{MIC}su(f)MI08254 Transposable element insertion No information available 
(Venken et al. 
2011) 
CSTF64 CSTF64 1 P{EP}CstF-64G16431 Transposable element insertion No information available 
(Bellen et al. 
2004) 
CSTF50 CSTF50 1 P{ID.GAL4AD}CstF50G10.1 Transposable element insertion No information available 
(Gohl et al. 
2011) 
Non-
Complex 
Symplekin Symplekin 3 
P{EPgy2}SymEY20504 Transposable element insertion No information available 
(Bellen et al. 
2004) 
Sym30m1 P-element activity No information available 
Personal 
communication 
to FlyBase 
Sym16m2 P-element activity No information available 
Personal 
communication 
to FlyBase 
PAP hrg 10 
P{RS5}hrg5-SZ-3571 Transposable element insertion No information available 
(Ryder et al. 
2004) 
PBac{WH}hrgf06255 Transposable element insertion No information available 
(Bellen et al. 
2004) 
P{EPgy2}hrgEY10340 Transposable element insertion No information available 
(Bellen et al. 
2004) 
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P{GSV1}hrgs-222.2 Transposable element insertion 
Dpp pathway-like phenotype in 
wing 
(Cruz et al. 
2009) 
P{RS5}hrg5-HA-2037 Transposable element insertion No information available 
(Ryder et al. 
2004) 
P{SUPor-P}hrgKG01510 Transposable element insertion No information available 
(Bellen et al. 
2004) 
hrg10 P-element activity Notched wing margin (Murata et al. 2001) 
P{UAS-RBZ.ftz-F1}hrgP1 Transposable element insertion 
Mutants have a notched wing 
phenotype 
(Murata et al. 
2001) 
hrg1 P-element activity Reduced number of crystal cells in late embryos 
(Milchanowski 
et al. 2004) 
P{lacW}hrgk07619 Transposable element insertion 
Reduced number of crystal cells in 
late embryos 
(Milchanowski 
et al. 2004) 
PABPN1 Pabp2 8 
P{PTT-GA}Pabp2ZCL3178 Transposable element insertion No information available 
(Benoit et al. 
2005) 
P{XP}Pabp2d09497 Transposable element insertion No information available 
(Bellen et al. 
2004) 
PBac{RB}Pabp2e02513 Transposable element insertion No information available 
(Bellen et al. 
2004) 
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P{UAST-
YFP.RabX1.T19N}Pabp201 
Transposable 
element insertion 
Enhanced wing nicking phenotype 
caused by dom knockdown in 
wings 
(Kwon et al. 
2013) 
P{SUPor-P}Pabp2KG02359 Transposable element insertion No information available 
(Bellen et al. 
2004) 
Pabp255 P-element activity 
Lethality during late 
embryogenesis, different 
distribution of polyA tail lengths 
(Benoit et al. 
2005) 
Pabp26 P-element activity 
Development arrested at stage 8, 
about half have polarity defects or 
a thin chorion 
(Benoit et al. 
2005) 
P{GawB}Pabp2NP5913 Transposable element insertion No information available 
(Hayashi et al. 
2002) 
 
  
I addressed the question of what is their biological relevance for Drosophila 
development. In order to do this, I first analysed mutant lines for CFI25 and CFI68 
(alleles P{EP}CG3689G19200 and P{PTTGC}CG7185CC00645) (See table 2.1 and 
3.1) for viability from embryos to adulthood. By doing this I could obtain an 
indication of their roles for development, which will be then studied in subsequent 
chapters. As shown in Figure 3.13, mutants for both CFI25 and CFI68 show 
lethality and are inviable as adults. The alleles tested are transposable element 
insertions, meaning that a complete removal of the gene product, as in the case 
of a null mutation, is not necessarily expected. Nevertheless, a penetrance of 
100% is still observed for this phenotype. Furthermore, an unexpected 
observation in mutants for CFI25 led me to investigate this line further, as we will 
discuss in Chapter 4. 
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Figure 3.13  CFI mutants are inviable and do not develop into adulthood  
Viability essay with wild types (W) and homozygous mutants for CFI25 and CFI68 
(P{EP}CG3689G19200 and P{PTTGC}CG7185CC00645), the values represent the 
mean of the percentage of adults (N = 30, biological triplicate). Note that both 
mutations make the individual inviable as adults. Error bars represent the SEM, 
statistical significance was assessed with unpaired two tailed t-test (* p < 0.05). 
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3.3 Discussion  
The work presented in this chapter first shows that the Drosophila CPA machinery 
is as complex as its human counterpart. The advantages of Drosophila as a 
powerful genetically tractable system make it an excellent system to study the 
main question of this study, which is to understand how APA is controlled during 
neural development. Although humans and Drosophila diverged more than 700 
million years ago (Nei et al. 2001), I show that all CPA factors are not only present 
in the Drosophila genome, but show a level of similarity to the human version of 
the proteins up to 79% for the case of CFI members. These observations, though 
somehow expected given previous comparisons of gene similarity between 
Drosophila and humans (Bier 2005; Aoyagi and Wassarman 2000), are 
reassuring for the use of this model system to address the mechanisms 
controlling APA in the nervous system. Moreover, they suggest that the CPA 
machinery has been under high evolutionary pressure over time. Accordingly, 
most of the key protein domains for CPA factor function have been conserved 
between Drosophila and humans (Darmon and Lutz 2012). Exceptions to this fact 
are, for instance, the absence of the “pro/gly-rich” region in the Drosophila 
CSTF64 protein, also absent in yeast, which is present in the human counterpart 
(Takagaki et al. 1992), this region is adjacent to the hinge, which interacts with 
CSTF77 and symplekin in a mutually exclusive manner (Ruepp et al. 2011). The 
molecular function of this “pro-gly rich” region is yet unknown. Likewise, a 
pentapeptide repeat motif known as “MEARA/G” which is next to the “pro/gly rich” 
domain in the human CSTF64 protein, towards its C-terminal, is also absent in 
Drosophila. This region has also an unknown function, although it has been 
shown in vitro to form a helical structure in solution (Richardson et al. 1999). 
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Although the former domains are not present in the Drosophila CSTF64 protein, 
the key domains for the function of this protein are, such as the RNA Recognition 
Motif (RRM), which allows CSTF64 to physically bind to pre-mRNAs on their 
Downstream Sequence Elements (DSE) (Takagaki and Manley 1997), as well as 
the hinge region and its C-terminal domain, which was shown to form a three-α-
helix bundle structure. This structure is required for polyadenylation and for 
interaction with Pcf11 (Qu et al. 2007). Thus, the presence of these domains in 
Drosophila allow us to infer that its function has been conserved during evolution. 
The results of this chapter also describe that the expression levels of CPA factors 
during Drosophila embryogenesis show a comparable trend. In which high levels 
of expression are observed during early stages and low levels are observed 
during late stages of embryogenesis. A question that emerges from this 
observation is: What is the cause of this general reduction in expression levels? 
One way of investigating this would be to observe whether common regulatory 
elements in the form of promoters and enhancers, control CPA factor genes 
locally in the genome. However, these genes are dispersed in the genome, being 
located in all 3 main chromosomes and distant from each other (Drosophila has 
four chromosome pairs, but chromosome 4 is much smaller and contains fewer 
genes (Sun et al. 2000)). Thus, gene expression control through common 
regulatory elements seems unlikely. However, the expression levels mined from 
databases show that all CPA factors are maternally delivered into embryos. In 
adults, the high expression levels in both testis and ovaries suggest that CPA 
factor transcript levels decrease as a function of use during embryogenesis. From 
this information it could be speculated that during the maternal to zygotic 
transition and towards late embryogenesis, CPA factors start being expressed 
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and enriched in the nervous system. Nonetheless, the point at which this process 
happens for CPA factors is not known, neither are all promoters and regulatory 
elements that control their expression. I also show that the larval nervous system 
shows an enrichment in expression of nearly 70% of all CPA factors, with the 
members of CFI being the ones with the highest expression values not only in 
larval brains, but also in adult brains. Despite the fact that adult brains do not 
show an enrichment in CPA factor expression in comparison with other tissues, 
such as the ovaries and the testis, where an enrichment is definitely observed.  
From in situ hybridisation, I have clarified this picture by showing that the 
members of CFI: CFI25 and CFI68 in Drosophila embryos show neural 
expression patterns during late stages of embryogenesis. These results show an 
interesting correlation with the observed phenomenon of longer 3’UTR isoforms 
in hundreds of genes observed in Drosophila during late embryonic, larval, pupal 
and adult life (Hilgers et al. 2011; Thomsen et al. 2010; Smibert et al. 2012). This 
observation also raises the question: How is APA controlled in non-neural tissues 
given their apparent lack of expression of CFI members? A plausible answer is 
that because of the detection limits of the techniques employed, non-neural 
tissues still express CFI and potentially other CPA factors, although in much lower 
levels than the ones observed in neural tissues. Furthermore, at least in larval 
and adult tissues we can observe that all other tissues show expression of CPA 
factors even if the nervous system of larvae or the reproductive organs in adults 
show considerably higher expression levels (Figures 3.6, 3.7 and 3.8). 
Fascinatingly, this biological property of the nervous system to express long 
3’UTRs has been shown to be even more widespread, concerning also the 
complex mammalian brain (Miura et al. 2013). These observations point towards 
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the need for mechanisms that can explain this pervasive trend. Experiments 
addressing this observation have started to be explored in recent years. For 
example, The RNA-binding protein ELAV was shown by our laboratory to control 
Hox RNA-processing. More specifically, removal of ELAV leads to a shortening 
in the 3’UTR of the Hox gene Ultrabithorax (Ubx). As a matter of fact, ectopic 
expression of ELAV during germ band extension stage, during which the short 
isoform of Ubx is expressed, leads to an increase in the long isoform (Rogulja-
Ortmann et al. 2014). These experiments show that ELAV is sufficient to control 
Hox RNA-processing in vivo. Yet, the control of APA during neural development 
by core CPA factors is not well understood. Other experiments have shown that 
the knockdown of CPA factors can alter APA decisions in cells. Interestingly, 
CFI25 has been shown to be primarily mediating this process in HeLa cells (Kubo 
et al. 2006; Masamha et al. 2014). This has also been shown to be the case for 
more CPA factors by using siRNA knockdowns in C2C12 cells, where some 
principles were discovered. For instance, Pcf11 and Fip1 enhance the use of 
proximal PAS, while CFI25, CFI68 and PABPN1 enhance the use of distal PAS 
(Li et al. 2015). 
Finally, I show that although more than 85% of all Drosophila CPA factors offer 
the option of uncovering their biological roles by studying what occurs in mutant 
conditions given the availability of mutant stocks, only a surprising 25% of them 
have been studied in this context in Drosophila. Hence, the main aims of this 
thesis are to (i) understand how APA is controlled during neural development and 
(ii) address the biological roles of APA and core CPA factors. In light of the 
preliminary and promising results presented in this chapter, the further questions 
are addressed for the case of CFI in the next chapters. 
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Chapter 4  
Normal expression of the cleavage and 
polyadenylation factor CFI25 is required for 
feeding behaviour in Drosophila 
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4.1 Chapter overview 
In the previous Chapter I showed that 14 out of the 16 core CPA factors in 
Drosophila have publicly available mutant stocks that can be used to study CPA 
factor function and biological relevance in vivo. So far, only four Drosophila CPA 
factors have been studied in the literature (Figure 3.12): Clp1, PABPN1, PAP and 
CSTF77. Interestingly, mutations in the studied CPA factors show a variety of 
effects on different tissues. PAP mutations affects wing morphology (Murata and 
Ogura 1996) while CSTF77 mutations affects bristle formation in the adult 
(Schalet and Lefevre 1973) (Table 3.1). These results point towards CPA factors 
having varied roles at the tissue and organismic level beyond their established 
molecular functions.  
In the following Chapter, I analyse the uncharacterised Drosophila gene CG3689, 
which encodes the orthologue of mammalian CFI25. I show that a mutation in 
CFI25 (by means of an insertion of a transposable element) leads to a 
developmental arrest at the first instar larval stage. Moreover, the cause of this 
arrest is a defect in larval feeding, in which CFI25 mutant larvae show a collapsed 
mouth hook phenotype as well as defects in passage of food from the pharynx to 
the midgut. I hypothesised that one or more downstream target genes must be 
affected in CFI25 mutants so that their abnormal APA isoforms or total mRNA 
expression levels trigger the observed phenotypes. A bioinformatic pipeline 
provided nine candidate target genes, from which four have affected APA 
patterns in CFI25 mutants (S6k, klu, RanBPM and lov) and three have affected 
mRNA expression levels (S6k, klu and lov). These results suggest that CFI25 has 
important roles for Drosophila neural development and behaviour.   
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4.2 Results 
4.2.1 CFI25 mutants are developmentally arrested during first instar larvae 
stage  
In Chapter 3 I analysed the Drosophila CPA orthologues and showed that the 
members of CFI are (i) the most conserved factors at the protein level between 
humans and Drosophila (Figure 3.1), (ii) they are among the most abundantly 
expressed genes in both larval and adult brains (Figure 3.6), (iii) they show neural 
expression patterns during late embryogenesis (Figure 3.10 and 3.11) and (iv) 
mutations in CFI25 and CFI68 lead to unviability in adulthood (Figure 3.13). In 
fact, I observe that CFI68 mutants died during embryogenesis, which was not the 
case for CFI25 mutants. The reason for this difference can be due to both the 
nature of the alleles tested and also because CFI25 and CFI68 do not play exactly 
the same molecular function, as discussed in Chapter 1.  
The first question to answer was to understand at what point during the life cycle 
of Drosophila CFI25 mutants die, if at all, to see whether CFI25 is required for 
survival in the same way as CFI68. To address this, I did a viability experiment 
with three independent populations of synchronised embryos (N=50), using 
Oregon R wild type embryos as a control, and let them develop into adulthood, 
scoring for each individual that reached every life stage from embryo to L1, L2, 
L3, pupae and adults (Different larval stages were distinguished according to 
previously described anatomical features  (Ashburner, 1989) (For a diagram of 
the Drosophila life cycle, see Figure 3.5 panel A). From this experiment I 
observed that the majority of CFI25 mutants did not reach the L2 stage (Figure 
4.1). This obviously led to the next question, regarding the reasons behind the 
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lack of viability of second instar larva in CFI25 mutants. To address this, I again 
did a survival experiment with three independent populations of synchronised 
embryos (N=50) using Oregon R wild type embryos as a control, but this time, 
only the numbers of first instar larvae were measured over time (in days). By 
doing this, we can know at what point the lethality occurred in the mutants, i.e. if 
it occurs during the first instar larvae stage (L1), or just after entering the second 
larval instar stage (L2). What I found was quite surprising, as it could be observed 
that CFI25 mutants stay as L1 larvae for up to 5 days after hatching from the egg 
chambers, whereas wild type larvae stay as L1 larvae only for 24 hours and then 
moult into the second larval instar (L2), following the normal developmental 
program. This means that CFI25 mutants do not reach the second larval instar 
because they remain developmentally arrested at the first instar larval stage 
(Figure 4.2). 
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Figure 4.1 CFI25 is essential for larval viability  
Survival experiment with wild types and CFI25 homozygous mutants, the values 
represent the mean of the percentage of individuals that reach each life stage (N 
= 50, biological triplicate). Note that less than 20% of the mutants reach the L2 
stage. For each stage within the life cycle, a representative image is shown (From 
figure 3.5). Error bars represent the SEM, statistical significance was assessed 
with unpaired two tailed t-test per life stage (* p < 0.05). 
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Figure 4.2 CFI25 mutants are developmentally arrested during first instar 
larval stage 
Survival experiment with wild types and CFI25 homozygous mutants, the values 
represent the mean of the percentage of first instar larvae during each day after 
egg laying (N = 50, biological triplicate). Note that from day 2, a significant number 
of L1s are present for CFI25 mutants, while the wild types moult into L2s. The 
number of L1s for the mutant gradually decrease over time because they die at 
this stage. Error bars represent the SEM, statistical significance was assessed 
with unpaired two tailed t-test per life stage. All comparison were above sampling 
error. Note: n.s = Non significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 
0.0001. 
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4.2.2 CFI25 mutants show a feeding phenotype 
After observing that CFI25 mutants stay developmentally arrested as first instar 
larvae, I explored the reasons behind the observed phenotype. One possibility is 
that defects in hormonal signalling involved in larval transitions, for example 
Ecdysone, which normally pulses throughout the life-cycle to induce 
developmental transitions (Yamanaka et al. 2013), has some kind of defect, 
therefore impairing the ability of CFI25 mutants to moult into the L2 stage. 
Another possibility is that the defects in CNS formation from the mutation of CFI25 
make these mutants unable to move or function at all, therefore only allowing 
them to hatch from an embryo as an L1 that will not develop further. What was 
found, unexpectedly, was that CFI25 mutants show a feeding phenotype, by 
which most hatched L1 individuals do not feed and therefore do not grow, which 
results in the delayed or arrested development of the larvae.  
I decided to quantify this phenotype, and to score for feeding, I exposed freshly 
hatched L1s to blue yeast paste for one hour at 25ºC (See Chapter 2).  This 
allows the food to be seen through the translucent skin of the larvae. I scored for 
blue food intake in CFI25 mutants and I observed that approximately 80% of the 
freshly hatched L1s do not show any food intake (Figure 4.3). CFI25 mutants 
(Allele G19200) have an insertion of a 7987 bp P{EP} element in its 5’UTR, which 
was generated by the Gene Disruption Project (Bellen et al. 2011; Bellen et al. 
2004). I measured feeding in both heterozygous (G19200/+) and homozygous 
(G19200/G19200) mutants and I observed that the phenotype is significant only 
in the latter case, showing that this a recessive allele. As controls, I generated a  
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Figure 4.3 CFI25 mutants show a feeding phenotype  
(Legend on the following page) 
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Figure 4.3 CFI25 mutants show a feeding phenotype 
(A) Representative pictures of CFI25 mutant L1s during a feeding test on plates 
with blue yeast paste at 0, 20, 40 and 60 minutes. The red arrow in each panel 
indicate a larva during the feeding test. Note that the animals stay attracted to the 
blue yeast during the time that the experiment takes, similarly to wild types (B) 
Representative pictures of wild type and mutant first instar larva after one hour of 
exposure to blue yeast paste, note that CFI25 mutants do not show signs of food 
intake. (C) Gene map diagram of the location of CFI25 in the Drosophila genome, 
the grey boxes represent UTRs, the yellow boxes represent exons and the 
horizontal lines connecting boxes represent introns, the arrowheads represent 
the orientation of transcription. The location of the insertion of transposable 
elements used for this experiment is indicated by red triangles (D) Quantification 
of food intake in Wild Types (OR, see table 2.1), w (Genetic background of CFI25 
mutation), CG4022 mutants (PBac{PB}CG4022c05627 and 
P{GSV6}CG4022GS12916), CFI25 heterozygous (G19200/+) and homozygous 
mutants (G19200/G19200) and CFI25 revertants (N = 30, biological triplicate, 
error bars represent the SEM). 
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revertant by excision of this P{EP} element from the original CFI25 mutants by 
using a Δ2-3 transposase transgenic line (See Chapter 2), these revertants lost 
the observed feeding phenotype and behave as the wild type. In addition, the 
transcriptional start site of CFI25 is located 200 bp away from the transcriptional 
start site of CG4022, a gene with no reported molecular function (See figure 4.3). 
This led to the question of whether the phenotype observed is caused by 
transcriptional disruption of this gene instead of CFI25, given that the promoters 
of both genes are not characterized. To address this consideration, I used two 
insertional mutants affecting the 5’ UTR of CG4022. The first mutant is a 7257 bp 
insertion from the Gene Disruption Project (Allele PBac{PB}CG4022c05627) (Bellen 
et al. 2004) and the second is another 6836 bp insertion from the Gene Search 
System (P{GSV6}CG4022GS12916) (See Chapter 2) (Toba et al. 1999). A feeding 
phenotype was not observed in these mutant stocks. These experiments show 
that the insertion of this P{EP} element in the 5’ UTR of CFI25 mutants (Allele 
G19200) is specific to the cause of the observed phenotype. As mentioned 
earlier, the nature of this mutation in CFI25 is an insertion of a transposable 
element in its 5’UTR (Figure 4.3, panel C). Therefore, a complete removal of 
CFI25 is not necessarily expected, but requires verification. To test this, the levels 
of CFI25 in both wild types and mutants were quantified in different ways. First, I 
looked at total mRNA levels by RT-PCR during late embryogenesis, where a 
reduction of approximately 80% of CFI25 could be observed in the mutants when 
compared with the control. Secondly, by using an antibody for the human version 
of CFI25 (See Chapter 2), whose immunogenic region is 86% similar in 
Drosophila, I was able to detect Drosophila CFI25 and observe a similar trend in 
Western Blot experiments. Lastly, by using the same in situ RNA probes used to 
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study the expression pattern of CFI25 in embryos (See Chapter 2 and Figure 
3.10), I observe that the mutants show a substantial reduction of signal in the 
ventral nerve cord in late embryos (Figure 4.4). I had previously tried to use this 
same antibody for immunofluorescence experiments against CFI25 in embryos, 
given the lack of antibodies for the Drosophila CFI members, but unfortunately 
the antibody did not show any signal (Data not shown). This is likely to be caused 
by this antibody recognising only the denatured protein, as used in WB 
experiments (Chapter 2).  
To address why CFI25 mutants are not able to feed at L1 stage, we first need to 
understand whether this is a morphological or behavioural defect. I first analysed 
the phenotype in more detail by examining the larval cephalopharyngeal skeleton 
(CPS). These structures are a group of connected sclerites of the anterior 
embryonic/larval digestive system and are used for feeding. The main CPS 
components are the mouth hooks, the H-piece and the cephalopharyngeal plates. 
The mouth hooks are two movable structures situated at the tip of the skeleton 
and used to shovel food into the pharynx, which are connected to the rest of the 
CPS by bilaterally symmetric processes. The H-piece is situated between the 
mouth hooks and the cephalopharyngeal plates on the ventral side and together 
with smaller components including the median tooth, act as a bridge to give 
rigidity to the CPS. The cephalopharyngeal plates are simpler in structure, 
showing both a ventral and dorsal division, which attach the CPS to the rest of 
the structures in the larval head. Their formation during embryogenesis is 
achieved during late stages in the gnathal segments, more specifically, the 
mandibular segment, where its structures are shaped by  
  
134 
 
 
Figure 4.4 CFI25 mutants show reduced levels of CFI25 RNA, as well as 
protein and a reduction of expression from the ventral nerve cord 
(Legend on the following page) 
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Figure 4.4 CFI25 mutants show reduced levels of CFI25 RNA, as well as 
protein and a reduction of expression from the ventral nerve cord 
(A-B) Representative bands from an RT-PCR experiment to measure CFI25 
mRNA levels in stage 16 embryos using RpA1 as a loading control (See Chapter 
2). (B) Quantification of (A) (Biological triplicate), mRNA levels are shown as 
percentage from the control. Note that CFI25 mutants show a significant 
reduction in mRNA levels. An unpaired two-tailed t-test was used to compare 
genotypes, * p < 0.05. (C) Western Blot experiment to measure CFI25 protein 
levels in stage 16 embryos using tubulin as a loading control (See Chapter 2). 
The same trend as in (A) is observed, this experiment was also performed in 
three independent biological replicates. (D) In situ hybridisation experiment for 
CFI25 in wild types and mutants, note that the mutants have a reduction in the 
signal coming from the ventral nerve cord in stage 16 embryos. DAPI was used 
to label the nuclei. The confirmation of the presence, location and orientation of 
the P{EP} element in CFI25 mutants was done by PCR (Data not shown). 
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secretion of cuticle by the cells lining the atrium, pharynx and frontal sac  
(Campos-Ortega and Hartenstein, 2013). The CPS is connected to specialized 
muscles involved in feeding, among them the cibarial dilator muscles that lift the 
roof of the pharynx and thereby widen its lumen, allowing food to be ingested 
(Schoofs et al. 2010; Jürgens et al. 1986).  
I observed that CFI25 mutants have anatomical defects in their mouth hooks, 
more specifically, their CPS shows a “collapsed” phenotype in which the dorsal 
and ventral processes of the cephalopharyngeal plates point inwards. As a result 
of this, the angle between the median tooth and the caudal processes is 
significantly larger in CFI25 mutants (Figure 4.5). This phenotype shows a similar 
penetrance as that of feeding (Nearly 80%, N = 30) and can explain in part the 
feeding defects observed in CFI25 mutants. Further, there are cases in the 
literature where mutated genes that control the fate of feeding structures from the 
mandibular and maxillary segments can also have an impact on feeding. For 
example, the Hox gene deformed (Dfd) precisely controls patterning in these 
segments. Its name comes from the deformed cephalic phenotype observed in 
mutants, reflecting failures during the process of head involution (Merrill and 
Turner 1987). Interestingly, a recent study showed that Dfd is required for the 
establishment and maintenance of the neuromuscular unit required for feeding, 
by specification of synapses and stage-specific sets of target genes during larval 
stages (Friedrich et al. 2016). Thus, the phenotype observed in CFI25 mutants 
could also be a reflection on effects on target genes with neural roles. 
I examined at what point during the larval feeding cycle CFI25 mutants were not 
able to ingest food. To address this, I exposed them for one hour with yeast paste  
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Figure 4.5 CFI25 mutants show anatomical defects in their 
cephalopharyngeal skeleton  
(Legend on the following page) 
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Figure 4.5 CFI25 mutants show anatomical defects in their 
cephalopharyngeal skeleton 
(A-B) Ventral view of anterior structures of first instar larvae in Wild Type (A and 
C) and CFI25 mutant (B and D), anterior is to the left. (C) Magnification of the 
CPS from the wild type (A) to show its normal anatomy during this stage. The 
dotted circle represents the angle between the median tooth and the caudal 
processes of the cephalopharyngeal plates. (D) Magnification of the CPS from 
CFI25 mutants (B), note that the dorsal and ventral processes of the 
cephalopharyngeal plates point inwards (marked with an asterisk) and also the 
angle between the median tooth and the caudal processes is larger, denoted by 
an arrowhead. (E) Structures of the CPS in the larval head from (Campos-Ortega 
and Hartenstein, 2013) for reference. (F) Quantification of the angle between the 
median tooth and the caudal processes in wild types and mutants (N = 20). An 
unpaired two-tailed t-test was used to compare genotypes, * p < 0.05. The scale 
bar represents 50 µm. mto = Median tooth, Hp = H-Piece, cp = Caudal process 
of the cephalopharyngeal plates, vp = Ventral process of the cephalopharyngeal 
plates, ci = Maxillary cirri, mh = Mouth Hook, ncl = neck clasps, op = oral process 
of the H-piece 
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mixed with DAPI (See Chapter 2), which has been shown to label the nuclei of 
not only fixed, but also living cells (Martin et al. 2005). The rationale of this 
experiment is that as the DAPI-stained yeast moves though the digestive system, 
the cells that come in contact with it will become labelled, as well as yeast cells 
themselves (Krol et al. 2003). Then, after the hour of exposure, I look at the extent 
of DAPI staining. It would be expected in the wild type controls, to have labelled 
the digestive system at least until the midgut. Compared to the wild type larvae, 
it was observed that CFI25 mutants are not able to pump food into their midgut, 
and the yeast paste stays trapped in their pharynx (Figure 4.6). 
In summary, these results show that CFI25 mutants are developmentally arrested 
at the L1 stage, the reasons behind which is a feeding phenotype, which prevents 
the onset of the larval transition into L2 stage. These defective CFI25 mutants 
have also been shown to have lower levels of CFI25 at the mRNA and protein 
level, which can now be considered the reason behind the phenotype observed. 
Lastly, CFI25 mutants also display defects in the anatomy of their CPS, as well 
as problems in the movement of food from the pharynx to the midgut, relating the 
phenotype to a morphological defect in these larvae. In the next section we will 
analyse other important aspects of feeding in CFI25 mutants, such as the nervous 
system and behaviour. 
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Figure 4.6 CFI25 mutants do not pump food into their midgut 
(Legend on the following page) 
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Figure 4.6 CFI25 mutants do not pump food into their midgut 
(A-D) Lateral view of anterior structures of first instar larvae in Wild Type (A and 
C) and CFI25 mutants (B and D), anterior is to the left. (A) After one hour of 
exposure to DAPI-stained yeast paste, the wild types show their anterior portion 
of the digestive system, known as the pharynx, completely labelled. (B) The same 
is observed for midgut in the wild types. A white dotted line is used to show the 
outline of the larvae. (C) Similarly, CFI25 mutants also show stained cells in their 
pharynx. However, (D) their midgut is not labelled and shows only background 
signal also observed in Non-DAPI control wild types used for auto fluorescence 
(Data not shown). These results show that CFI25 mutants do not pump food into 
their midgut and instead it gets trapped in the pharynx. Panels (A-B), as well as 
panels (C-D), were taken from the same individual. (E) Diagram of the larval 
digestive system (modified from Hartenstein, 1993), the two red frames represent 
the regions of interest shown in panels (A-D). The scale bar represents 50 µm. 
Relevant structures are ph = Pharynx, es = Esophagus, pv = Proventriculus, mg 
= Midgut.   
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4.2.3 CFI25 mutants do not show locomotory differences or major defects 
in the anatomy of the nervous system when compared with wild types 
In Chapter 3 the expression pattern of CFI25 in the late embryo was analysed 
and it was observed that it shows an enrichment in the nervous system (Fig 3.10). 
In the case of CFI25 mutants, a reduction of CFI25 expression can be observed 
in this tissue (Figure 4.6). In order to test whether the phenotype is related to the 
function of the nervous system, I performed behavioural experiments by 
measuring three different parameters related with locomotory behaviour and 
feeding. First, a common locomotory parameter was analysed, which is called the 
frequency of forward peristaltic waves per minute. By determining this, I can 
identify if CFI25 mutants move less and generally do not explore the substrate on 
which they are growing. The neural circuitry controlling this behaviour has been 
studied (Berni et al. 2012; Fushiki et al. 2016) and can be related to other neural 
genes that also show a feeding phenotype when mutated, such as lov, which has 
been described as presenting this phenotype as a consequence of locomotor 
defects (Bjorum et al. 2013).The results of this analysis showed that there is no 
significant difference in the frequency of forward peristaltic waves per minute 
between CFI25 mutants and wild type larvae (Fig 4.7).  
The remaining behavioural parameters I measured can be related between them. 
First I measured the fraction of the time of each recording (2 minutes) that the 
individual spent performing mouth hook movements. Then, given that the larvae 
display this activity in bouts, I measured how many bouts of mouth hook 
movements they did in each recording. These parameters allow us to detect how 
often the larvae decide to engage in the food intake motor program. Recurrent 
motor programs such as locomotor or feeding programs are controlled by central 
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pattern generators in the central nervous system. It has been shown that neuronal 
activation of only 20 neurons in the Drosophila larval brain, known as the “hugin” 
neurons, can suppress the motor program for food intake while induce the 
program for locomotion (Schoofs et al. 2014). Hugin neurons have that name 
because they express this neuropeptide which is a homolog of mammalian 
neuromedin U.  
After measuring the fraction of time spent eating and the amount of eating bouts 
in 2 minutes, I also did not see any difference between CFI25 mutants and 
wildtypes (Figure 4.7). These results suggest that it is unlikely that CFI25 mutants 
show this feeding phenotype because of defects in general movements involved 
in this behaviour. The central pattern generator controlling Drosophila feeding 
has been shown to be located in the subesophageal zone, and through lesion 
experiments, there is evidence that all the feeding rhythmic activity does not 
require the brain hemispheres or the ventral nerve cord for its function 
(Huckesfeld et al. 2015). 
Because the expression pattern of CFI25 during late embryogenesis shows an 
enrichment in the nervous system, I asked whether CFI25 mutants show 
abnormalities in the overall anatomy of their nervous system. To analyse and 
quantify this, I stained both the central and the peripheral nervous system in late 
embryos by labelling elav and futsch, respectively. (See Chapter 2). 
Elav is an RNA binding protein that is widely used a pan-neuronal marker. Also, 
mutations in elav can affect the anatomy of the nervous system  
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Figure 4.7 CFI25 mutants do not show behavioural differences related to 
feeding when compared with wild types 
(A-C) Diagrams representing the parameters measured in this experiment, (A) 
diagram of the forward peristaltic waves per minute, (B) Diagram of the fraction 
of time spent performing mouth hook movements. (C) Diagram of the number of 
mouth hook movement bouts in 2 minutes. (D-F) quantification of the parameters 
shown in (A-C) in CFI25 mutants and wild types. None of the parameters 
measured shows a significant difference between CFI25 mutants and wild types 
(N = 10). A non-parametric two-sided Mann-Whitney test was used to test for 
statistical significance, * P < 0.05. Larvae diagrams from panel A were kindly 
provided by Dr. Joao Osorio and were modified from (Picao-Osorio et al. 2015). 
Larvae diagrams from panels B and C were modified from (Schoofs et al. 2009). 
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(Zaharieva et al. 2015). Elav also has important roles for RNA processing and 
APA for several genes, including the Hox genes (Rogulja-Ortmann et al. 2014). 
Futsh is a protein that associates with microtubules and is necessary for dendritic 
and axonal growth (Hummel et al. 2000), this protein is detected by the 
monoclonal antibody 22C10 (See Chapter 2). This antibody is widely used to 
visualize the anatomy of the peripheral nervous system. After staining late 
Drosophila embryos with these markers and comparing wild types with CFI25 
mutants, I did not see any major differences between these genotypes (Figure 
4.8). When considering the results on locomotory behaviour, these anatomical 
analysis suggests that although the expression pattern of CFI25 shows an 
enrichment in the nervous system, neither locomotory behaviour nor major 
anatomical defects can be tied to the nervous system in these mutants.  
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Figure 4.8 CFI25 mutants do not show major defects in the anatomy of the 
central and peripheral nervous system when compared with wild types 
(A) Representative embryos from wild types (top row) and CFI25 mutants 
(Bottom row) stained for elav to show their CNS, as well as DAPI, to label the 
nuclei and show the contour of the embryos. (B) Representative embryos from 
wild types (top row) and CFI25 mutants (Bottom row) stained for Futch (22C10) 
to show their PNS and also DAPI. Note that there are no major visible defects in 
the anatomy of these structures between genotypes. 
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4.2.4 Identification of targets downstream of CFI25 and the feeding 
machinery 
CFI25 is a CPA factor that has been shown to control APA in vitro (Masamha et 
al. 2014; Kim et al. 2010; Masamha et al. 2016; Li et al. 2015). As previously 
discussed, the crystal structure of CFI25 suggests that when it binds to the UGUA 
motifs in an antiparallel fashion, the CFI complex is able to control APA by looping 
the pre-mRNA molecule (Yang et al. 2011). From these data, it can be 
hypothesised that the phenotype observed in CFI25 mutants is caused by 
alterations in the cleavage and polyadenylation patterns of one or more target 
genes at the molecular level. To test this hypothesis, I looked for potential target 
genes using a simple bioinformatic pipeline (Figure 4.9). Firstly, two “Gene 
Ontology” (GO) terms (Consortium 2000; Blake et al. 2015) were used to scan 
for target genes, “Larval Feeding Behaviour” and “Cephalopharyngeal skeleton”. 
These were selected because of their connection with the phenotype observed. 
Secondly, these GO terms were used as input in the Drosophila database 
“Flybase” (Attrill et al. 2016) and as a result, 16 genes were detected labelled by 
the GO term “Larval Feeding Behaviour” and seven genes with 
“Cephalopharyngeal skeleton”. This list of genes was then filtered by the 
requirement of two conditions, the first was if the genes showed neural 
expression, given the expression pattern of CFI25 (Figure 3.10) and the second 
was if the genes showed more than one APA isoform, because of the known 
molecular function of CFI25. As a result, eight genes remained labelled with 
“Larval Feeding Behaviour” and one gene with “Cephalopharyngeal skeleton”.  
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Figure 4.9 Bioinformatics pipeline to find candidate target genes 
downstream of CFI25  
(Legend on the following page) 
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Figure 4.9 Bioinformatic pipeline to find candidate target genes 
downstream of CFI25 
(A) Diagram of the bioinformatics pipeline used to identify candidate target genes 
to be studied in CFI25 mutants. (1) Two “Gene Ontology” (GO) terms (Consortium 
2000; Blake et al. 2015) were used to find target genes, “Larval Feeding 
Behaviour” and “Cephalopharyngeal skeleton”. These were selected because of 
their connection with the phenotype observed. (2) The selected GO terms were 
used as input in the Drosophila database “Flybase” (Attrill et al. 2016), (3) 16 
genes were detected labelled by the GO term “Larval Feeding Behaviour” and 
seven genes with “Cephalopharyngeal skeleton”. (4) This list of genes was 
filtered by two conditions, the first condition was if the genes showed neural 
expression because of the expression pattern of CFI25 and the second condition 
was if the genes showed more than one APA isoform, because of the known 
molecular function of CFI25. (5) After filtering, eight genes remained labelled with 
“Larval Feeding Behaviour” and one gene with “Cephalopharyngeal skeleton”. (6) 
These genes were selected for molecular analysis in CFI25 mutants. (B) Table 
of genes obtained by this pipeline, the first seven genes are the ones labelled by 
“Larval Feeding Behaviour” and the last one (kurtz) is the one labelled by 
“Cephalopharyngeal skeleton”. A brief summary of their molecular and biological 
function is shown. 
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Lastly, these genes were selected for molecular analysis in CFI25 mutants by 
assessing their patterns of APA by RT-PCR experiments. 
“Foraging” (for) encodes a cGMP-dependent protein kinase. As its name 
indicates, this gene was associated with larval foraging behaviour. Two natural 
alleles from the wild were described as “sitters” and “rovers”. “Sitters” cover a 
small area while engaged in feeding, whereas “rovers” traverse a large area while 
feeding. Interestingly, the frequency at which these alleles were observed in the 
wild was constant (Sokolowski 1980; Pereira and Sokolowski 1993). Later the 
expression pattern of for was described as showing neural expression, as well as 
expression in the larval proventriculus. In this same study, it was shown that 
overexpression of for in the adult nervous system increases sucrose 
responsiveness in sitters, which was known to be naturally higher in rovers, 
highlighting the roles of for in food-related behaviour (Belay et al. 2007). The 
broad expression pattern of for in the nervous system makes it an interesting 
candidate to be explored in CFI25 mutants. Nonetheless, CFI25 mutants do not 
show locomotory differences with wild types in terms of hyper o hypo activity, as 
assessed by their frequency of forward waves per minute, time spent moving the 
mouth hooks or activity bouts (Figure 4.7). Making them potentially less likely to 
show this phenotype because of behavioural genes such as for. 
Another candidate, “Inositol 1,4,5,-tris-phosphate receptor” (Itp-r83A), belongs to 
the InsP3 receptor family; it is a calcium channel that releases calcium from 
intracellular stores in response to extracellular signals. It has been shown that 
mutants for Itp-r83A show feeding defects and are smaller than the wildtypes. 
Interestingly, expression of Itp-r83A in the insulin producing cells (IPCs) in the 
larval brain of mutants is sufficient to restore the feeding deficit. However, despite 
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the fact that ubiquitous RNAi knockdown of Itp-r83A can mimic the feeding defect, 
specific knockdown in IPCs does not trigger the phenotype. There is a model 
proposed in which Itp-r83A activity in non-overlapping neuronal domains 
independently rescues larval phenotypes by non-cell autonomous mechanisms 
(Agrawal et al. 2009). The expression pattern of Itp-r83A has been mapped to 
the adult brain, peripheral sense organs, the mesoderm and muscle precursors 
in the embryo (Raghu and Hasan 1995). A few years later it was also described 
to show expression in the larval ring gland, an endocrine organ in the larva that 
secretes ecdysone, the hormone that triggers moulting and metamorphosis 
(Yamanaka et al. 2013). Accordingly, various alleles of Itp-r83A showed a 
delayed larval moulting phenotype (Venkatesh and Hasan 1997). Although 
broader than just confined to the nervous system, Itp-r83A is also a good 
candidate to be studied in CFI25 mutants. 
“Klumpfuss” (klu) is a zinc finger transcription factor whose relation with larval 
feeding was discovered in screen for larvae defective in this behaviour. 
Microarray analysis indicated that klu mutants showed altered expression of the 
neuropeptide Hugin (hug) (Melcher and Pankratz 2005). Hugin is expressed in a 
cluster of 20 neurons which can suppress the motor program for food intake while 
inducing the program for locomotion in larvae (Schoofs et al. 2014). Hug 
expression is also regulated by food signals and neuroanatomy of the hug-
expressing neurons shows that they project axons to several components of the 
feeding machinery, such as the pharyngeal muscles, as well as higher brain 
centers and neuroendocrine organs related to feeding. In addition, the dendrites 
of hug neurons are innervated by gustatory receptor-expressing neurons and 
also by internal pharyngeal chemosensory organs (Melcher and Pankratz 2005). 
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Klu has also been shown to have an important role in larval neuroblast (NB) self-
renewal, as it not only functions as a NB-specific transcription factor, but loss of 
klu causes premature differentiation of NBs. Overexpression of klu generates the 
formation of transplantable brain tumours (Berger et al. 2012). These 
observations reveal that Klu plays key roles in the specification of the nervous 
system by controlling gene expression and also acts as a transcription factor. 
These characteristics make  Klu a good candidate that can connect CFI25 
function with the observed phenotype. 
“Jim Lovell” (lov) is another transcription factor of the BTB/POZ family, identified 
in a forward genetic screen for animals with deficient responses to gravitaxis 
(Armstrong et al. 2006). Its name is derived from that of an astronaut who made 
pioneering work in microgravity. In another study, one lov allele was found to 
show locomotor defects as well as feeding defects in larvae. The authors showed 
that lov mutants are sluggish when compared to wildtypes and also show a higher 
frequency of spontaneous backward movements, which in wild types are only 
commonly seen when the individuals have contact with obstacles. As a result of 
problems in motor control, lov mutants show a feeding phenotype because of a 
slower rate in mouth hook movement, which results in impairment of the 
shovelling movements used to get food into their digestive system. As expected, 
lov starts being expressed during embryogenesis in nuclei of the developing 
nervous system. During late stages of embryogenesis, lov shows expression in 
nuclei of both the central and the peripheral nervous systems (Bjorum et al. 
2013). Although its expression pattern resembles that of CFI25 (Figure 3.10), the 
locomotory phenotypes observed in lov mutants are not observed in CFI25 
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mutants (Figure 4.7), suggesting that if lov is affected molecularly in CFI25 
mutants, it may not necessarily reflect the effects reported in lov mutations. 
“Neuropeptide F Receptor” (NPFR), as its name indicates, is the receptor of the 
“short neuropeptide F” (sNPF), which is structurally related to vertebrate 
regulatory peptides of the neuropeptide Y family. The expression levels of sNPF 
in the larval brain are correlated with the larvae's attraction to food and 
engagement in feeding behaviour. Its knockdown in the nervous system can lead 
to a decrease in food intake in both larvae and adults (Lee et al. 2004; Brown et 
al. 1999; Wu et al. 2003). NPFR is a G-protein coupled receptor whose relation 
with larval feeding comes from a study which showed that when NPFR is 
overexpressed in its own expression domain, both fed and fasted larvae show 
similar intake rates of liquid food. When NPFR-overexpressed larvae are forced 
to feed on solid food, which is less preferred under normal conditions, fed 
experimental larvae exhibited significant intake of the solid food when compared 
with fed controls (Wu et al. 2005). Also, the knockdown of NPFR by RNAi in its 
expression domain, or in the whole nervous system, leads to larvae that are 
deficient in motivated feeding of solid but not liquid food. These results show that 
NPFR is involved in food selection driven by hunger in Drosophila (Wu et al. 
2005). Thus, expression changes in NPFR caused by aberrant APA patterns in 
CFI25 mutants could in part explain why these mutants do not feed, even though 
they perform all the required movements (Figure 4.7). Experiments on food 
source selection will be required to assess if CFI25 mutants show differences in 
food preference and thus allowing us to relate it with NPFR if affected. 
“Ran-binding protein M” (RanBPM) is the Drosophila orthologue of the vertebrate 
“Ran Binding Protein in the Microtubule organizing center” genes. Its similarity 
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with the human RANBP9 gene suggests that RanBPM binds to RAN GTPase. In 
Drosophila, its biological function has been implicated in the regulation of germ 
line stem cell niche organization in the ovary as well as microtubule dynamics 
(Dansereau and Lasko 2008). The relation of this gene with larval feeding comes 
from a study in which an insertion of a P-element in the second exon of RanBPM 
makes the larvae show a feeding defect and impairs locomotion and response to 
light in larvae. These phenotypes are rescued after excision of this P-element, as 
in the case of CFI25 mutants. The expression pattern of RanBPM show that is 
expressed in the larval mushroom bodies, showing high expression in Kenyon 
cells (Scantlebury et al. 2010). The mushroom bodies are centers associated with 
olfaction, learning and memory in the central nervous system which are originated 
from only four neuroblasts per brain hemisphere during embryogenesis (Kunz et 
al. 2012; Kurusu et al. 2002). In addition, the mushroom bodies have an important 
role for feeding via the insulin signalling pathway (Zhao and Campos 2012). 
Although the molecular mechanism that links RanBPM with larval feeding has not 
been established, it is proposed that sNPF may be a target of RanBPM in neurons 
of the mushroom bodies, among others (Scantlebury et al. 2010). Thus, RanBPM 
could also be affected in CFI25 mutants and therefore affect feeding by gene 
expression changes through APA in the mushroom bodies. 
“Ribosomal protein S6 kinase” (S6k), as its names indicates, is a serine/threonine 
kinase whose mammalian orthologue is p70S6k. S6k was first described in 1996 
as being 78% similar at the protein level in the catalytic domain with its human 
counterpart. Drosophila S6k transfected in mammalian cells is able to 
phosphorylate the mammalian ribosomal protein S6 (RP6), which is a component 
of the 40S ribosomal subunit in eukaryotes (Watson et al. 1996; Erikson 1991). 
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The relation of S6k with larval feeding comes from the same study that covered 
the relation of NPFR with feeding (Wu et al. 2005), in this case, the authors show 
that manipulating S6k expression in larval insulin producing cells (IPC) can have 
an effect on larval feeding. More specifically, overexpression of S6k in IPCs leads 
to attenuated hunger response in fasted larvae and opposingly, downregulation 
of S6k by RNAi in the same cells triggers fed larvae to display motivated foraging 
and feeding. These results suggest that while NPFR can mediate food source 
selection, S6k within IPCs can mediate hunger regulation and response to food. 
The relation of S6k with the insulin pathway has also been studied in cultured 
cells and it has been shown that S6k is directly activated and phosphorylated by 
insulin through phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB), as 
well as Drosophila target of rapamycin (dTOR) (Lizcano et al. 2003). These 
observations suggest that S6k could also connect the observed phenotype in 
CFI25 through changes in expression in IPCs. Although the exact expression 
pattern of S6k is not reported, meaning that it could be expressed in other tissues. 
“Shibire” (shi) is the Drosophila orthologue of dynamin, a microtubule-activated 
GTPase involved in endocytosis and synaptic vesicle recycling. Its expression 
pattern is broad, though it shows an enrichment in both the central and peripheral 
nervous system during different life stages. In Drosophila there are several alleles 
of this gene that are temperature-sensitive, which means that at a restrictive 
temperature, there is an arrest in the recycling of synaptic vesicles at the 
neuromuscular junction, leading the individuals to be paralysed. In fact, the word 
“shibire” means “paralysed” in Japanese (Chen et al. 1992; Siddiqi and Benzer 
1976). This interesting phenomenon of disrupting synaptic transmission at a 
specific temperature, led to the development of genetic tools, by which  
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temperature-sensitive alleles of shi can be expressed using the Gal4/UAS system 
in a targeted fashion to induce expression in specific cells and tissues at specific 
times (Brand and Perrimon 1993). For example, by using this approach, synaptic 
transmission was blocked in neurons from the mushroom bodies in Drosophila to 
show that synaptic transmission is required for memory retrieval but not during 
acquisition or storage (Dubnau et al. 2001).  
The relation of shi with larval feeding behaviour comes from the same study that 
points to both S6k and NPFR as being involved in feeding (Wu et al. 2005). In 
this case the temperature-sensitive alleles were expressed in the NPFR 
expression domain. When the restrictive temperature was applied, fasted 
experimental larvae showed an attenuated feeding response to solid but not liquid 
food. While at the permissive temperature, both fasted control and experimental 
larvae displayed normal feeding responses to both liquid and solid foods. These 
results suggest that the sNPF/NPFR neuronal pathway can influence the intensity 
and the duration of the feeding response in Drosophila larvae and thus, so can 
shi. What is more, because of its relationship with NPFR, shi could also explain 
in part the phenotype observed in CFI25 mutants. Although its expression pattern 
is broad and this will make difficult to point what specific tissues are responsible 
for the phenotype observed in CFI25 mutants. 
“kurtz” (krz) is a β-arrestin (non-visual arrestin); these proteins are involved in the 
desensitization and endocytic internalization of G protein coupled receptors 
(Lefkowitz 2005). During late embryogenesis, krz is expressed in the central 
nervous system, maxillary cirri, the pharynx and antennal sensory organs 
(Roman and Davis 2000). These anterior structures are related to the 
cephalopharyngeal skeleton, which is why this gene appeared in our pipeline as 
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it can be found under this GO term. An allele of krz generated by insertion of a P-
element (krz1) was shown to generate dark melanotic tumours primarily in the fat 
body of third instar larvae. This gene is named kurtz after the character in Joseph 
Conrad’s “The Heart of Darkness” alluding to the dark melanotic tumours seen in 
the larvae by the authors (Roman et al. 2000). Although this gene has not been 
involved directly in larval feeding, its relevance for the development of the CPS 
made me take it into account to be tested in CFI25 mutants (See Figure 4.5). 
A diagram of the anterior structures of the Drosophila larva involved in feeding, 
as well as the neural network and the tissues where the genes described above 
are expressed are shown in Figure 4.10. In the next section, I analyse the 
expression of these genes in CFI25 mutants, to test the hypothesis on whether 
their expression lies downstream of CFI25 and can therefore explain the feeding 
phenotype observed in CFI25 mutants. 
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Figure 4.10 The larval feeding machinery and expression of target feeding 
genes 
(Legend on the following page) 
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Figure 4.10 The larval feeding machinery and expression of target feeding 
genes 
Diagram of anterior feeding structures in the Drosophila third instar larva: In black 
are represented the mouth hooks, in red are represented the muscles that control 
mouth hook movements, in purple is represented the esophagus, in turquoise are 
represented nerves of the ENS. The yellow arrows indicate relevant tissues of 
expression of feeding target genes, the red arrows indicate larval structures and 
the red labels indicate each nerve and ganglion of the ENS. Anterior is to the left. 
AN = Antennal nerve, FNJ = Frontal Nerve Junction, FN = Frontal Nerve, RN = 
Recurrent Nerve, HCG = Hypocerebral Ganglion, NCS = Nervi 
Cardiostomatogastrici, PVN = Proventricular Nerve, PVG = Proventricular 
Ganglion, SOG = Subesophageal Ganglion, NBs = Neuroblasts, CNS = Central 
Nervous System, PV = Proventriculus, MG = Midgut, RG = Ring Gland, IPCs = 
Insulin Producing Cells, MB = Mushroom Body. Based on (Schoofs et al. 2014). 
 
 
,  
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4.2.5 RanBPM, S6k, klu and lov have affected APA patterns in CFI25 
mutants 
The previous section highlighted the results of applying a simple bioinformatics 
pipeline with which I found nine candidate genes that have been involved in 
feeding and show both APA isoforms and neural expression (Figure 4.9). The 
molecular function of these genes is diverse and there are kinases, arrestins and 
transcription factors present in the sample pool. Though all these genes have a 
component of neural expression during Drosophila development, the tissues 
where they are expressed are also diverse, going from specific cells as the case 
of S6k, where changes in expression in IPCs is sufficient to affect feeding (Wu et 
al. 2005), to broad expression patterns, such as the entire nervous system in the 
case of lov (Bjorum et al. 2013).  
Given that a reduction in CFI25 levels can affect APA patterns in cells in culture 
(Li et al. 2015; Kubo et al. 2006; Masamha et al. 2014) and CFI25 mutants show 
a reduction of CFI25 levels at the RNA and protein levels, as well as a decrease 
in expression in the VNC of late embryos at the RNA level (Figure 4.6), I 
addressed the question of whether these target genes have affected APA 
isoforms in CFI25 mutant first instar larvae. The role that APA plays for the 
biological function of these genes is not described in the literature. Nonetheless, 
I detected the existence of these different 3’ UTR isoforms from the databases, 
which are validated by RNA-seq (Attrill et al. 2016). In order to assess APA 
changes in these selected target genes related to feeding, I designed primers for 
semi-quantitative RT-PCR experiments to get amplicons from the 3’UTRs of 
these genes (See Chapter 2 and Table 2.5). More specifically, I aimed to detect 
an amplicon labelled as “Universal” that amplifies the short 3’UTR of the gene, 
  
161 
therefore, amplifying all or most of the RNA isoforms of it, and an amplicon 
labelled as “Distal” that amplifies only the long or longest 3’UTR of the gene. After 
obtaining these amplicons by RT-PCR with cDNA from whole wild type and CFI25 
mutant first instar larvae (And using RpA1 as a loading control), I divided the 
Distal signal by the Universal signal, obtaining a “Distal/Universal” (Dis/Uni) ratio. 
This ratio is a dimensionless value that reflects changes in the length of the 3’UTR 
of a given gene. Thus, a higher “Dis/Uni” ratio reflects a lengthening of the 3’UTR, 
whereas a lower “Dis/Uni” ratio reflects a shortening of the 3’UTR. This 
experimental approach has been widely use to study the effects on APA in 
different biological conditions both in vitro and in vivo (Miura et al. 2014; Rogulja-
Ortmann et al. 2014). The results of this analysis in the feeding target genes is 
shown in Figure 4.11. It can be observed that RanBPM, S6k, klu and lov show 
significantly lower Dis/Uni ratios in CFI25 mutants when compared with wild 
types. As shown in the representative RT-PCR amplicons (shown in the middle), 
RanBPM shows lower signal for the distal amplicon, which can be interpreted as 
a retraction of its 3’UTR in the CFI25 mutant condition. S6k, klu and lov show 
stronger signals for the universal amplicon, which can be interpreted as more 
production of the short 3’UTR isoforms or a general overexpression of these 
genes in the mutant condition. All these effects, when measured as Dis/Uni ratios, 
result in a lower value for CFI25 mutants when compared with wild types. To 
obtain an indication of the total mRNA expression levels of these genes in CFI25 
mutants, I used the signal from the Universal amplicons and normalized them by 
RpA1. In the case of RanBPM, we used primers that amplify the gene at the sixth  
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Figure 4.11 RanBPM, S6k, klu and lov have affected APA patterns in CFI25 
mutants 
(Legend on the following page) 
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Figure 4.11 RanBPM, S6k, klu and lov have affected APA patterns in CFI25 
mutants 
(A) Diagram of the strategy to assess APA in feeding target genes, the grey 
boxes represent the coding sequence and the black horizontal lines represent 
both the universal (top) and the distal (bottom) 3’UTRs. The red arrows indicate 
RT-PCR primer amplicons. (B-J) Semi-quantitative RT-PCR experiments to 
measure APA in feeding genes. To the left, a diagram of the feeding machinery 
as shown in fig 4.10, this time indicating the relevant tissues of expression of 
each target gene in red. In the middle, representative amplicons for the universal 
and distal 3’UTRs in both wild types and CFI25 mutants. To the right, 
quantification of RT-PCR experiments, for each gene a biological triplicate was 
performed, values are shown as Dis/Uni ratios (See Chapter 2 for information on 
semi-quantitative RT-PCR experiments design). Note that S6k (D), RanBPM (G), 
Klu (I) and Lov (J) have different Dis/Uni ratios when compared with the control. 
These experiments were performed as biological triplicates. Error bars represent 
the SEM. Unpaired two-tailed t-tests were used to compare genotypes, * p < 0.05. 
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exon-exon junction, amplifying all mRNA isoforms (See table 2.5). The results of 
this analysis are shown in Figure 4.12. Here it could be seen that S6k, klu and 
lov showed higher expression levels in CFI25 mutants when compared with wild 
types. However, RanBPM expression levels were not different between 
genotypes. These results show that the effects on the 3’UTRs of these genes by 
CFI25 are different, and while for RanBPM only the long isoform was affected, 
for the remaining S6k, klu and lov there is more production of the short portion of 
their 3’UTRs. Thus, RanBPM is the only case were we can clearly distinguish 
APA as retraction of the long 3’ UTR from a general overexpression observed in 
S6k, klu and lov. A summary of the effects in feeding genes in CFI25 mutants is 
shown in figure 4.13 
 
  
165 
 
Figure 4.12 S6k, klu and lov have higher mRNA levels in CFI25 mutants 
(Legend on the following page) 
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Figure 4.12 S6k, klu and lov have higher mRNA levels in CFI25 mutants 
(A-I) Quantifications of mRNA target feeding genes levels by semi-quantitative 
RT-PCR, the values are normalized by RpA1 and shown as biological triplicates 
(See Chapter 2). Note that klu (E), lov (F) and S6k (H) have higher mRNA levels 
when compared with the controls. The universal primers for lov also bind to the 
last exon of isoform RE, which is 3’UTR in isoform RF (lov has 5 RNA isoforms). 
Isoform RE has a different transcription start site than isoforms RC and RF, thus, 
the increase in lov mRNA levels might be a specific increase in isoform RE. shi 
has 15 RNA isoforms, the “Uni” amplicon was set to cover as many 3’UTRs as 
possible, which are 8. In the other 7 isoforms these primers target intron 
sequences. Given that polyadenylated mRNA was used for these RT-PCR 
experiments, these isoforms were not amplified by PCR and thus, the expression 
levels of shi are possibly an underestimation of the absolute mRNA levels. 
Nonetheless, the “Dis/Uni” ratios for shi in fig 4.11 were not affected. These 
experiments were performed as a biological triplicates. Error bars represent the 
SEM. Unpaired two-tailed t-tests were used to compare genotypes, * p < 0.05. 
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Figure 4.13 Summary of feeding genes affected in CFI25 mutants 
Diagram from figure 4.10 showing in red the genes with affected APA patterns in 
CFI25 mutants (Figure 4.11) and in green the genes that do not show significant 
differences. From these 4 genes, klu, lov and S6k also show significantly higher 
expression of mRNA levels (Figure 4.12).  
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4.3 Discussion  
The work presented in this Chapter shows that a mutation by means of an 
insertion of a transposable element in the Drosophila orthologue of the CPA factor 
CFI25 leads to a developmental arrest during the first instar larvae stage (Figure 
4.2) and this phenotype is due to a defect in larval feeding behaviour (Figure 4.3). 
Excision of this P-element by using Δ2-3 transposase is sufficient to rescue the 
mutants to a wild type phenotype. Additionally, CFI25 mutants at the phenotypic 
level show a “collapsed” mouth hook phenotype (Figure 4.4) and defects in food 
movement from the pharynx to the midgut (Figure 4.5). Regarding the former, 
analysis of krz RNA in CFI25 mutants, a β-arresting gene involved in the 
formation of the CPS, among other biological roles (Roman et al. 2000), did not 
show differences in both APA and mRNA expression levels, making this gene 
unlikely to be a link with the phenotype observed (Figures 4.11 and 4.12). 
Nonetheless, several alleles of klu have been reported to show mouth hook 
defects, but the authors neither give a detailed account nor show images for the 
phenotypes observed (Klein and Campos-Ortega 1997) to be able to compare 
this with the phenotype observed in CFI25 mutants. Besides, CFI25 mutants do 
show differences in klu APA, as well as mRNA levels, making this gene an 
interesting candidate to study further (Figures 4.11 and 4.12). Regarding the latter 
phenotype observed in CFI25 mutants, showing trapped food in their pharynx 
(Figure 4.5), none of the candidate genes that were studied showed a similar 
phenotype when genetically manipulated. Nevertheless, this phenotype has been 
observed before for genes related with feeding. For example, mutants for ppl, a 
protein with homology to a vertebrate enzyme involved in glycine catabolism, 
show exactly the same phenotype as CFI25 mutants (Zinke et al. 1999). Yet, ppl 
  
169 
is exclusively expressed in the embryonic and larval fat body, a tissue where we 
do not see expression of CFI25 at the mRNA level (Figure 3.10). Also, ppl 
mutants show a wandering phenotype, a behaviour we do not see in CFI25 
mutants (Figure 4.7). Taken together, these observations indicate that ppl is also 
unlikely to be a linking gene for the phenotype observed in CFI25 mutants. 
Another candidate target gene affected in CFI25 mutants is lov, a transcription 
factor of the BTB/POZ family. lov shows a broad expression pattern in the 
nervous system of late embryos (Bjorum et al. 2013), which is comparable to the 
expression pattern observed for CFI25 at similar developmental stages (Figure 
3.10). In spite of this, lov mutants feeding phenotype is attributed to locomotor 
defects in regards to forward locomotion and mouth hook movements (Bjorum et 
al. 2013). None of these effects were observed in CFI25 mutants (Figure 4.7), 
also making this gene unlikely to be the link with the feeding phenotype observed 
in CFI25 mutants.  
Although changes in the 3’UTR of genes do not change the encoded protein 
sequence and therefore, their structure. They can still affect important aspects of 
protein function, such as protein amounts and localization. A shortening in 
3’UTRs can lead to an increase in protein production, because a shorter 3’UTR 
will now bind fewer trans-acting factors that can negatively impact mRNA such 
as microRNAs and RBPs. For example, it has been shown that the 
overexpression of proto-oncogenes, which leads to tumorigenesis, is due to a 
shift of APA patterns from long to short 3’UTRs (Mayr and Bartel 2009). On the 
contrary, an elongation of 3’UTRs is observed during organogenesis and cell 
differentiation, where mRNAs are exposed to more intricate post-transcriptional 
regulation by these same trans-acting factors. For example, differentiation of 
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C2C12 cells into myotubes is associated with 3’UTR lengthening (Ji et al. 2009), 
as well as neural development (Thomsen et al. 2010; Hilgers et al. 2011). 
Changes in 3’UTR length can affect protein localization, for example, the long 
3’UTR of the human CD47 gene enables expression of this protein in the cell 
surface, whereas the short 3’UTR RNA isoform enables localization to the 
endoplasmic reticulum (Berkovits and Mayr 2015). 
A shift could be observed in 3’UTR APA for s6K, lov, RanBPM and klu in CFI25 
mutants, which was reflected in higher production of the short isoforms for s6K, 
lov and klu, while RanBPM shows a decrease in the long isoform without 
noticeable changes in the production of the short isoform (Figure 4.11). Since we 
are unable to rule out effects on the other genes that were not detected because 
of limitations in the sensitivity of the technique used (Semi-quantitative RT-PCR) 
it can only be partially confirmed. Still, a similar trend has been observed after 
CFI25 depletion in human cells for TIMP-2, syndecan2, ERCC6 and DHFR, 
where the short RNA isoforms where increased after CFI25 knockdown, when 
assessed by northern blot experiments (Kubo et al. 2006). The feeding 
phenotypes observed for RanBPM, lov, and klu in the literature, were caused by 
a reduction of these genes products by means of mutation by insertion of 
transposable elements (Scantlebury et al. 2010; Bjorum et al. 2013; Melcher and 
Pankratz 2005), as in the case of our CFI25 mutants. In CFI25 mutants, there is 
an upregulation of these genes at the mRNA level (Figure 4.12), which potentially 
also leads to an upregulation at the protein level, although I could not measure 
protein levels of these genes due to lack of antibodies. These results make it 
difficult to predict a molecular mechanism that explain the feeding defect 
observed in CFI25 mutants that involves these genes. Nevertheless, S6k gives 
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an interesting case. This because it was shown that overexpression of S6k in 
IPCs leads to an attenuation of feeding response of both solid and liquid food, 
even though both control and experimental larvae were fasted for 120 minutes 
before the essay. Furthermore, their frequency of mouth hook contraction 
decreases in comparison with the control, leading to a defect in feeding (Wu et 
al. 2005). Similarly, CFI25 mutants show an increase in S6k at the mRNA level 
(Fig 4.12), making S6k an interesting gene to be studied in the future. Its detailed 
expression pattern is not known, although it has been shown by northern blot 
experiments that is expressed across all embryonic and larval stages, as well as 
in adults (Watson et al. 1996).  
Modification of CFI25 expression in IPCs would be an interesting experiment to 
assess if the changes provoked by CFI25 levels in only these cells are sufficient 
to induce a feeding phenotype. Likewise, a reduction of S6k levels by RNAi in 
IPCs in a CFI25 mutant background would also be informative, the prediction to 
see a partial rescue of feeding in these animals because of a correction in S6k 
levels. A more informative experiment to show that changes in S6k APA are 
sufficient to cause a feeding phenotype in CFI25 mutants would be to mimic the 
changes in the 3’UTR of S6k observed in CFI25 mutants by means of targeted 
mutation. For example, by elimination of the distal PAS using CRISPR (Hsu et al. 
2014; Bassett and Liu 2014). Consequently, I propose a model in which depletion 
of CFI25 in neural tissues leads to an upregulation of S6k in IPCs by a switch to 
the use of its proximal PAS. Thus, triggering the phenotype observed. Future 
experiments such as the ones proposed previously can help us in the 
understanding of this phenotype at the molecular level. 
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Finally, though this allele of CFI25 has a very interesting phenotype, which is 
bound to be informative to show the biological roles of CPA factors in vivo when 
studied further, it is the only available allele of CFI25 so far which is limiting 
because the phenotypes observed in a particular allele, such as this one, can at 
times only show an incomplete view of gene function because of pleiotropy. For 
example, different polymorphisms of the gene Catsup, a negative regulator of 
tyrosine hydroxylase, are independently associated with diverse phenotypes, 
such as variation in longevity, locomotor behaviour and sensory bristle number 
(Carbone et al. 2006). What is more, phenotypes observed by P-element 
insertional mutants can be highly diverse and different from a true null mutant 
even if different transposable elements are inserted within the same gene only a 
few base pairs apart. For example, different P-element insertions in the gene 
neutralized have different effects on olfactory behaviour, aggression and 
mechanosensory stimulation, these behavioural phenotypes are correlated with 
distinct structural changes in integrative centers in the brain, the mushroom 
bodies, and the ellipsoid body of the central complex (Rollmann et al. 2008). The 
P{EP} insertion in CFI25 mutants is localized in the 5’UTR, meaning that although 
I assessed for feeding phenotypes in insertions upstream of this region (Figure 
4.3 panel D), I cannot rule out effects on regulatory regions affecting CFI25 
transcription, whose promoters and enhancers are not well characterised. This 
could potentially lead to quantification of the effects of an allele that does not 
behave as a true amorph. There is only one chromosomal deficiency that covers 
this region, which is more than 70 kbps long and disrupts 29 genes 
(Df(3L)BSC113), making it cumbersome to carry out informative 
complementation tests using this deficiency line. What is more, this CFI25 allele 
  
173 
over this large deficiency is not able to trigger a feeding phenotype. An analysis 
of the genes covered by this deficiency indicates that more than half of them have 
unknown molecular functions and are not characterized, making it necessary in 
the future to generate new alleles of CFI25 by independent methods, such as 
CRISPR, as well as more genetic tools in this chromosomic region, to understand 
how CFI25 is involved in Drosophila larval behaviour fully. 
In summary, despite the limitations of this study, I uncover new biological and 
neural roles for a CPA factor that is part of the most conserved complex between 
humans and Drosophila (Figures 3.1 and 3.3), which has also been implicated as 
a central actor in the control of APA in mammalian cells (Kim et al. 2010; Kubo et 
al. 2006; Li et al. 2015) as well as in relevant medical conditions, such as 
glioblastoma tumorigenesis (Masamha et al. 2014). In the next Chapter I will 
study how the levels of the members of the CFI complex can control APA during 
Drosophila neural development. 
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Chapter 5  
CFI levels control alternative 
polyadenylation within the developing 
nervous system 
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5.1 Chapter overview 
In the previous chapter I showed that a mutation in the Drosophila orthologue of 
CFI25 had effects in larval feeding behaviour, as well as effects in APA patterns 
in the target feeding genes S6k, klu, RanBPM and lov (Figure 4.11). In Chapter 
3 I also showed that the expression pattern of both CFI25 and CFI68 is enriched 
in the nervous system during late stages of embryogenesis (Figures 3.10 and 
3.11). Given that the nervous system expresses long 3’ UTR isoforms in a tissue-
specific manner, in this chapter I address the question of whether the expression 
levels of CFI factors within this tissue are used as a cue to express such isoforms.  
I expressed RNA-interference (RNAi) constructs made to target both CFI25 and 
CFI68 within the physiological context of the developing nervous system in late 
embryos, where I then assessed effects in APA on genes with reported 3’ UTR 
neural extensions by categorising them according to the length of these 
extensions, given their potentially different biological roles. First, I observed that 
the reported 3’ UTR lengths of 29 out of 30 neural-extended genes do not match 
the values given by the current databases, as their transcripts are shorter or 
longer than originally published. Some of these have 3’ UTR lengths similar to 
those observed in mammalian transcripts. Furthermore, 50% of the tested neural 
extended genes have altered APA patterns after the depletion of CFI factors 
within the nervous system after RNAi. These results suggest that the observed 
neural enrichment in expression of CFI factors within the nervous system are 
used as a cue for 3’ UTR extensions during Drosophila neural development. 
 
  
176 
5.2 Results 
5.2.1 There is an extension of 3’UTRs within the developing nervous 
system  
In Drosophila, as in all insects, there are 8 Hox genes that are clustered into two 
complexes. The Antennapedia complex consists of five genes that are expressed 
towards the anterior end of the embryo, within the anteriorposterior axis: labial 
(lab), proboscipedia (pb), deformed (Dfd), sex combs reduced (Scr), and 
Antennapedia (Antp). The Bithorax complex consists of the remaining three 
genes that are expressed towards the posterior end of the embryo within the 
same axis: Ultrabithorax (Ubx), abdominal-A (abd-A) and Abdominal-B (Abd-B) 
(Mallo and Alonso 2013; Lewis 1978). Four of the Hox genes: Antp, Ubx, abd-A 
and Abd-B, present APA isoforms where there is evidence of short and long 
3’UTRs being produced (Thomsen et al. 2010). This process helps to diversify 
the way in which miRNAs and RBPs can regulate these key developmental genes 
to ensure precise expression levels in different tissues as well as the precise 
patterning of the animal along the anteroposterior axis. As mentioned earlier, it is 
interesting that during early embryogenesis in Drosophila, the short 3’UTR is 
predominantly expressed in the epidermis, however, during late embryogenesis 
the long 3’UTR starts being produced and is restricted to the nervous system 
(Thomsen et al. 2010). A detailed example of this phenomenon is shown in Figure 
5.1 for abd-A, where it can be seen that from stage 13 onwards, the long 3’ UTRs 
starts being expressed and this expression becomes restricted to the nervous 
system. This trend of neural 3’ UTRs has been shown to be shared among the  
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Figure 5.1 Hox genes show a lengthening of their 3’UTRs during neural 
development  
(A) Drosophila embryos across different stages from top to down showing the 
mRNA localization of abdominal-A during embryogenesis by FISH using RNA 
probes that target the short (universal) or long (distal) APA isoforms (See chapter 
2). Note that the extended RNA isoform starts being expressed during stage 13 
(red arrow) and is restricted to the nervous system. (B) Sense controls for the 
probes used in stage 16 embryos. Note that there is no signal from the ventral 
nerve cord. 
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four Hox genes that display APA isoforms (Thomsen et al. 2010). This 
phenomenon was later shown to be more global and involves many more genes 
than the Hox gene clusters (Hilgers et al. 2011; Smibert et al. 2012). Curiously, 
while the extended 3’UTR (only extension beyond short 3’ UTR considered) 
observed in Hox genes can be of up to 1.4 kb long, as in the case of AntP and 
Ubx, other genes have reported extensions of up to 11 kb (only extension beyond 
short 3’ UTR considered as well), as in the case of mei-P26 (Hilgers et al. 2011). 
While it has been shown that the biological function of long 3’UTRs is linked to 
the targeting of trans-acting factors, such as miRNAs and RNA binding proteins 
(Patraquim et al. 2011; Gupta et al. 2014), extensions of lengths such as the 
reported ones in the literature may not be explainable only by this biological 
function in the cell. Thus, the reasons why 3’ UTRs can be extended beyond the 
requirements for differential miRNA/RBP regulation remain unknown. 
I questioned whether the abundance of CFI factors within neurons acts as a cue 
to control PAS selection in extended genes during neural development. For this 
purpose, given that the expression patterns of both CFI25 and CFI68 show an 
enrichment in the nervous system during late embryogenesis (Figure 3.10 and 
3.11), they are the most abundant CFI factors in neural tissues (Figure 3.6 and 
3.9) and the most conserved complex between humans and Drosophila (Figure 
3.3), it appears that CFI is also good candidate to address this question in 
Drosophila. Furthermore, the molecular structure and function of CFI in mammals 
have been well described in the literature (Yang et al. 2011).  
This hypothesis of neural APA control by CFI factor abundance will also put to 
test the model proposed by James Manley and colleagues in the physiological 
context of neural development. This was described in the case of CSTF64 with 
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the IgM heavy chain during B-cell differentiation, in which the abundance of 
CSTF64 acts as a switch for the selection of two different PAS within this gene, 
which determines whether there is either production of a membrane-bound or 
secreted protein (Takagaki et al. 1996). While analysing the reported genes with 
neural-3’ UTR extensions to test this hypothesis, I found that the 29 out of the 30 
“Neural-extended genes” reported in 2011 by Valérie Hilgers and colleagues 
have reported 3’ UTR lengths that do not match the current databases. This was 
found by comparing the current FlyBase data (Flybase release 6.12, July 2016) 
with their results. The length of the 3’ UTRs of the 30 extended genes as 
published in the Hilgers study in comparison with the FlyBase current values are 
shown in Table 5.1. The authors only give approximate values for the length of 3’ 
UTRs in that study, and because of this, if the differences are of less than 50 bp, 
this has been considered as ‘no difference’ between the old and new data, 
especially given that 30% of the 3’UTR lengths discrepancies fell below this range 
(Difference ≈ 0 in table). The difference calculated between the new and old data 
is shown in red for negative values (current 3’ UTR shorter than previously 
reported) and in green for positive values (current 3’ UTR longer than previously 
reported). “Short” is the shortest 3’ UTR sequence available and “Extended” is 
the longest 3’ UTR sequence available without taking in account the “Short” 
sequence included in it when applies.  
The most dramatic difference in FlyBase versus experimental data is the 
longest gene reported in the Hilgers study – mei-P26 – for which the extended  
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Table 5.1 3’ UTR length comparison between Hilgers et al and current data 
Gene 
Short 
3’UTR 
length 
(Hilgers et 
al) (kb) 
Current 
short 
3’UTR 
length (kb) 
Difference 
(kb) 
Extended 
3’UTR 
length 
(Hilgers et 
al) (kb) 
Current 
extended 
3’UTR 
length (kb) 
Difference 
(kb) 
pum 1.200 1.188 -0.012 ≈ 0 3.400 3.414 0.014 ≈ 0 
nrg 0.100 0.128 0.028 ≈ 0 3.000 3.051 0.051 
ago1 1.400 0.435 -0.965 4.600 4.150 -0.45 
gB13F 0.100 0.050 -0.05 3.400 3.329 -0.071 
step 0.300 0.279 -0.021 ≈ 0 3.800 1.263 -2.537 
wdb 0.500 0.527 0.027 ≈ 0 4.000 3.367 -0.633 
nmo 0.500 0.410 -0.09 4.200 3.814 -0.386 
fne 0.300 1.202 0.902 4.200 3.725 -0.475 
nej 0.500 0.192 -0.308 4.500 4.073 -0.427 
ADAR 0.200 0.247 0.047 ≈ 0 4.300 4.064 -0.236 
shep 0.900 0.927 0.027 ≈ 0 5.500 4.865 -0.635 
hrb27C 0.700 0.591 -0.109 6.400 6.011 -0.389 
elav 0.900 0.556 -0.344 7.200 8.001 0.801 
brat 1.300 0.593 -0.707 8.500 7.906 -0.594 
imp 1.100 0.856 -0.244 8.400 8.344 -0.056 
mei-P26 0.900 0.844 -0.056 11.900 17.650 5.75 
dpld 1.500 0.238 -1.262 4.500 4.303 -0.197 
heph 0.900 0.371 -0.529 4.700 4.497 -0.203 
rbp6 1.500 0.057 -1.443 6.900 6.836 -0.064 
bol 1.100 0.603 -0.497 5.000 4.454 -0.546 
fas1 0.900 0.857 -0.043 ≈ 0 2.600 1.723 -0.877 
ga49B 1.200 0.120 -1.08 3.600 3.931 0.331 
cam 0.800 0.116 -0.684 3.400 4.899 1.499 
msi 1.700 0.389 -1.311 5.000 7.287 2.287 
pdp1 2.000 1.989 -0.011 ≈ 0 4.000 2.879 -1.121 
tyf 0.800 0.262 -0.538 3.000 3.760 0.76 
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cip4 0.500 0.527 0.027 ≈ 0 1.500 1.039 -0.461 
mub 1.400 0.926 -0.474 7.100 8.588 1.488 
CG34360 1.100 0.461 -0.639 7.600 7.115 -0.485 
rbp9 1.500 0.730 -0.77 5.000 4.318 -0.682 
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3’ UTR was reported to be of 11.9 kb but it actually is 17.650 kb long. Although 
this discrepancy in 3’ UTR length may not be of high relevance to address the 
question on the mechanisms by which neural APA is controlled, it suggests that 
3’ UTR length control is relevant for the nervous system and perhaps more genes 
undergo this process that have not been yet discovered. When considering the 
case of mei-P26, which has an actual length of the distal 3’ UTR of almost 150% 
the originally reported value, it highlights what could be the biological function of 
these 3’ UTRs (discussed later).  
The reason why the length of 3’ UTRs in the Hilgers study are different to those 
originally reported has probably to do with the fact that the RNA-seq database 
used for reference: The National Center for Biotechnology Information (NCBI) 
Reference Sequence (RefSeq) database (Pruitt et al. 2014) is continually curated 
and updated. Therefore, over the course of five years there was more sequencing 
depth which revealed the 3’ UTR lengths in more detail. 
In this chapter I address the question of the biological mechanism by which the 
3’ UTR extensions are achieved. In order to do this, I performed RNAi 
knockdowns of CFI25 and CFI68 within the developing nervous system by using 
the Gal4/UAS system (Brand & Perrimon 1993) to target expression of the dsRNA 
with an elav driver, which drives expression in neural tissues (See Table 2.1) in 
stage 16 embryos (Campos-Ortega and Hartenstein, 2013). The embryos were 
then assessed for the effects on APA in reported 3’ UTR neural-extended genes. 
These experiments are discussed in the next section. 
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5.2.2 The knockdown of CFI25 and CFI68 within the developing nervous 
system affects APA in Hox genes and 3’ UTR-extended genes 
Natural variations of CPA factor expression during biological processes have 
been reported previously. For example, during differentiation of C2C12 cells into 
myotubes, there is a downregulation in the expression levels of the three CSTF 
members: CSTF50, CSTF64 and CSTF77 (Ji et al. 2009). In this same study the 
authors found that the levels of τCSTF64 were also upregulated during the same 
process. τCSTF64 is a paralog of CSTF64 which is absent in Drosophila (Figure 
3.2). τCSTF64 has been shown to mediate testis-specific PAS selection in 
mammals, whereas the normal CSTF64 gene is inactive during male meiosis in 
the mouse. Similarly, as shown in Chapter 3, there was a correlation between 
CPA factor mRNA levels and the progression of Drosophila embryogenesis. More 
specifically, factors that are part of the same complex showed a decrease in 
mRNA levels as embryonic development progresses (Figure 3.4). As shown for 
CFI (Figure 3.10 and 3.11), this is caused by restricted expression patterns in the 
nervous system, hence showing an increase in expression in this tissue when 
compared with others (Figure 3.6). These observations suggest that variation in 
CFI factors abundance during neural development is what controls 3’ UTR length.  
To test this hypothesis, we need to manipulate CFI factor levels in order to 
evaluate whether this is what controls 3’ UTR length in this tissue. Since both 
subunits of CFI, CFI25 and CFI68, are essential for the functioning and coherent 
assembly of the CFI complex, I address this question by focusing on both of them. 
Similar experiments have been widely performed in vitro, for example, human 
cells have been extensively used to downregulate CFI factors to then assess 
effects on 3’ UTRs (Kubo et al. 2006; Masamha et al. 2014). However, HeLa cells 
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and other cell lines have themselves a cancerous origin, and it has been shown 
that 3’ UTR lengths and APA are misregulated during cancer (He et al. 2016; 
Mayr and Bartel 2009; Erson-Bensan and Can 2016). Also, it has been shown 
that alterations in Fip1 abundance can alter stem cell self-renewal and somatic 
cell reprogramming by 3’ UTR shortening (Lackford et al. 2014). Yet, the read-
out obtained by these experiments may not reflect the changes that would occur 
in a natural context in vivo. These experiments still provide evidence in favour of 
the idea of CPA factor abundance behind the control of APA and thus influencing 
biological processes.  
In order to test whether CFI factors abundance acts as the mechanism controlling 
APA within the developing nervous system, I selected the genes described in the 
Hilgers study with their curated 3’ UTR lengths, as well as the Hox genes. Further, 
different 3’ UTR lengths may have different biological functions. While short 
extensions are coherent with the concept of differential miRNA/RBP regulation 
(Patraquim et al. 2011; Gupta et al. 2014), extremely long 3’ UTRs may play other 
biological functions beyond the aforementioned ones, which if existing, are 
largely unexplored. Hence, I separated the extended genes in three categories 
according to the length of their extended 3’ UTRs. By doing this, I can then relate 
if effects observed after CFI factor depletion can be related with this property. 
Thus, the three different categories are labelled as “Short 3’ UTRs” for the 
extensions of less than 2 kb. “Medium 3’ UTRs” for the extensions of less than 5 
kb and “Long 3’ UTRs” for the extensions of 6 kb or more. This classification is 
based on the distribution observed for distal 3’ UTR length, which is non-linear 
and reflects these three categories. This classification resulted in seven genes 
within the “Short 3’ UTR” category, with all four Hox genes falling within this 
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category. 18 genes within the “Medium 3’ UTR” category and nine genes within 
the “Long 3’ UTR” category. I then selected representative genes from each 
category in a proportional way to how many genes are within each one. Thus, I 
selected 5 genes from the “Short” and “Long” category and 10 genes from the 
“Medium” category to be tested for effects on APA after knockdown of CFI factors 
within the developing nervous system. The ranking of extended genes plus the 
selection of genes for testing, together with their biological function is shown in 
Figure 5.2.  
To assess for the efficiency of the RNAi treatments, for CFI25 the levels of protein 
expression were quantified using the same antibody previously used for Western 
Blot experiments (Figure 4.6). For CFI68 I tried an antibody against the human 
version of CFI68 whose immunogenic region is 80% similar in Drosophila but 
unfortunately it did not work (Data not shown). The reasons of this likely to be for 
not having the exact required matches for antibody binding in spite of the high 
overall similarity. Nonetheless, by semi-quantitative RT-PCR, a reduction in 
CFI68 levels could be observed although this may be an underestimation of the 
real magnitude of the knockdown at the peptide level. After quantification, it was 
concluded that RNAi led to a reduction of nearly 40% in CFI25 protein levels and 
of nearly 30% in CFI68 mRNA levels (Figure 5.3).  
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Figure 5.2 Categories for 3’ UTR length of Hox genes and reported neural-
extended genes and biological function of selected genes 
(Legend on the following page) 
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Figure 5.2 Categories for 3’ UTR length of Hox genes and reported neural-
extended genes and biological function of selected genes 
(A) Ranking of Hox and neural-extended genes from (Hilgers et al. 2011) 
according to the curated length of their extended 3’UTR. The length of their short 
3’ UTR is also shown for reference. (B) Genes selected from each category for 
APA testing experiments after neural knockdown of CFI factors. The precise 
curated length of their 3’ UTR, as well as an example of their biological function 
is also shown. 
(D. M. Lee and Harris 2013)(Yamamoto et al. 2006)(Yu et al. 2003)(Neely et al. 2010)(Ye et al. 
2004)(Zaharieva et al. 2015)(Toma et al. 2002)(Keegan et al. 2011)(Marek et al. 
2000)(Rehwinkel, Behm-ansmant, and Gatfield 2005)(D. Chen, Qu, and Hewes 2014)(J. Berger 
et al. 2008)(Bivik et al. 2015)(Thomas Hummel, Schimmelpfeng, and Kla 1999)(Medioni et al. 
2014)(Page et al. 2000) 
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Figure 5.3 RNAi efficiencies of neural knockdown of CFI factors during 
late embryogenesis 
 (Legend on the following page) 
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Figure 5.3 RNAi efficiencies of neural knockdown of CFI factors during 
late embryogenesis 
(A) Diagram representing the location of CFI25 within the CPA machinery, CFI25 
levels in stage 16 embryos for the control (elav > +) and the knockdown of CFI25 
within the nervous system (elav > CFI25 RNAi), assessed by Western Blot in 
three independent biological replicates. In each experiment, after normalizing by 
tubulin, each control was used as 100% and the value for the knockdown was 
transformed according to its control in each separate experiment. (B) Diagram 
representing the location of CFI68 within the CPA machinery, CFI68 levels in 
stage 16 embryos for the control (elav > +) and the knockdown of CFI68 within 
the nervous system (elav > CFI68 RNAi), assessed by semi-quantitative RT-PCR 
in three independent biological replicates. In each experiment, after normalizing 
by RpA1, each control was also used as 100% and the value for the knockdown 
was transformed according to its control in each separate experiment. An 
unpaired two-tailed t-test was used to compare genotypes, * p < 0.05. 
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To assess the effects on APA in the selected genes after neural depletion of CFI 
factors, semi-quantitative RT-PCR was used (See Chapter 2). This was 
conducted similarly to the experiments done in Chapter 4, to assess for effects 
on APA in feeding genes. Primers were designed to conduct amplification of the 
“Universal” and the “Distal” 3’UTRs. Depending on the number of mRNA isoforms 
of each gene, and their specific patterns of APA, the “Universal” amplicons were 
designed to amplify the shortest 3’ UTR in all or as many isoforms as possible for 
the cases where, given their sequence length and composition, it was feasible to 
amplify those regions by PCR. When this was not possible, the next short, shared 
3’UTR sequence was selected as “Universal”. Conversely, the “Distal” primers 
were designed to amplify the longest 3’UTRs for each of the target genes, which 
also depending on how many and the nature of the mRNA isoforms for each 
gene, would amplify only one or more than one isoform (For primer design see 
Chapter 2). Please note that if the “Universal” primers are less efficient than the 
“Distal” ones for PCR amplification, or if the “Universal” primers only target a 
subset of transcripts for a given gene, such as the case of nrg, it is possible to 
have lower “Universal” than “Distal” signal, although this may seem 
counterintuitive.  
After amplifying the above-mentioned regions by PCR from late embryos from 
the control and the knockdown of either CFI25 or CFI68 within the nervous 
system, I calculated the “Distal/Universal ratio” for the control and each one of 
the treatments. For each sample, RpA1 was amplified as a loading control. The 
results of this analysis are shown in Figures 5.4, 5.5, 5.6 and 5.7. From these 
results it can be observed that within the “Short 3’ UTR” category of genes, two  
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Figure 5.4 The knockdown of CFI25 and CFI68 within the developing 
nervous system affects APA in abd-A and Abd-B 
(Legend on the following page) 
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Figure 5.4 The knockdown of CFI25 and CFI68 within the developing 
nervous system affects APA in abd-A and Abd-B  
(A) Ranking and categories of Hox and selected neural-extended genes for 
knockdown experiments from (Hilgers et al. 2011) according to the curated length 
of their extended 3’ UTRs. The curated length of their short 3’ UTR is also shown 
for reference (B) “Dis/Uni” ratios of target genes in the knockdown of each one of 
the members of CFI within the nervous system in stage 16 embryos. Each gene 
was analysed in three independent biological replicates together with the control 
in which no RNAi was used (elav > +). For each graph, representative RT-PCR 
bands of the Universal and Distal amplicons are shown for each one of the 
genotypes. Note that the “Universal” amplicons of abd-A (1) and Abd-B (2) in the 
knockdown of both CFI25 and CFI68 are more intense than the control, which 
generates lower “Dis/Uni” ratios. Unpaired two-tailed t-tests were used to 
compare each RNAi against CFI25 or CFI68 with the control, * p < 0.05. 
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Figure 5.5 The knockdown of CFI25 and CFI68 within the developing 
nervous system affects APA in nrg  
(Legend on the following page) 
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Figure 5.5 The knockdown of CFI25 and CFI68 within the developing 
nervous system affects APA in nrg 
“Dis/Uni” ratios of target genes in the knockdown of each one of the members of 
CFI within the nervous system in stage 16 embryos. Each gene was analysed as 
in Figure 5.4. Note that the “Distal” amplicon of nrg (2) in the knockdown of CFI25 
is more intense than the control. On the contrary, the “Universal” amplicon of this 
gene in the knockdown of CFI68 is less intense than the control. These changes 
generate significantly higher “Dis/Uni” ratios in the knockdowns when compared 
with the control. Unpaired two-tailed t-tests were used to compare each RNAi 
against CFI25 or CFI68 with the control, * p < 0.05. 
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Figure 5.6 The knockdown of CFI25 within the developing nervous system 
affects APA in nmo, ADAR, nej, shep, and hrb27C 
(Legend on the following page) 
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Figure 5.6 The knockdown of CFI25 within the developing nervous system 
affects APA in nmo, ADAR, nej, shep, and hrb27C 
“Dis/Uni” ratios of target genes in the knockdown of each one of the members of 
CFI within the nervous system in stage 16 embryos. Each gene was analysed 
as in Figure 5.4. Note that the “Distal” amplicons of nmo (1), ADAR (2), nej (3), 
shep (5) and hrb27C (6) in the knockdown of CFI25 are more intense than the 
control, which generates significantly higher “Dis/Uni” ratios in the knockdown 
when compared with the control. However, none of the knockdowns for CFI68 
generates significant changes in the “Dis/Uni” ratio when compared with the 
control. Unpaired two-tailed t-tests were used to compare each RNAi against 
CFI25 or CFI68 with the control, * p < 0.05. 
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Figure 5.7 The knockdown of CFI25 within the developing nervous system 
affects APA in brat, while the knockdown of CFI25 and CFI68 affects APA 
in imp 
(Legend on the following page) 
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Figure 5.7 The knockdown of CFI25 within the developing nervous system 
affects APA in brat, while the knockdown of CFI25 and CFI68 affects APA 
in imp 
“Dis/Uni” ratios of target genes in the knockdown of each one of the members of 
CFI within the nervous system in stage 16 embryos. Each gene was analysed as 
in Figure 5.4. Note that the “Distal” amplicon of brat (1) in the knockdown of CFI25 
is more intense than the control, which generates significantly higher “Dis/Uni” 
ratios. On the contrary, the “Universal” amplicon of imp (3) in the knockdown of 
both CFI25 and CFI68 within the nervous system is more intense than the control, 
which generates a lower “Dis/Uni” ratio when compared with the control. Unpaired 
two-tailed t-tests were used to compare each RNAi against CFI25 or CFI68 with 
the control, * p < 0.05. 
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of the Hox genes show effects in APA: abd-A and Abd-B. After the knockdown of 
both CFI25 and CFI68 within the developing nervous system, these posterior Hox 
genes undergo an increase in the production of the “Universal” 3’ UTR amplicon 
(Figure 5.4), which is reflected in a significant decrease in their “Distal/Universal” 
ratios when compared with the control. Interestingly, these genes express the 
shortest extended 3’ UTRs within the ranking, with extensions of only 413 and 
503 bp for abd-A and Abd-B, respectively. These observations could mean that 
there is an increase in the production of short abd-A and Abd-B after CFI 
depletion. Within the “Medium 3’ UTR” category, I observe that neuroglian (nrg), 
nemo (nmo), ADAR, nejire (nej) and alan shepard (shep) show an increase in the 
production of the “Distal” 3’ UTR amplicon after the knockdown of CFI25 (Figures 
5.5 and 5.6), while the knockdown of CFI68 generates a decrease in the 
production of the “Universal” 3’ UTR amplicon in nrg (Figure 5.5). Both changes 
generate an increase in the “Distal/Universal” ratios. nrg is a cell-surface protein 
member of the Ig superfamily which is involved in axonal sprouting and dendrite 
branching within the Drosophila central and peripheral nervous (Bieber et al. 
1989; Yamamoto et al. 2006), it expresses nine different mRNA isoforms and 
uses five different PAS to generate diverse APA isoforms, its shortest 3’ UTR is 
only 128 bp long and only shared with two other of the mRNA isoforms, therefore 
not working as a true Universal 3’ UTR. To design primers for the “Universal”, I 
selected a 3’ UTR of approximately 1 kb long shared among five mRNA isoforms. 
The primers for the “Distal” targeted the longest 3’ UTR which is approximately 3 
kb long and only present in one of the nine mRNA isoforms (for primer design 
see Chapter 2, Table 2.5). The effects observed for CFI68 therefore could be due 
to a decrease in the production of the selected short 3’ UTR for PCR, leading to 
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an increase in the “Dis/Uni” ratio. Within the “Long 3’ UTR” category, 
heterogeneous nuclear ribonucleoprotein at 27C (Hrb27C) and brain tumour 
(brat) also show a significant increase in the production of the “Distal” 3’ UTR 
amplicon after the knockdown of CFI25 (Figure 5.6 and 5.7), the knockdown of 
CFI68 does not generate significant changes. On the other hand, IGF-II mRNA-
binding protein (imp) shows a significant increase in the “Proximal” 3’ UTR 
amplicon after the knockdown of both CFI25 and CFI68, leading to a reduction in 
their “Distal/Universal” ratios, similarly to the case observed in the Hox genes 
(Figure 5.7). Imp is within the opposite range of 3’UTR lengths in the ranking, 
being the second longest extended 3’ UTR, with an extension of more than 8 kb 
(Figure 5.2). These results suggest that CFI depletion enhances the use of the 
distal PAS of nrg, nmo, ADAR, nej and shep, while this depletion in CFI enhances 
the use of the proximal PAS of imp, generating an overexpression of the short 
isoform. 
In summary, I have observed and shown that 10 out of the 20 genes tested show 
changes in their APA patterns after CFI factor depletion in the nervous system. 
Furthermore, from these 10 affected genes, two belong to the ‘short’ 3’ UTR 
category (abd-A and Abd-B), five belonged to the ‘medium’ 3’ UTR category (nrg, 
nmo, ADAR, nej and shep) and three belonged to the ‘long’ 3’ UTR category 
(hrb27C, brat and imp). Naturally, this led to the question of why only a subset of 
genes showed significant effects in APA after neural CFI depletion as interpreted 
by the increase or decrease in their “Distal/Universal” ratios. In order to address 
this question, the next step was to look for a potential relationship between the 
length of their extended 3’ UTR and sensitivity to CFI factor depletion.  
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5.2.3 There is no clear relationship between 3’ UTR length of target genes 
and effects in APA by knockdown of CFI factors within the developing 
nervous system  
In the previous section I showed that there were a range of different responses 
in APA of 50% of the genes tested after the knockdown of CFI factors within the 
developing nervous system in stage 16 embryos. The two Hox genes with the 
shortest 3’ UTR, abd-A and Abd-B, as well as the second longest 3’UTR gene, 
imp, showed an increase in the production of short 3’ UTR isoforms after the 
knockdown of both CFI25 and CFI68 (Figure 5.4). This trend has been previously 
observed in other genes after inducing knockdown of CFI25 in human cells (Kubo 
et al. 2006). Seven genes within the “Medium” and “Long” 3’ UTRs categories 
presented an increase in the production of the extended 3’ UTR isoforms after 
the knockdown of CFI25. Effects of this nature are rare, yet still reported for 
several human genes in C2C12 cells after the knockdown of CFI members 
including Casp8, Map3k3, Rab13, Fbxo8 and Sox11, among several other (Li et 
al. 2015) 
The results observed after CFI depletion generate two immediate questions: (i) 
What are the reasons for the different directions in Dis/Uni ratios observed after 
CFI factor depletion in the nervous system? And (ii) Why only a subset of genes 
are sensitive to CFI depletion while others are not? To address the first question, 
I hypothesised that this is due to the length of the extensions of each of the 3’ 
UTRs tested. Thus, an increase in sensitivity is expected as the length of the 
extension increases. To test this, I assigned a parameter named as “Δ APA”, 
which is the quotient between the “Distal/Universal” ratio for each one of the 
RNAis and their respective controls. Thus, values close to 1 mean ‘no difference’, 
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values <1  mean ‘shortening', and >1 are ‘lengthening’ of 3’ UTRs. For all genes 
tested,  Δ APA values against the length of their extended 3’ UTRs are shown in 
Figure 5.8. There is no statistically robust correlation between 3’ UTR length and 
the observed effects on APA. This observation suggests that it is not the 
extension of 3’ UTRs per se what makes these genes more or less sensitive to 
CFI depletion. Instead, sequence composition or other properties such as 
transcript stability or transcriptional input may be the cause. To investigate 
whether composition rather than overall 3’ UTR length can explain why only a 
subset of the tested genes are affected by CFI factor depletion, I scanned the 3’ 
UTR sequences of the genes affected by CFI depletion for enrichment of motifs 
in an unbiased way in comparison with the genes that were not affected by using 
MEME (Multiple Em for Motif Elicitation) (Bailey and Elkan 1994). Thus, the 
hypothesis to be tested is whether genes affected by CFI depletion show an 
enrichment in binding sites for CFI. The results of these experiments are 
discussed in the next section. 
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Figure 5.8 There is no clear relationship between 3’ UTR length of target 
genes and effects in APA by knockdown of CFI factors within the 
developing nervous system 
(Legend on the following page) 
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Figure 5.8 There is no clear relationship between 3’ UTR length of target 
genes and effects in APA by knockdown of CFI factors within the 
developing nervous system 
(A and B) Average of Δ APA values in 3 biological replicate experiments for the 
knockdown of CFI25 (A) and CFI68 (B). Linear, logarithmic and polynomial 
curves were fitted through the data points with and without mei-P26, which given 
its extremely long 3’ UTR can be considered and outlier within the axis. The best 
fit only gives a low multiple R-squared coefficient in the case of CFI25 RNAi (0.2, 
data not shown), which drops to half when is adjusted by sample size. A dotted 
line is drawn in the ratio with value 1 to represent the inflexion point in Δ APA. 
Error bars represent the SEM. 
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5.2.4 Bioinformatic analysis of motif enrichment in 3’ UTRs of neural-
extended genes 
In order to verify whether it is sequence composition and not only 3’ UTR length 
behind the reason why only 50% of the tested extended genes were sensitive to 
CFI depletion, I scanned their 3’ UTR sequences for motif enrichment in an 
unbiased way by using discriminative analysis with MEME (Multiple Em for Motif 
Elicitation) (Bailey and Elkan 1994). This bioinformatic tool discovers ungapped 
motifs that are enriched in a given sequence by using statistical modelling 
techniques to automatically choose the best width, number of occurrences, and 
description for each motif. The hypothesis that drives these experiments is that 
this platform will be able to detect an enrichment in binding sites for CFI in the 
genes that were sensitive for CFI depletion. Furthermore, experiments in 
mammalian cells have shown that genes sensitive to CFI depletion have an 
enrichment in CFI binding motifs in their 3’ UTRs (Li et al. 2015). However, 
contrary to the canonical “UGUA” element known in mammals, which  was 
accurately described by SELEX experiments in 2003 (Brown and Gilmartin 2003), 
evidence suggests that insect pre-mRNAs use binding sites for CFI with a more 
degenerate sequence (Hutchins et al. 2008). In order to scan for motif enrichment 
in the 3’ UTR of genes that were sensitive to CFI depletion, I extracted the 
sequences of the long 3’ UTRs (Complete 3’ UTR sequence) of the 20 genes 
tested from Flybase (Release from July 28, 2016) (Attrill et al. 2016). Then, 
MEME was used to scan for significantly (E-value < 0.05. The E-value is an 
estimate of the expected number of motifs with the same width and site count, 
that one would find in a similarly sized set of random sequences) enriched motifs 
in the long 3’ UTRs of genes sensitive to CFI depletion compared with the long 3’ 
  
206 
UTRs of genes that were not sensitive to CFI depletion. As a negative control, I 
performed the same comparison but with the shuffled sequences of the 3’ UTRs. 
This last comparison, as expected, did not detect any significantly enriched motif, 
showing that the discovered enriched motifs are not the product of random 
combinations of nucleotides. The results of this analysis are shown in Figure 5.9. 
Two motifs were significantly enriched in the long 3’ UTRs of the genes affected 
by neural CFI depletion when compared with the 3’ UTR of the genes that were 
not affected. Interestingly, Motif 2 shows similarity with the mammalian 
sequences in its first nucleotides (Figure 5.9 Panel C) (Brown and Gilmartin 2003) 
and also an enrichment of ‘T’s that is consistent with the broad description of the 
insect CFI binding site, which in the mosquito Anopheles gambiae has been 
described as “AAAN(A/T)TTT” (Hutchins et al. 2008). Hence, these results show 
that genes that were sensitive to CFI depletion have an enrichment in this motif, 
which is proposed as the binding site for CFI. However, further evidence is 
needed to interpret these results as a true binding site for CFI. To address this, I 
mapped the position of motif 2 within the 3’ UTRs of each one of the seven genes 
in which it was found by MEME: nrg, abd-A, ADAR, hrb27C, imp, brat and Abd-
B and compared its location with respect to the location of the different 
polyadenylation signals (PAS). The binding site for CFI in mammals has been 
described as located 30-40 nucleotides upstream from the PAS (Brown and 
Gilmartin 2003; Georges Martin et al. 2012; Venkataraman et al. 2005). Although 
binding of CFI has also been reported within 100 nucleotides upstream of the 
cleavage site in mammals (Martin et al. 2012). In insects, the position  
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Figure 5.9 Bioinformatic analysis of motif enrichment in 3’ UTRs of neural-
extended genes affected by CFI depletion 
(Legend on the following page) 
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Figure 5.9 Bioinformatic analysis of motif enrichment in 3’ UTRs of neural 
extended genes affected by CFI depletion 
(A) Table showing the categories used for analysis with simplified gene models 
representing the length the distal 3’ UTRs. The complete 3’ UTR sequences were 
used for comparison between genes with affected APA patterns after CFI 
depletion with the genes not affected, depicted by the vertical double arrow. (B) 
Significant motif enrichment analysis by MEME after comparison of the long 3’ 
UTRs showed in (A), Motif 2 is selected for further analysis. The same analysis 
done with the shuffled 3’ UTRs does not detect enrichment (Data not shown) (C) 
Magnification of motif 2 from (B), the table represents the results from SELEX 
experiments as done in (K. M. Brown and Gilmartin 2003), note that ‘T’ is used 
instead of ’U’ because 3’ UTR sequences from Flybase are retrieved as DNA 
code. Note that the first nucleotides of Motif 2 show similarity with the mammalian 
sequences. Also, the high enrichment of ‘T’ is consistent with the broad 
description of the insect CFI binding site from (Hutchins et al. 2008). 
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of this binding site has been reported within the range of 50 – 100 nucleotides 
upstream of the PAS (Hutchins et al. 2008). Hence, I scanned the position of 
Motif 2 in the sensitive genes with respect to the location of the different PASs. 
In this way, if the motif is (i) found upstream of the PAS and (ii) at a distance of 
50-100 nucleotides, this will suggest that Motif 2 acts as a true CFI binding motif 
in that gene. The results of this analysis are shown in Figure 5.10. I observe that 
these two conditions are achieved only for Abd-B, in which motif 2 is found 144 
bp upstream of the last PAS. In the other cases, Motif 2 is found upstream of the 
second PAS of nrg, the first PAS of abd-A and the last PAS of ADAR, hrb27C, 
imp and brat. However, its location is too far away from the expected distance 
between this motif and the PAS to act as the binding site of CFI in these genes. 
These results show that this enrichment in Motif 2 can only partially explain why 
this subset of genes is sensitive to CFI depletion and suggests that potentially 
there are other mechanisms involved, which will be discussed in the next section. 
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Figure 5.10 Location of Motif 2 with respect to the PAS in the 3’ UTRs of 
genes affected by CFI depletion  
(Legend on the following page) 
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Figure 5.10 Location of Motif 2 with respect to the PAS in the 3’ UTRs of 
genes affected by CFI depletion  
(A-G) Gene diagrams of nrg (A), abd-A (B), ADAR (C), hrb27C (D), imp (E), brat 
(F) and Abd-B (G), ranked from top to down according to the p-values for motif 2 
enrichment (p-values represent the probability that an equal or better site would 
be found in a random sequence of the same length conforming to the background 
letter frequencies). The grey box represents the coding sequence of each gene, 
the 3’ UTR is represented as a black line with its length indicated at the end for 
each gene, the location of the PAS is depicted by a black inverted triangle and 
the location of Motif 2 is depicted by a red square. The distance from Motif 2 to 
each one of the PAS, as well as the specific sequence of Motif 2 in each gene 
are shown. Note that only in the case of Abd-B (G), the location of Motif 2 is 
consistent with it acting as a true CFI binding motif given its location upstream of 
the PAS and the distance (144 bp). These results suggest that motif 2 can only 
partially explain the sensitivity to CFI depletion in these target genes and that 
other mechanisms may be involved. 
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5.3 Discussion  
The work presented in this chapter shows that the neural knockdown of CFI25 
and CFI68 in late embryos affects APA patterns in a subset of genes reported for 
neural extensions in 3’ UTRs (Hilgers et al. 2011). Relatedly, the annotation of 
the length of these genes does not match the current databases, and while the 
general change in length is seen as sequences shorter than previously 
annotated, specific cases for longer sequences are observed (Table 5.1), with 
mei-P26 being the most dramatic example by having a curated extended 3’ UTR 
of 17.650 kb, similarly to mammalian transcripts (Miura et al. 2013). As mentioned 
earlier, the biological roles played by these extensively long 3’ UTRs remain 
unknown, given that differential miRNA and RBP targeting does not require such 
extensions to be achieved. This is what happens in the Hox genes (Patraquim et 
al. 2011). One scenario could be that extensively long 3’ UTRs play roles beyond 
post-transcriptional regulation, by tethering transcripts to their DNA templates 
and releasing them in a timely-controlled way that can complement transcriptional 
control by promoters and enhancers. Another potential scenario is that this 
extensively long 3’ UTR may serve as transcriptional checkpoints, where pre-
mRNAs require assessment by different molecular machineries such as the ones 
controlling splicing, 5’ capping and non-sense mediated RNA decay before finally 
releasing the transcripts for translation. These processes ensure that the 
produced proteins work in an optimal way. This hypothesis is consistent with the 
fact that hundreds of neural transcripts in Drosophila (Smibert et al. 2012) and 
thousands in mammals (Miura et al. 2013) undergo these processes, given that 
the complexity of the nervous system may require extra layers of gene expression 
checkpoints to ensure functionality.  
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Here I have also shown that neural-specific depletion of CFI factors within the 
developing nervous system in late embryos can affect APA patterns in reported 
neural-extended genes (Hilgers et al. 2011). Interestingly, while abd-A, Abd-B 
and Imp showed an increase in the production of proximal amplicon and therefore 
a reduction in their “Distal/Universal” ratios after CFI knockdown. Nrg, nmo, 
ADAR, nej, shep, hrb27C and brat show an increase in the production of the distal 
amplicon and therefore an increase in their “Distal/Universal” ratios after CFI 
knockdown. These results are not simply explainable by 3’ UTR length, given that 
we cannot see any clear relationship between these two variables (Figure 5.8). 
Likewise, after analysing the full 3’ UTR sequences of the genes affected by CFI 
depletion, a motif was found that resembles the binding site of CFI, according to 
comparison with descriptions in mammals (Brown and Gilmartin 2003) and 
insects (Hutchins et al. 2008). Nonetheless, this motif only fulfils the conditions to 
function as the binding site of CFI in the 3’ UTR of Abd-B, given that is located 
144 bp upstream of the second PAS (Figure 5.10 Panel G). One way of further 
testing if this and other discovered motifs function as true binding sites for CFI is 
to use mutagenesis. For example, by applying CRISPR (Hsu et al. 2014; Bassett 
and Liu 2014) to mutate these sites and then analyse whether the patterns of 
APA of these genes during neural development are affected.  
The results observed in this study suggest that other mechanisms may be 
involved in the differential sensitivity of neural-extended genes to CFI depletion. 
For example, differential transcript stability or transcriptional input. Further 
exploration of the different 3’ UTRs of all the genes that undergo neural-
extensions in combination with manipulation of CPA factor expression during 
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neural development can be therefore a good way of exploring the mechanisms 
that control APA in this developmental context in Drosophila. 
Most of the effects observed in our knockdown experiments produced an 
increase in the Dis/Uni ratio. Although effects of this nature are rare, they have 
been reported for several genes in human cells (Li et al. 2015). In the literature, 
both CFI25 and CFI68 have been described broadly as repressors of proximal 
PAS (Martin et al. 2012), this means that when their expression levels are 
downregulated, they favour the use of proximal PAS, which leads to a global 
shortening of 3’ UTRs. The effects we observe for abd-A, Abd-B and imp are 
totally in line with this model, because an upregulation of the proximal 3’ UTRs is 
observed (Figure 5.4 and 5.7). Given that in this study we only used 20 specific 
genes, we cannot rule out the possibility that the low sampling size when 
compared with the previous studies generated a bias in our interpretation, by 
detecting outliers in an otherwise opposite trend. One way of expanding these 
experiments is to subject the samples to transcriptome-wide analysis as the ones 
described previously (Li et al. 2015; Masamha et al. 2014) and to purify RNA that 
comes specifically from neurons. This could be achieved by using TU-tagging, 
which is a technique used in Drosophila to isolate cell type-specific RNA from 
complex tissues by expressing uracil phosphoribosyltransferase (UPRT) in a 
tissue specific manner. Then, its substrate 4-thiouracil is delivered to the 
organism by soaking the embryos in it, generating Thio-RNA only in the cells 
expressing UPRT, which can be subsequently purified (Miller et al. 2009).  
In summary, here I have shown that the expression levels of CFI factors can 
control APA within the nervous system. This suggests that the observed 
enrichment of CFI expression in this tissue (shown in Chapter 3 Figures 3.10 and 
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3.11) can be directly linked to the reported 3’ UTR extensions. This evidence is 
similar to that which was shown in vitro. Future experiments to establish this 
model can be the ectopic expression of CFI members in non-neural tissues by 
using the Gal4-UAS system (Brand and Perrimon 1993) to see if there is a shift 
at the transcriptomic level by genes acquiring “neural” profiles of APA. This same 
approach can be used to boost the expression of CFI factors within the nervous 
system to test the model of CPA factor abundance and PAS selection proposed 
by James Manley and colleagues (Takagaki et al. 1996), where we would expect 
the opposite results as those observed by RNAi knockdown as have been shown 
here.  
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Chapter 6  
General Discussion 
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6.1 General discussion 
The work presented in this thesis provides novel insights on the regulation of APA 
during neural development and highlights the biological roles of CPA factors at 
the organismal level beyond their well-established molecular function by studying 
them in the context of the in vivo formation and function of the nervous system in 
Drosophila melanogaster. 
APA is a pervasive mechanism of post-transcriptional control that generates 
mRNAs with different 3’ ends in more than 60% of all human and mammalian 
genes (Derti et al. 2012; Hoque et al. 2013) (Chapter 1). As well as in 
approximately half of all genes in other vertebrates, such as zebrafish, and 
invertebrates, such as C. elegans and Drosophila (Ulitsky et al. 2012; Smibert et 
al. 2012; Jan et al. 2011). This selection of different 3’ UTRs can have different 
biological functions, including mRNA localization, stability and translation 
efficiency, having a direct impact on the diversity of the transcriptome and the 
proteome (Di Giammartino et al. 2011). Interestingly, the expression of long 3’ 
UTR isoforms during development in hundreds of genes in Drosophila and 
thousands of genes in mammals is restricted to the nervous system (Thomsen et 
al. 2010; Smibert et al. 2012; Miura et al. 2013), in which differential targeting by 
miRNAs and RBPs have been the main purposes explained in the literature for 
their biological function within neural tissues. 
The molecular mechanisms that control APA are not well understood. 
Experiments in vitro in mouse B-Lymphocytes showed that the IgM heavy chain 
gene produces two mRNA isoforms by APA: A membrane bound protein or a 
secreted one (Takagaki et al. 1996). This shift between the two isoforms was 
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shown to be a product of the abundance of the CPA factor CSTF64, in which high 
levels of CSTF64 favoured the use of the proximal PAS and therefore a secreted 
protein, while low levels of CSTF64 favoured the use of a distal PAS and 
therefore a membrane-bound protein. This evidence led to a mechanistic model 
that is prevalent today as one of the molecular mechanisms that control APA by 
means of CPA factor abundance and differential PAS strength. Nonetheless, 
experiments in vitro present limitations in which we cannot reproduce what is 
observed in multicellular organisms, let alone to understand the mechanisms by 
which these extensively long 3’ UTRs are expressed within a developing nervous 
system. 
In this thesis I focused on the molecular mechanisms that control APA during 
neural development, as well as the biological relevance of CPA factors for neural 
formation and function. The work was centred on the following questions: (i) What 
are the molecular factors that control APA during Drosophila development? (ii) 
Does the nervous system express different levels of CPA factors in comparison 
to other tissues to express comparatively long 3’ UTRs during development? (iii) 
Can the manipulation on CPA factor within the developing nervous system affect 
APA in neural extended genes and so provide evidence for the “CPA factor 
abundance” model in this novel context? And (iv) what are the biological roles of 
CPA factors for neural function and behaviour? To address these questions I 
used Drosophila melanogaster as a novel model-system to study APA in contrast 
with work in vitro. Considering therefore the physiological context of neural 
development. 
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6.2 Cleavage and polyadenylation factor expression and extension of 3’ 
UTRs during neural development 
As mentioned earlier, since 2010 it has been reported that the nervous system in 
both vertebrates and invertebrates undergoes an extensive lengthening of 3’ 
UTRs in the nervous system (Thomsen et al. 2010; Hilgers et al. 2011; Smibert 
et al. 2012; Miura et al. 2013). Yet, these studies have not explored the 
mechanisms by which this phenomenon is achieved by the CPA machinery.  
A study in 2013 addressed the question on what is the biological meaning of 
variation in 3’ UTR length in different human tissues. They show that ubiquitously 
expressed genes use APA to achieve tissue-specific expression of these 3’ UTR 
isoforms, which are then  targeted by ubiquitously expressed miRNAs to act on 
them differentially (Lianoglou et al. 2013). Still, one key question that emerges 
from this study is: What is the mechanism by which these tissues express long 3’ 
UTR isoforms in the first place? This question can be addressed by analysing 
CPA factor expression levels in the tissues sampled and looking for a correlation 
that can be experimentally tested. 
This work shows that in Drosophila there is a relationship between tissue-specific 
CPA factor expression and neural 3’ UTR length in which neural tissues express 
higher levels of CPA factors in comparison with others during embryonic and 
larval life (Chapter 3). Also, the most conserved CPA complex between humans 
and Drosophila, CFI, which is also the most neural-enriched CPA complex in 
Drosophila larvae and adults, shows a restricted expression pattern in the 
embryonic nervous system at the time where extensively long 3’ UTRs are 
reported (Chapter 3). This work also shows that variations in the expression 
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levels of the members of CFI during this stage by RNAi knockdown have a knock-
on effect on neural-extended genes APA (Chapter 5), strongly suggesting that 
this neural-enrichment of CFI factor expression act as a cue within neurons to 
express these long 3’ UTR isoforms. This takes the “CPA factor abundance” 
model to a novel developmental context that has not been explored before in the 
field. These results encourage us to take this approach to a genome-wide 
transcriptomic level by which we can explore further the mechanisms by which 
neural-3’ UTR extensions are achieved involving also more members of the 
identified Drosophila CPA machinery (Chapter 3). Further, Drosophila allows the 
use of well-established molecular tools that have not been applied in the literature 
to address the question on the molecular mechanisms that control APA. For 
example, by overexpressing subsets of CPA factors in different tissues or by 
expressing synthetic constructs with collections of experimental 3’ UTRs to then 
study their APA effects after genetic manipulation of CPA factor abundance. 
Thus, experiments like the ones proposed above can allow us to use the 
embryonic nervous system or other tissues with biased 3’ end isoforms as test 
tubes to study this pervasive post-transcriptional modification. 
6.3 Biological roles of cleavage and polyadenylation factors 
When genes with well-established molecular functions are studied in a 
multicellular organism in different contexts, including behaviour, development or 
physiology, the phenotypes that are observed in mutant conditions at times can 
be remarkable. A good example of this is the miRNA locus iab4/8. This miRNA 
locus is located within the Bithorax complex in Drosophila and controls the 
expression of Hox genes located in this region, including Ubx. Interestingly, 
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although somehow expected, its ectopic expression in the halteres can lead to 
homeotic transformations from halteres to wings through precisely effects in Ubx. 
(Ronshaugen et al. 2005). Nevertheless, recent work has shown that this same 
miRNA locus can affect larval behaviour dramatically, in which a mutation in this 
miRNA locus makes the larvae unable to correct its position when turned upside-
down. This behaviour is known as “Self-righting” (Picao-Osorio et al. 2015). The 
authors show that the phenotype is caused by a derepression of its target Ubx in 
two metameric neurons of the central nervous system and therefore uncovers 
new behavioural roles for miRNAs, a family of transcriptional regulators that are 
generally not well described in their relation with behaviour. 
This work shows that a mutation in the Drosophila orthologue of CFI25 leads to 
defects in larval feeding, which causes a developmental arrest at the L1 stage in 
these mutants (Chapter 4). This phenotype at the anatomical level is caused by 
defects in the morphology of the CPS as well as defects in food ingestion. At the 
molecular level, four feeding-related genes are affected in the mutant condition 
(Ranbpm, S6k, lov and klu) and can potentially link the observed phenotype with 
CFI25. Previous studies have related a small subset of CPA factors with other 
biological roles. For example, mutations in the Drosophila orthologue of PAP 
leads to defects in the patterning of the adult wing margin. Although the exact 
molecular mechanism was not uncovered in these studies, the authors offered 
evidence for PAP as an important regulator of the Notch signalling pathway in 
Drosophila (Murata et al. 2001; Murata and Ogura 1996). These observations 
demonstrate that, similarly as miRNA iab 4/8, whose molecular function is 
thoroughly described in the literature (Ronshaugen et al. 2005; Pease et al. 2013; 
Bender 2008; Tyler et al. 2008), novel roles for larval behaviour can still be 
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unexpectedly uncovered. Consequently, this work suggests that the CPA 
machinery in Drosophila is potentially another system to be explored in this 
context, which has been largely ignored as a result of doing experiments in vitro, 
where this fascinating aspect cannot be studied. 
6.4 Concluding remarks 
In conclusion, this thesis explores different aspects of the control of APA by 
abundance of core CPA factors, it also explores the biological function of these 
factors for the formation and function of the nervous system. I present a novel 
experimental approach to study the control of APA in the context of multicellularity 
and development, by which new research in the field can take into account this 
layer of complexity to address the mechanisms by which APA operates. These 
findings advance therefore the current understanding of the molecular 
mechanisms that control APA during neural development and identifies one of 
potentially many biologically relevant roles played by the CPA machinery for 
behaviour.  
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Appendix 
 
Identification and characterization of novel factors 
that act in the nonsense-mediated mRNA decay 
pathway in nematodes, flies and mammals 
 
This appendix aims to present a collaboration in which I participated together with 
my supervisor (Dr. Claudio Alonso) between our laboratory and Dr. Javier 
Caceres from the Institute of Genetics & Molecular Medicine at the University of 
Edinburgh (http://www.hgu.mrc.ac.uk/index.html) in the field of RNA processing 
in eukaryotes. This work was published in 2014 in “EMBO Reports” (Casadio et 
al. 2014) and my specific contribution is explained in the following section. 
Additionally, the published manuscript is attached in this thesis. 
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nompA as a novel NMD factor in Drosophila  
NMD is a cellular surveillance mechanism that degrades transcripts with 
premature stop codons, avoiding the translation of truncated proteins which could 
be harmful for the cell, making it a relevant process for animal development 
(Metzstein and Krasnow 2006; Alonso 2005). 
The core factors involved in NMD in Drosophila have been well described in the 
literature (Alonso 2003; Avery et al. 2011). Nevertheless, a new screening for 
novel NMD factors in the model organism Caenorhabditis elegans shows that 
noah-2 is a worm novel NMD factor which has an ortholog with arthropods, but 
not with vertebrates. In Drosophila, the orthologue of noah-2 is nompA (Chung et 
al. 2001), a peripheral nervous system (PNS) specific protein. Our study offers 
evidence for nompA as a novel NMD factor by using a GFP-NMD reporter 
(Metzstein and Krasnow 2006). This contribution is shown in figure 3 of the 
attached manuscript.  
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